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In recent decades, advances in electrophysiological techniques have enabled 
understanding of neuronal network activity, with in vitro brain slices providing insights into 
the mechanisms underlying oscillations at various frequency ranges. Understanding the 
electrical and neuro-pharmacological properties of brain networks using selective receptor 
modulators in native tissue allows to compare such properties with those in disease models 
(e.g. epilepsy and Parkinson’s). In vivo and in vitro studies have implicated M1 in execution 
of voluntary movements and, from both local network in vitro and whole brain in vivo 
perspectives. M1 has been shown to generate oscillatory activity at various frequencies, 
including beta frequency and nested theta and gamma oscillations similar to those of rat 
hippocampus. In vivo studies also confirmed slow wave oscillations in somatosensory 
cortex including delta and theta band activity. However, despite these findings, non-thalamic 
mechanisms underlying cortical delta oscillations remain almost unexplored. Therefore, we 
determined to explore these oscillations in vitro in M1 and S1. 
Using a modified sagittal plane slice preparation with aCSF containing neuroprotectants, 
we have greatly improved brain slice viability, enabling the generation and study of dual 
rhythms (theta and gamma oscillations) in deep layers (LV) of the in vitro sensorimotor slice 
(M1 and S1) in the presence of KA and CCh. We found that theta-gamma activity in M1 is 
led by S1 and that the amplitude of gamma oscillations was (phase-amplitude) coupled to 
theta phase in both regions. Oscillations were dependent on GABAAR, AMPAR and 
NMDAR and were augmented by DAR activation. Experiments using cut/reduced slices 
showed both M1 and S1 could be intrinsic generators of oscillatory activity. 
Delta oscillations were induced in M1 and S1 by maintaining a neuromodulatory state 
mimicking deep sleep, characterised by low dopaminergic and low cholinergic tone, 
achieved using DAR blockade and low CCh. Delta activity depends on GABAAR, GABABR 
and AMPAR but not NMDAR, and once induced was not reversible. Unlike theta-gamma 
activity, delta was led by M1, and activity took >20mins to develop in S1 after 
establishement of peak power in M1. Unlike M1, S1 alone was unable to support delta 
activity. 
Dopamine modulates network activity in M1 and it is known that fast-spiking interneurons 
are the pacemakers of network rhythmogenesis. Recent studies reported that dopamine 
(DA) controled Itonic in medium spiny, ventrobasal thalamus and nucleus accumbens 
neurons by modulation of GABARs or cation channels. In the current study, voltage-clamp 
whole cell recordings were performed in fast spiking interneurons (FS cells) in Layer V of 
M1. These recordings revealed tonic and phasic GABAAR inhibition and when DA was bath 
applied, a slow inward current (IDA) was induced. IDA was mediated by non-specific cationic 
TRPC channels following D2R-like receptor activation. 
Overall, my studies show the strong interdependence of theta-gamma rhythmogenesis 
between M1 and S1, dominanace of M1 at delta frequency and the crucial role of dopamine 
in controlling FS cell activity. Further exploration of these rhythms in models of pathological 
conditions such as Parkinson`s disease and Epilepsy may provide insights into network 
changes underlying these disease conditions. 
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AA Ascorbic acid 
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IPSP  Inhibitory postsynaptic potential 
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1 Introduction 
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1.1 Brain rhythms 
Brain rhythms are voltage fluctuations of electrical activity of neuronal assemblies and are 
shaped by geometry and alignment of those assemblies (Buzsaki, 2006). Hans Berger first 
recorded rhythmic electric signal in humans in 1929 using the electroencephalograph (EEG) 
device. The reliable nature of the EEG device attracted both clinicians and scientists, which 
lead to research into brain rhythms, their mechanisms, origin, and roles in health and 
disease. Nowadays, neuronal voltage changes can be measured by EEG or indirectly via 
magnetoencephalography (MEG) on the scalp and intracranially with subdural electrodes 
(electrocorticography) in vivo. Extracellular local field potential recordings (LFPs; 
mechanisms detailed below) can also detect these rhythms and this approach is widely 
used in vitro alongside single-cell electrophysiology techniques. Brain rhythms are 
categorized depending on frequency band (number of cycles per second, units: Hertz (Hz)). 
Different types of rhythms include: very slow oscillations (<1 Hz), delta (2-4 Hz), theta (4-
11 Hz), alpha (8-13 Hz), mu (7-10 Hz) beta (13-30 Hz), gamma (30-100 Hz) and very fast 
oscillations (>100 Hz) (Steriade et al., 1993; Curio et al., 1994). In LFP experiments, activity 
at different frequency band is measured by their relative power (amplitude of the power 
spectrum). It is evident that brain rhythms are associated with specific brain functional 
activity. For example, research suggests roles in physiological functions such as sleep & 
wakefulness (delta rhythm), memory formation (theta and gamma rhythms) and 
consolidation (delta), cognitive processing and integration (gamma activity; Thallon and 
Bertrand, 1999; Singer, 1999) and in diseases such as Parkinson`s disease, schizophrenia, 
epilepsy, and Alzheimer`s disease (Brown et al., 2001; Herrmann and Demiralp, 2005). 
1.1.1 Neuronal contribution to the LFP 
Local field potential recording (electric potential Ve) is generated by the summation of 
currents flowing in and out (sink and source respectively) of neuronal elements (synapses, 
dendrites and somata) and across the extent of extracellular recording site. The amplitude 
and frequency of LFP activity depends upon contributions from these various current 
sources as well as properties of the brain tissue. Amplitude is inversely proportional to the 
distance (r) between recording site and source. Hence, larger the distance between the 
source and recording site the less information obtained from LFP (see review Buzsaki et 
al., 2012). The most important contributor to LFP is synaptic activity. The overlapping 
activity of several similar compartments induces a measurable signal, which is made 
possible by kinetically slow events like synaptic currents (Elul 1971; Logothetis, 2004 
Niedermayer et al., 2005). Hence, the tree-like structure of neurons formed by soma and 
dendrites with electrically excitable properties affected by several thousand synapses 
provides the basis of LFP signals.  
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Synaptic NMDA and AMPA receptors mediate excitatory events by enabling the flow of 
calcium and sodium ions respectively. Influx of these cations (Ca2+ and Na+) to intracellular 
space from extracellular space creates an extracellular current sink. To achieve electrical 
balance, this sink is balanced by a source. Passive current flows along the neurons as an 
opposing ion flow from intracellular to extracellular space which, together with the original 
sink, forms a dipole. Synaptic GABAA receptors mediate inhibitory currents involving the 
flow of Cl- which creates an active source in the extracellular space and need an intracellular 
sink to achieve electrical balance. However, it is difficult to determine if the identified source 
or sink is active or passive unless the type of synapse is known (Buzsaki et al., 2003, 2006, 
2012). Since the chloride ion equilibrium potential is near to resting membrane potential, 
inhibitory events are assumed to contribute very little to the LFP (Bartos et al., 2007; Koch 
1999). However, inhibitory currents can induce transmembrane hyperpolarising currents in 
fast spiking neurons (when the membrane gets depolarised) and are known to contribute to 
LFP in generating fast oscillations in hippocampus (Trevelyan et al., 2009; Glickfeld et al., 
2009; Oren et al., 2010; Bazelot et al., 2010). Pyramidal neurons also generate strong 
dipoles owing to the separation distance between active sink or source and the return 
current, and have been suggested to contribute greatly to the LFP (Buzsaki et al., 2012). 
Nevertheless, interneurons are significant contributors to LFP where the contribution from 
pyramidal neurons is paced and controlled via inhibitory interneurons, di-synaptically. This 
was reported in invasive studies in cortex of human and monkey (Telenczuk et al., 2017) 
and is consistent with data from hippocampal slices (Bazelot, 2010). Spike waveform 
features such as shape of the spike has enabled the classification of inhibitory (narrow 
spikes) and excitatory (broad spikes) neurons (Peyrache et al., 2012) but exceptions do 
exist such that non-fast spiking interneurons display a broad waveform spike (Fuentealba 
et al., 2008) whilst some excitatory neurons in motor cortex display narrow spikes 
(Vigneswaran et al., 2011). Intracellular and extracellular recordings at synaptic sites of 
excitatory (e.g. NMDAR) and inhibitory (GABAR) receptors are illustrated in figure 1.1. 
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Figure 1.1 An illustration of field potentials at an excitatory and inhibitory at both 
synaptic and non-synaptic sites. 
Intracellular and extracellular recordings shows a rapid EPSP/IPSP at a synaptic site on 
dendrite but a slower and smaller EPSP/IPSP at soma. (A) Source (positive) flows outward 
and inward (negative) sink at synaptic site whilst the opposite is true for inhibitory synapse 
(B) Note the source at synaptic site and sink at soma.
Source: http://clinicalgate.com/electroencephalography/.
Strong currents that are generated across extracellular space are fast action potentials that 
are detected as spikes or ‘units’ (e.g. Koch, 1999). Despite the high amplitude Ve generating 
ability of Na+ spikes, they were thought not to contribute greatly to LFP or EEG (Niedermeyer 
et al., 2005; Nunez et al., 2006) due to their short duration (<2 ms). However, synchronous 
firing from many neurons (population) is known to play a role in high frequency activity 
(Buzsaki et al., 2012) suggesting a role of action potentials in LFP (Pettersen et al., 2008). 
Voltage dependent Ca2+ spikes are often triggered by a back-propagating action potential 
to distal dendrites (lakram et al.,2009) or because of excitatory post synaptic potentials 
(EPSPs) mediated by NMDA receptors (Hirsch et al., 1995; Schiller et al., 2000; Polsky et 
al., 2004; Larkum et al., 2009). Due to their long-lasting nature (10-100 ms) and large power 
(10-50 mV) dendritic Ca2+ spikes are considered to play a role in the LFP (Wong et al., 1979; 
Llinas et al., 1988; Schiller et al., 2000; Stuart et al., 2008). Other non-synaptic contributors 
include voltage dependent intrinsic currents (Ih and IT) in resonance (neuronal ability to 
respond to a frequency band) (Llinas, 1998) and gap junctional potentials. 
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1.2 Gamma oscillations 
Gamma oscillations were first designated as beta-like waves (35-45 Hz) (Jasper and 
Andrews, 1938). Later, they began to be referred to as 40 Hz oscillation (Das and Gastaut, 
1955). Then, in the late 19th century, gamma rhythms were named based on the frequency 
range (30-70 Hz) of oscillations (Bressler and Freeman, 1980) and they have since become 
the most commonly studied type of oscillation in various regions of brain. Many studies have 
been carried out in hippocampus (in vitro and in vivo) due to its clear laminar organization 
and densely packed pyramidal neurons that give rise to high amplitude gamma oscillations 
spontaneously in vitro (Modebadze, 2014, Shah, 2016).  
 
1.2.1 Mechanistic aspects of gamma oscillatory activity 
In vivo studies have reported that there are two rhythm-generating structures in 
hippocampus: dentate gyrus and CA3 (Csicsvari et al., 2003). In vitro pharmacological 
induction methods of gamma oscillations have been demonstrated using approaches such 
as hypertonic potassium solution and tetanic stimulation but the most commonly used 
method is the bath application of cholinergic agonist, carbachol (CCh) and/or kainate 
receptor agonist, kainic acid (KA) or metabotropic glutamate receptor agonist (CHPG) 
(Whittington et al., 1995; Fisahn et al., 1998; Fisahn et al., 2004; Hajos and Paulsen, 2009). 
Gamma oscillations have been  reported in various regions: in hippocampus (CA3 and CA1) 
(Buzsaki et al., 1983; Whittington 1995; ; Bragin et al., 1995; Fisahn et al., 1998 ;Gillies et 
al., 2002; Mann et al., 2005), somatosensory cortex (Buhl et al., 1998) striatum (Berke et 
al., 2004; Tort et al., 2008) entorhinal cortex (Cunningham et al., 2003), amygdala (Sinfield 
and Collins, 2006), cerebral cortex (Middleton et al., 2008), olfactory bulb (Adrian, 1942, 
Freeman, 1975) and primary motor cortex (Johnson et al., 2017). However, the time 
required to induce activity and concentrations of KA and CCh varies with the region and 
slice preparation. ING (interneurons network gamma) (Whittington, 1995; Traub et al., 
1996a) and PING (pyramidal-interneuron network gamma) are the two models proposed as 
mechanisms of gamma oscillations in vitro as illustrated in figure below (Whittington et al., 
2010) both depending on interneuron populations in cortex. (McCormick, 1996; Wang, 
1993; Wang 1999; Minlebaev et al., 2011).  
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Figure 1.2 Schematic representation of acting models of ING and PING. 
1.2.2 ING 
Interneuronal gamma (ING) arises from a neuronal population consisting of only inhibitory 
interneurons in which the important factors include: mutually connected interneurons, a time 
constant mediated by GABAAR, driving current to initiate interneuron spiking in the absence 
of fast phasic excitatory drive (Wang & Rinzel 1992; Whittington et al., 1995; Wang & 
Buzsáki 1996; Traub et al., 1996b;). During ING (figure 1.2), one population (group 1) of 
interneurons fire action potentials (AP), generating IPSC in another connected population 
of interneurons (group2). When the required net excitation of interneurons is available then 
group 2 generates rebound spikes with IPSCs in group 1 and the cycle repeats. This 
recurrent chain of events suggest inhibition to be essential for synchronisation (Van 
Vreeswijk et al., 1994). Oscillatory frequency is strongly determined by the IPSC decay time 
kinetics (Wang and Buzsaki, 1996; Tiesinga and Jose, 2000; Buzsaki and Wang, 2012). 
Hence, a GABAAR modulator, pentobarbital, decreases the frequency of oscillations via 
increased IPSC decay time, confirming the critical role of IPSC kinetics in determining the 
frequency (Segal and Baker, 1984; Fishan et al., 2004). Nevertheless, there is no clear 
understanding of where the source of exciatation in ING model. 
1.2.3 PING 
Pyramidal-Interneuronal gamma (PING) is a mechanism of gamma oscillations based on 
reciprocal interactions between populations of pyramidal and inhibitory neurons (Wilson and 
Cowan, 1972; Freeman, 1975; Leung, 1982; Ermentrout & Kopell, 1998; Borgers and 
Kopell, 2003; Brunel & Wang, 2003; Geisler et al., 2005). These oscillations rely upon 
phasic excitation and inhibition to synchronise (Roopun et al., 2009; Fisahn et al., 1998). 
These oscillations have been suggested to be more persistent than ING like oscillations 
due to their alternative fast excitation and delayed inhibition that occurs in a cyclic manner 
(Buzsaki and Wang, 2012). Like ING model, enhancing IPSC kinetics using pentobarbital 
reduced the frequency and oscillations were abolished upon addition of GABAAR 
antagonist. Hence, GABAAR mediated IPSC decay time determines the frequency of the 
oscillations (Freeman, 1975, Leung, 1982) which is now known to be a characteristic feature 
of PING both in vivo and in vitro (Mann et al., 2005; Hájos and Paulsen, 2009; Bragin et al., 
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1995; Csicsvari et al., 2003; Hasenstaub et al., 2005; Tiesinga and Sejnowski, 2009). Unlike 
ING model, PING like oscillations were found to be dependent on AMPAR due to the 
reliance on excitatory drive (Cunningham et al., 2003). Interestingly, pharmacological 
manipulation of IPSC kinetics has shown to have comparatively more impact on frequency 
of ING, suggesting the stability of the network was enhanced upon the recruitment of 
pyramidal cells in PING (Whittington et al., 2000). 
1.2.4 Evidence for ING and PING in vivo and in vitro 
In vitro ING-like mechanism was first observed in CA1 in the presence of the metabotropic 
glutamate receptor agonist, DHPG or high potassium solution plus blockade of ionotropic 
glutamate receptors (Whittington et al., 1995; Traub, 1996; LeBeau et al., 2002; Whittington 
et al., 2010) and also by bath application of KA (Fisahn et al., 2004). Cholinergically induced 
PING like mechanisms have also been identified in hippocampal and cortical slices (Fisahn 
et al., 1998) and KA and CCh also induced the same (Whittington, 2010; Modebadze, 2014; 
Nicholas, 2016). Further studies (Fuchs et al., 2007) have shown that the amplitude of 
gamma oscillations was decreased when AMPAR expression was genetically knocked 
down, presumably due to disturbed interaction between pyramidal and interneuron cells. 
Depolarising cortical interneurons by optogenetically exciting ChR2 channels in vivo has 
shown an increase in gamma amplitude when recording extracellularly whilst a decrease in 
gamma power was observed by hyperpolarising interneurons via halorhodopsin (Sohal et 
al., 2009). It was also reported that when random light pulses were used to drive 
interneurons in vivo, power in the gamma frequency range was enhanced in comparison to 
other frequency bands (Cardin et al., 2009). However, many studies suggest ING to be an 
artefact since the source of excitation is unknown which needs further exploration. 
1.3 Theta oscillations 
Theta rhythm with a frequency range of 4-10 Hz has been the subject of many investigations 
in the rodent hippocampus (Bland, 1986; Bland et al., 2002; Cunningham et al., 2003; 
Jacobs, 2010; Jacobs, 2014). Previous studies have defined hippocampal 1-4 Hz as delta 
(Clemens et al., 2013), as theta (Fell et al., 2003) and also theta/delta (Mormann et al., 
2008) and discrepancies still exist. Despite these issues relating to frequency banding, 
hippocampal 1-4 Hz and 4-8 Hz oscillations found in human and rodents respectively have 
been reported to have functional similarities in that they exhibit an activation during 
navigation and memory tasks and show analogous coupling pattern with gamma oscillations 
(Ekstrom et al., 2005; Jacobs, 2014).  
Hippocampal theta in rodents can be divided into two types: atropine sensitive theta (4-9 
Hz) which is associated with automatic movement and atropine insensitive theta (6-12 Hz) 
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which is found during voluntary movements (Vanderwolf, 1969; Kramis et al., 1975).  Since 
Local field potential is the summation of EPSPs and IPSPs on the soma and dendrites of 
pyramidal cells it is assumed that theta activity is the interplay between two different dipoles 
(current generators). One being the excitatory input received by pyramidal cells and the 
other being inhibitory input from GABAergic neurons (Buzsaki, 2002). The role of theta 
oscillations in spatial memory was demonstrated by behavioural studies in which specific 
pattern at theta frequency corresponds to firing of place cells corresponding to visual cues 
(O`Keefe, 1976) and the phase relationship between spiking and theta activity of place cells 
was identified to shift depending on the location (O`Keefe and Reece, 1993), suggesting 
that location was encoded by phase precession. 
 
1.4 Phase-amplitude coupling (PAC) 
Studies have demonstrated that certain brain functions such as cognition are achieved by 
simultaneous activity in multiple frequency bands (Schutter and Knyazev, 2012). It is 
evident that each frequency band plays a specific role in functional aspects like perception 
and cognition (Cohen, 2008) but further insight may be provided by uncovering the relation 
and interaction between different frequency band oscillations (Jensen and Colgin, 2007). 
Such interaction is termed cross-frequency coupling (CFC) which has received greater 
interest in recent years in the field of neuroscience. CFC has been identified in signals 
obtained from LFP, electroencephalogram, electrocortigram recordings (Bragin et al., 1995; 
Lakatos et al., 2005; Canolty et al., 2006; Demiralp et al., 2007; Jensen and Colgin, 2007; 
Cohen, 2008; Kramer et al., 2008; Young and Eggermont 2009). 
CFC was categorised in two forms: phase-amplitude coupling (PAC) and phase-phase 
coupling (PPC). The former is the type of CFC investigated in this thesis. PAC is also known 
as nested oscillations in which the phase of low frequency oscillations (example: theta) 
determines the power or amplitude of high frequency oscillations (example: gamma). Thus, 
amplitude of high frequency oscillation (nested) is synchronised with the phase of low 
frequency oscillation (nesting) (Palva et al., 2005). This type of CFC enables observation of 
the inter-frequency relationship aspects that correspond to low frequency and the amplitude 
of higher frequency components of local cortical circuit (Canolty and Knight, 2010). 
Behavioural studies have suggested that PAC is involved in sensory integration, 
attentiveness and memory organisation (Lisman and Idiart, 1995; Lisman, 2005; Schroeder 
and Lakatos, 2009; Voytek et al., 2010). Several brain regions have been reported to show 
PAC, including hippocampus (Bragin et al., 1995), neocortex (Canolty et al., 2006) and 
basal ganglia (Cohen et al., 2008) and PAC is evident in rodents (Bragin et al., 1995; Tort 
et al., 2008), sheep (Nicol et al., 2009) and monkeys (Lakatos et al., 2005) as well as in 
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humans (Cohen et al., 2008), Schematic representation is shown in figure 1.3. Note from 
the figure that the amplitude of fast oscillations is always greatest at a certain phase of low 
frequency oscillation, this is called the coupling phase. 
Figure 1.3 Representative PAC 
Top trace is the sum of both (fast and slow) oscillations in 
which the amplitude of fast oscillations corresponds to the 
phase of slow oscillation. 
Figure 1.4 Illustration of phase-amplitude coupling analysis with different modulation 
indices (cases 1-4).  
(A) Left traces are the example summation of fast and slow oscillations (top traces) and
filtered data of coupling strength (bottom traces), right traces are the corresponding phase-
amplitude analysis graphs (B) bar graph of corresponding modulation index of all cases (1-
4). Note greater the coupling strength greater the modulation index. Obtained from Tort et
al., 2010 for illustration purposes.
Several methods of measuring PAC have been reported (Canolty et al., 2006; Tort et al., 
2010) but each of them have advantages and disadvantages. The figure 1.4 illustrates 
phase amplitude coupling analysis and corresponding modulation index of theta and 
gamma taken as an example. In this thesis, the method and Matlab scripts provided by Tort 
et al., 2010 were used for PAC analysis (see results chapter 3). 
28 
1.5 Oscillatory patterns during sleep 
Various sleep stages were first described by Loomis et al., (1937) who demonstrated the 
spectrum of EEG from wakefulness to deep sleep. In the 1950, REM (Rapid Eye Movement) 
stage was distinguished and sleep stages were reclassified as NREM (Non-Rapid Eye 
Movement) and REM stage (Dement and Kleitmen, 1957). Various rhythmic patterns were 
described in thalamocortical systems during sleep stages, including infra-slow: 0.02-0.1 Hz, 
slow (0.2-1 Hz), delta (1-4 Hz), spindle (12-14 Hz) theta (3-7 Hz), and fast: 20-60 Hz and 
ultra-fast: 100-600 Hz (Bazhenov and Timofeev, 2006). 
Figure 1.5 Elucidating the EEG recordings during various stages from awake to deep 
sleep stages and the associated oscillations during each stage. 
Low amplitude but high frequency oscillations were identified in wakeful stages and REM 
stages whereas, high amplitude low frequency oscillations were characterized in deep sleep 
stages. Source: Hockenbury and Hockenbury 2010. 
Five stages of sleep cycle were characterized in humans. The first four stages are grouped 
as (NREM) sleep stage with last deepest one (stage 4) is punctuated by episodes of REM 
(Rechtschaffen and Kales, 1968) as illustrated in figure 1.5. 
The sleep cycle is known to progress in following order, N1-N2-N3-N4-REM (Feinberg and 
Floyd, 1979). Stage 1 is a transitional stage between sleep and waking and is associated 
with low voltage EEG with mixed frequencies at alpha (4-7 Hz) and theta (7-10 Hz) band. 
Alpha oscillations are often seen in this relaxed state (Carskadon and Dement, 2011) and 
this stage lasts about 1-7 minutes, constituting about 2% of the sleep cycle. Stage 2 
comprises sleep spindles (10-17 Hz), K+ complexes, typically constitutes about 45-55% in 
adults (even more in young adults) of sleep cycle and lasts about 20-30 minutes. Stage 3 
consists of a mixture of theta and delta waves of frequency 0.1-1 and 1-4 Hz. Stage 3 occurs 
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longer periods during initial sleep cycles. This stage is characterized by the lowest breathing 
rate and blood pressure with increased dreaming (Carskadon and Dement, 2011) and delta 
activity. Stage 4 is defined by high amplitude delta oscillations (2-4 Hz). Stage 3 and 4 are 
often described as slow-wave or delta sleep stage and represents 15-20% of sleep cycle. 
EEG recordings revealed that these stages are characterised by ‘up’ and ‘down’ states of 
cortex in which neurons in cortex are depolarised in ‘up’ state and may fire action potentials 
whilst ‘down’ state is when the cells are hyperpolarised and do not fire (Steriade et al., 1991, 
1993a, 1993b, 2001; Contreras and Steriade, 1995; Werth et al., 1996; Timofeev et al., 
2000a, 2000b, 2001; Molle et al., 2002; Clemens et al., 2007). Stage 5 (REM stage), which 
lasts for 5-15 minutes is an indication of end of NREM stages and is characterized with 
rapid eye movements, loss of muscle tone and dreaming. It is thought that sleep stages 
always begin with NREM stages (lasts about 50-70 minutes) followed with REM (5-25 
minutes) stage in a cyclic manner for about four times every night (Rechtschaffen and Kales, 
1968; Amzica and Steriade 1998; Carskadon and Dement, 2011). REM sleep was found to 
be dominant during later cycles of sleep whilst N3 and 4 are dominant in earlier cycles 
(Aeschbach and Borbely, 1993). 
 
1.6 Delta oscillations and sleep 
The delta rhythm was first described by Walter in 1936 as a specific slow wave recorded 
during an EEG investigation of pathological tumours. The frequency range for delta wave 
activity is between 0 and 4 Hz as implicated in International Federation of Societies for 
Electroencephalography and Clinical Neurophysiology (IFSECN) (1974). However, 
frequency ranges such as 1-4 Hz (Ursin, 1968), 0.5-4 Hz (Frost and Kellaway et al., 1966), 
0.5-5 Hz (Gibbs and Gibbs, 1951) and 0.1-3.5 Hz (Niedermeyer 1999) are often mentioned 
in the literature. A wide range of research has been carried out to disclose the relation 
between the EEG and cellular mechanisms (Creutzfeldt et al., 1966; Frost and Kellaway et 
al., 1966; Rappelsberger et al., 1982). There is more than one phenomenon in the 
frequency range of 0-4 Hz which includes slow oscillations (<1 Hz) and delta (1-4 Hz) 
oscillations. Several studies are available demonstrating the origins of slow-wave 
oscillations (<1 Hz) in thalamus (Crunelli and Hughes, 2010) neocortex (Compte et al., 
2003; Shu et al., 2003; Hasenstaub et al., 2005; Haider et al., 2006), in cortex (Sanchez-
Vives and McCormick, 2000) yet very little is known about delta oscillations in terms of origin 
and mechanism underlying the rhythm at 2-4 Hz, though it is assumed that there are at least 
two types such as thalamic and cortical delta oscillations, depending on the source of origin. 
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1.6.1 Thalamic delta oscillations 
Thalamic delta oscillations were characterized in vivo in motor, sensory, association and 
intralaminar thalamic nuclei of cats (Steriade et al., 1991b; Dossi et al., 1992) and in vitro in 
neurons of the rodent lateral geniculate (LG) (McCormick and Pape, 1990; Leresche et al., 
1990). The rhythmicity in these oscillations is generated intrinsically as a result of interplay 
between two inward currents of thalamic relay neurons: low-threshold Ca2+ current (IT) and 
hyperpolarisation activated cation (Na+ and K+) current (Ih). Long-lasting hyperpolarisation, 
below -65 mV in a neuron of thalamus activates slow Ih, which causes depolarisation of 
membrane potential which activates IT, generating a Ca2+ spike which in turn triggers a burst 
of high frequency Na2+ action potentials. Ih is deactivated and IT is inactivated during the 
burst of spikes and burst termination is followed by hyperpolarising overshoot mediated by 
a Ca2+-dependent afterhyperpolarising K+ current (IKCa). During bursts, both Ih and IT are 
deactivated and inactivated because of voltage dependency and transient nature 
respectively. The post-burst after hyperpolarisation (AHP) activates Ih and starts the next 
cycle of oscillations (McCormick and Pape, 1990). This mechanism is illustrated in figure 
1.6. 
Figure 1.6 Intracellular mechanism of thalamic delta oscillations (adapted from 
McCormick and Pape 1990). 
Ih is sensitive to both voltage and Ca2+ concentration, the fluctuations in Ca2+ concentration 
can alter the strength of Ih. This converts delta activity into a waxing/waning pattern which 
is like that of thalamocortical neurons in intact cat (Dossi et al., 1992) and changes to clock-
like after neocortex removal (Timofeev et al., 2000). Moreover, similar activity of rebound 
bursts at delta range was also noticed in thalamic slice preparations (McCormick and Pape, 
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1990; Leresche et al., 1990; Soltesz et al., 1991) and in single neurons of computer models 
(Toth and Crunelli, 1992; Destexhe et al., 1993; Wang, 1994). 
1.6.2 Cortical delta oscillations 
Early studies reported delta oscillations in isolated cortex of cats (Frost and Kellaway et al., 
1966) and of neocortical origin after thalamectomy (Villablanca and Salinas-Zeballos, 1972; 
Villablanca, 1974). In addition, Ball et al., demonstrated that the delta oscillations emerge 
in between ll/lll and V layers of cortex (Ball et al., 1977). Cortical delta is far less well 
understood than thalamic delta. Some studies suggest that thalamic delta is independent 
of cortical delta rhythm as it existed after decortication (Steriade et al., 1985; Pare et al., 
1987). On the other hand, delta oscillations were desynchronised after decortication proving 
that the thalamic delta is synchronised by long-range cortical connections (Timofeev and 
Steriade, 1996). These controversial reports suggest the need for further investigation of 
cortical delta rhythm. Nevertheless, a recent study in slices containing secondary 
somatosensory/parietal area S2/Par2 has enabled pharmacological induction of delta 
oscillations first time in vitro by maintaining a neuro-modulatory state equivalent to that of 
sleep (Carracedo et al., 2013). 
1.7 Primary motor cortex (M1) 
The primary motor cortex (M1) contributes greatly to the execution of voluntary movements 
and motor learning (Rioult-Pedotti et al., 1998). In early studies, Penfield and Boldrey used 
low intensity micro-stimulation of M1 in human surgical patients to show its organization in 
a somatotopic manner of leg, arm, head and face, which was termed the “Motor 
Homunculus” (Penfield and Boldrey, 1937). The homunculus elucidates a somatotopic M1 
map with each area and corresponding body parts (see figure 1.7). In 1968 Stoney et al., 
(1968) followed up the studies in M1 using the intra-cortical electrical stimulation method. 
This technique enabled various researches to investigate and prove the topographic 
organization in M1, where the microelectrode was inserted into M1 and moved in small 
steps across the area (Asanuma and Ward, 1971; Kwan et al., 1978; Donoghue et al., 
1992). However, areas associated with body parts showed overlap and were also widely 
spread and/or were present in multiple representations (Nudo et al., 1992; Sane and 
Donoghue, 2000). This functional overlapping was further established by various imaging 
techniques (positron emission tomography (PET) and functional magnetic resonance 
imaging (fMRI)) (Colebatch et al., 1991) and, hence, the homunculus is perhaps too simple 
a representation of motor somatotopy. Pyramidal cells form 70% of the neuronal population 
in M1 (Sloper et al., 1979). Moreover, a greater diversity in size of pyramidal cell is observed 
in M1 than in any other cortical area. For instance, there is a fourfold range of pyramidal 
cell body area in precentral gyrus compared to a tenfold range of pyramidal cell body area 
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in M1 (Jones and Wise, 1977). M1 is oriented in vertical columnar pattern which comprises 
of five horizontal layers: superficial (l,ll&lll) and deep (V,Vl) layers. 
Figure 1.7 Somatotopic representation of the sensory and motor cortical 
representation of body regions. 
Note the extensive representation of the hands in the motor map. Source: Joseph R (2000) 
http://brainmind.net/BrainLecture5.html. 
1.7.1 Layer l 
Layer l (Ll) is termed as the plexiform layer, and is known to be devoid of excitatory 
pyramidal neurons (Chu et al., 2003). Hence, it is mostly comprised of inhibitory 
interneurons (Gabbott and Somogyi, 1986) which provide inhibitory input to pyramidal cells 
in other layers (Chu et al., 2003). Douglas and Martin identified two structurally different 
interneurons such as Retzius-Ccajal neurons and small neurons in Ll. This layer possesses 
axons from Lll-Vl and receives inputs from other cortical areas and thalamus (Douglas and 
Martin, 2004). 
1.7.2 Layer ll/lll 
Layer ll (Lll) and Layer lll (Llll) are termed as external granular layer and external pyramidal 
layer respectively. Both pyramidal and non-pyramidal cells were characterised in Lll/lll. 
Pyramidal cells receive inputs from S1 and send axon collaterals either to LV or are confined 
to Lll/lll. Non-pyramidal cells do not possess apical dendrites and are categorised into fast 
spiking (FS), late spiking (LS), low threshold spiking (LTS), and regular spiking non-
pyramidal cells (RSNP) (Kawaguchi, 1995) in these layers. Douglas and Martin reported 
that cells Lll/lll have dense thalamic axonal inputs and bear receptors for various 
neuromodulators including 5-HT, dopamine, and noradrenaline (Douglas and Martin, 2004). 
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1.7.3 Layer lV 
M1 has always been considered to be agranular (Brodmann, 1909; Shipp, 2005; Bastos et 
al., 2012; Shipp et al., 2013) due to the apparent absence of an anatomically definable LlV 
(Donoghue and Wise, 1982; Beaulieu, 1993; Zilles et al., 1995) which makes it unique 
compared to other cortical regions. However, several recent studies (Krieg, 1946; von 
Bonin, 1949; Caviness, 1975; Deschênes et al., 1979; Skoglund et al., 1997; Cho et al., 
2004, Kuramoto et al., 2009; Rowell et al., 2010; Mao et al., 2011; Kaneko, 2013; García-
Cabezas and Barbas, 2014; Yamawaki et al., 2014) suggest the existence of connectivity 
patterns that are like those of LlV in other sensory regions, despite the lack of cyto-
architectural visibility of this layer. The cells present in a thin area between Llll and LVa in 
mouse have been identified to have synaptic connections like LlV which includes: excitatory 
projections from thalamus, long range corticocortical projections and excitatory projections 
to Lll/lll (Yamawaki et al., 2014). Interestingly, LlV of M1 does not contain stellate cells that 
were present in sensory regions but instead have pyramidal type neurons across a thin 
laminar zone (Yamawaki et al., 2014; Barbas et al., 2015).  
1.7.4 Layer V 
Layer V (LV) is called the internal pyramidal layer and is characterised by the presence of 
large, special cells called Betz cells (Betz, 1894) which is the unique feature of LV in M1 
(but like the large Meynert cells of deep primary visual cortex (V1)). Betz cells occupy a 
large volume in deep layers of M1 and have giant cell bodies (Meyer 1987) and make up 
12% of the pyramidal cell assemblies (Rivara et al., 2003). Also, these cells are 
heterogeneous in structure and therefore exist not just pyramidal form but also triangular 
and spindle like forms (Braak, 1976). The smaller pyramidal cells are known to possess 
prominent apical dendrites which project to the pial surface and have terminations in 
superficial layers of M1 (Cho et al., 2004) whilst the axons from these cells projects to spinal 
cord. Those large cells in LVa project their axons to basal ganglia (BG) (Lei et al., 2004) 
and their apical dendrites receive input from Lll/lll (Kaneka et al., 2000). 
1.7.5 Layer Vl 
Layer Vl is called the fusiform layer. It has been demonstrated that many of pyramidal cells 
in this layer have their inputs from, and projections to thalamus (Kaneka et al., 2000). 
Colossal interneurons form a source of input to pyramidal and non-pyramidal cells in this 
layer (Karayannis et al., 2007). Parvalbumin (PV) positive interneurons are also prominently 
identified in this layer. 
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1.8 Cortico-cortical and sub-cortical connections 
Major cortico-cortical connections (as represented in figure 1.8) in rats are granular S1 
(transfers contralateral and ipsilateral sensorimotor signal), S2-PV region somatosensory 
cortex (dysgranular) of both same and contralateral cerebral hemisphere (White and 
DeAmicis, 1977; Porter and White, 1983; Welker et al., 1988) contralateral M1 had callosal 
connections. Sub-cortical reciprocal connections (as indicated in Fig 3B) are found with 
motor thalamus (Ventral lateral thalamus), reticular thalamic nucleus, central lateral nucleus 
(cerebello-thalamic pathway) and Zona inserta (regulatory inputs in and out M1) (Donoghue 
and Parhan, 1983; Koralek et al., 1990; Reep et al., 1990; Fabri and Burton, 1991; Rouiller 
et al., 1993; Izraeli and Porter, 1995; Hoffer et al., 2013). 
Figure 1.8 Cortical and subcortical connections of M1 in rats and mice 
A) Representation of cortical connections. S1-somatosensory cortex, dysgranular
somatosensory cortex, PP-posterior parietal cortex, S2-second somatosensory area, PV-
parietal ventral somatosensory cortex, M2-second motor area, V1-primary visual cortex. B)
Subcortical connections of M1 in rats and mice. VL-Ventral lateral nucleus, CL-central
lateral nucleus, RT-reticular nucleus, ZI-Zona inserta. Other connections to spinal cord and
brain stem. Arrows indicate reciprocal connections. Adapted from: Young N et al., 2012
Motor cortex. The mouse nervous system.
1.9 Intrinsic laminar organisation of M1 in rats 
It is thought that the major ascending pathway is LVa to Lll/lll and the dominant descending 
pathway is from Lll/Llll to L Va (Weiler et al., 2008). It is assumed corticocortical connectivity 
is obtained from cells in both deep and superficial layers whereas thalamocortical output is 
onto deep layers. Photo-stimulation techniques recently revealed excitatory circuits (Weiler 
et al., 2008) connecting to various regions. Synaptic transmission is regulated by calcium 
binding protein containing interneurons which include parvalbumin (PV), calbindin (CB), and 
calretinin (CR) expressing cells in rats and mice (Celio 1990; Van Bredrode et al., 1991; 
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Resibois and Rogers 1992; Mucignat-Caretta et al., 2002) most of these neurons appear in 
two bands which correspond to Lll/lll and LV/VI. In spite of well-established long-range 
connections between M1 and other regions of cortex as well as M1 and sub-cortical 
connections in rodents, far less is known about intrinsic circuit organization in rat M1 
compared to other cortical regions. 
1.10 Primary somatosensory cortex (S1) 
Brain architecture studies were started in 20th century (Broadmann, 1909; Vogt and Vogt, 
1919; Von Economo, 1929) but only in the middle of this century were various sensory parts 
of the brain like auditory cortex, visual cortex, and somatosensory cortex described 
(Woolsey et al., 1946, 1958). Primary somatosensory cortex (S1) which is also called a 
Broadmann Area 3b and consists of a mediolateral strip of cortex that extends from the 
medial wall of the cerebral hemisphere towards the lateral sulcus, where it curves anterior 
and ends on the ventral surface of the frontal cortex. S1 is known to share a similar 
anatomical structure within various species except the absence of barrel cortex in humans. 
1.10.1 Layer l 
L1 of S1 is known to contribute to modulating feed forward transfer of information from 
thalamus (Galazo et al., 2008) but does not contain pyramidal cells (Ren et al., 1992). Also, 
known to have reciprocal connections with the arborizing pyramidal tufts of Lll (Zhu and 
Zhu, 2004). 
1.10.2 Layer ll/lll 
Lll and lll have high proportion of pyramidal cells, densely packed but no apical dendrites in 
Lll whilst there are apical dendrites in Llll that extend to Ll. Inputs to Lll are from LIV and LV 
whereas Llll inputs are only from LIV (Lefort, 2009), but outputs extend to LVa and LVI. Lll 
is known to process long range connections to M1 (Alloway, 2008) 
1.10.3 Layer IV 
LIV also known as Barrel cortex in rodents contains star pyramidal cells and spiny stellate 
cells. Input projections are known to be from lemniscus thalamus (Gibson et al., 1999; 
Bureau et al., 2006) and from neurons within same column (Feldmeyer et al., 1999; 
Petersen and Sakmann, 2000) besides intracolumnar projections and trans-columnar 
projections form LlV (Schubert et al., 2003; Egger et al., 2008; Staiger et al., 2009;). 
Doughlas and his colleagues described “canonical microcircuit” which is a closed loop 
comprising of series of excitatory feed forward connection, which were innervated by 
thalamus LIV via the lemniscal pathway which in turn projects to Lll and Llll (Douglas et al., 
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1989). In rodents, every whisker is characterised by well-structured arrangement almost 
similar to whisker layout (Woolsey and Vander Loos, 1970). 
1.10.4 Layer V 
LV receives feedback from LVI (Mercer et al., 2005). LVa constitutes medium principal 
neurons projecting to M1 and striatum (Alloway, 2008), connections have been reported 
from the layer itself as well as LlV. LVb contains very large pyramidal cells (Schubert et al., 
2001) and IB neurons which are involved sub-cortical connections (de Kock and Sakmann, 
2008). Projections from this layer have been identified to be thalamus to trigeminal nucleus 
and spinal cord. 
1.10.5 Layer VI 
Layer Vl in S1 is characterised as LVIa and b. whilst the former contain spiny pyramidal 
neurons LVIb contains fewer neurons and is known to intermingle with horizontal pathways 
(Clancy and Cauller, 1999). Input projections to this layer are from LV and LlV (Mercer et 
al., 2005; lefort et al., 2009) and output projections are reciprocally connected to thalamus, 
reticular nucleus and ventrobasal nucleus (Ledergerber and larkum, 2010) 
1.11 Sensorimotor circuit 
Mao et al., managed to sketch a vibrissal sensorimotor loop in mice (Mao et al., 2011) by 
assembling their long-range connections with local cortical circuits (Lefort et al., 2009; Sato 
and Svoboda, 2010; Hooks et al., 2011) and thalamocortical circuits (Lu and Lin, 1993; 
Bureau et al., 2006; Petreanu et al., 2009; Meyer et al., 2010b). When some external input 
triggers sensory neurons in trigeminal ganglion activity passes via the brain stem, VPM and 
to LIV of S1 (Petersen 2007; Sato and Svoboda, 2010). LIV projections activate Lll/lll which 
in turn activates LVb (Armstrong-James and Fox, 1987; Brecht and Sakmann, 2002; Brecht 
et al., 2003; Manns et al., 2004; Lefort et al., 2009; Hooks et al., 2011). Projections from 
Lll/lll and LVa connect to M1 with strong targets mostly in upper layers such as Lll/lll and 
LVa but also have weak projections to LVb and LVl (Mao et al., 2011). Lll and LVa which 
receive strong input from S1 reciprocate projections back to S1 unto Lll/lll, LVa and strong 
synapses were found in LVb (Petreanu et al., 2009) making a dual synaptic feedback loop 
(S1, L2/3/5A ←→ M1, L2/3/5A) creating connection between M1 and S1 as described in 
figure 1.9. 
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Figure 1.9 Sensorimotor circuit representing reciprocal and long-range connections. 
Trans-cortical projections from M1 to S1 are represented in purple and red for projections 
from S1 to M1. Intra-cortical projections are denoted in blue, Lll/lll to LVa, Lll/Llll to LVa and 
LVb in M1, LIV to Lll/lll, Lll/lll to LVb, LVa to Lll/lll in S1. Thickness of the lines represent 
connection strength. Targets of M1 include (LVb and LVl to PO (posterior thalamic nucleus) 
magenta, brainstem nuclei (LVb to BS, green), superior colliculus (LVa and LVb to SC, 
cyan), Zona inserta (LVa and LVb to ZI, orange). Adapted from Mao et al., 2011. 
1.12 Types of cells in cortex 
Neurons in cortex are categorised as excitatory (glutamatergic/principal) pyramidal or 
stellate cells (pyramid or star-like like morphology) and inhibitory (GABAergic) non-
pyramidal interneurons cells. In cortex, principal cells constitute about 80 % (Gao and 
Zheng, 2004; Halabisky et al., 2006) whilst the rest comprises interneurons which play a 
critical role in regulating cortical activity and rhythmogenesis (Beaulieu et al., 1992). 
1.12.1 Pyramidal cells constitute most of the neuronal population and are known to be 
prime output cells in M1 (Sloper et al., 1979). These cells also contribute to excitatory inputs 
within the local circuit in M1 due to the presence of axonal collaterals (Douglas and Martin, 
2004). Electrophysiological studies in rats revealed two types of pyramidal cells in 
sensorimotor slices (Connors et al., 1982; McCormick et al., 1985; Van Brederode and 
Snyder; 1992; Chen et al., 1996). Intrinsically bursting (IB) neurons are identified by their 
bursts of spikes followed by non-adapting and low frequency action potentials. In contrast 
to regular spiking (RS), pyrmaidal cells show adaptation in spike frequency (Chen et al., 
1996). 
Layer V of M1 is characterised with specialised large, pyramidal cells called Betz cells like 
Meynert cells in visual cortex (Betz, 1874). Betz cells are 20 times the size of other 
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pyramidal cells in deep layers of cortex and constitute up to 12 % of total pyramidal 
population (Rivara et al., 2003). Betz cells are classified into two types depending upon their 
projections. Type I cells have thick, tufted apical dendrites and perform intrinsic burst firing 
activity (Molnar and Cheung 2006) and have their projections to striatum, superior colliculus, 
spinal cord and basal pons. Type ll Betz cells are always regular spiking and have slender 
and obliquely aligned apical dendrites (Molnar and Cheung, 2006). These cells have their 
projections to ipsilateral striatum or contralateral hemisphere. Betz cells are further 
categorised depending on the increase or decrease of firing rate upon the injection of 
hyperpolarising current (Spain 1991a, 1991 b, 1994). Betz cells are larger but fewer in the 
superficial region (LVa) than in deep area (LVb).  
1.12.2 Interneurons constitute a minority of the population yet are crucial for controlling 
network activity by forming short range connections and are known to inhibit the target cells 
by releasing GABA (McBain and Fishan, 2001; Somogyi and Klausberger 2005). 
Interneurons are often categorised based on morphology, physiology, histology but it is 
rather difficult to categorise them using electrophysiological methods due to overlapping 
characteristics (Kawaguchi, 1993; Jones, 1993; McBain and Fisahn, 2001). Broadly 
speaking, however, electrophysiological classification in M1 has revealed four types of 
interneurons: low threshold spiking (LTS), fast spiking cells (FS), regular spiking non-
pyramidal cells (RSNP) and late spiking cells (LS) (Kawaguchi and Kubota, 1997) as 
described in table below. 
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Cell type RMP (mV) Spike 
width 
(ms) 
Neurochemical 
substances 
Morphological 
type 
Synaptic 
targets 
FS -77.4- -
73.0 
0.43-0.59 parvalbumin, 
cholecystokinin 
basket, 
chandelier 
soma, AIS, 
thick 
dendrites 
RSNP -66.0- -
60.06 
0.75-1.06 somatostatin Martinotti thin 
dendritic 
branches 
LTS, 
BSNP 
~-57.5 0.94 VIP, calrectin, 
NPY 
double bouquet dendrites, 
soma 
LS ~-67.2 0.77 calbindin neurogliaform dendritic 
spines 
Table 1.1 Types of interneurons that M1 may contain and their properties 
Various types of cells based on electrophysiological properties: FS (fast spiking), RSNP 
(regular spiking non-pyramidal), LTS (low threshold spiking), LS (late spiking). 
Neurochemical classification (immune positive to): parvalbumin, cholecystokinin, 
somatostatin, calrectin, calbindin. Morphological classification (based on the shape): 
Basket, chandelier, Martinotti, double bouquet, Neurogliaform. RMP: resting membrane 
potential (mV) FS<LS<RSNP<LTS, and spike width (ms), FS<LS≤RSNP<LTS. 
(Kawaguchi, 1995; Halasy et al., 1996; Kawaguchi and Kubotoa, 1997; Cauli et al., 1997).  
Fast spiking cells (FS) are basket and chandelier type which fire at high frequency (non-
adapting) upon depolarising current. They exhibit short half-width action potentials (AP) but 
large afterhyperpolarisation (AHP). FS cells are immunopositive for parvalbumin and 
cholecystokinin proteins (Kawaguchi, 1993a, 1993b; Kawaguchi, 1995; Kawaguchi and 
Kubota, 1997; Galarreta and Hestrin, 2002). Late spiking (LS) are neurogliaform cells with 
symmetrical dendrites. They show a delay in onset of action potential preceded by slow 
ramp to threshold level (Chu et al., 2003). Firing can be generated from hyperpolarised and 
depolarised states and they also show non-adapting patterns of firing. These cells are 
immunopositive to calbindin. (Kawaguchi, 1995; Kawaguchi and Kubota, 1996). Low 
threshold spiking (LTS) are double bouquet-like cells, immunopositive for calretinin. These 
cells show multiple spike behaviour on current injection (Kawaguchi and Kubota, 1997; 
McBain and Fisahn, 2001). Regular spiking non-pyramidal cells (RSNP) are different to 
those that are described above. Regular and adapting spike behaviour was noticed 
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displaying two groups based on the “notch” after spike behaviour upon application of 
depolarising current (Kawaguchi and Kubota, 1996, 1997 and 1998). 
1.12.3 Inhibition in cortex 
Synaptic inhibition in cortex is present in diverse groups of GABAergic interneurons (as 
described above in 1.12.2 section) and are classified based on their morphology, chemical 
and electrical properties (Fishell and Rudy, 2011). There are distinct subtypes of 
interneurons based on the chemical they produce which include: Parvalbumin (PV) 
neurons, somatostatin (SOM) neurons, vasoactive intestinal polypeptides (VIPs) producing 
neurons and calbindin (CB) in mouse neocortex (Xu et al., 2010).  PV neurons are identified 
to target cell bodies and proximal dendrites of pyramidal cells to control pyramidal activity 
(Thomson and Lamy, 2007, Tanaka et al., 2011). The mutual connections between basket 
shaped fast spiking neurons have also been reported to be primarily on soma and proximal 
dendrites in majority of populations by performing paired recording experiments and light 
microscopic analyses (Gupta et al., 2000; Tamas et al., 2000). However, immunoreactivity 
for connexin36 protein has revealed that gap junctions were distributed not just on proximal 
but the distal dendrites in rat neocortex (Fukuda and Kosaka, 2003; Fukuda et al., 2006). 
Martinotti cells which are SOM producing cells target distal dendrites of pyramidal cells 
(Kawaguchi and Kubota, 1997). VIP+ and CR+ neurons have known to modulate local 
SOM+ cells enabling dendritic disinhibition to pyramidal neurons in cortex (Lee et al., 2013) 
and this disinhibition was found to be engaged in specific behavioural states. The activity of 
VIP+ cells was high in S1 during whisking (Lee et al., 2013) 
1.13 Neurotransmitters, receptors and mechanism of action in cortex 
1.13.1 GABA 
γ-Aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the mammalian 
central nervous system (CNS) (Bormann, 2000) which controls neuronal firing, network 
oscillation and regulates excitability of neurons (Kullmann et al., 2012). GABA was identified 
in brain tissue in 1950 (Roberts, 1950; Awapara, 1950) but the inhibitory action of GABA 
was only identified in 1956 by Takashi Hayashi and Nagai (Hayashi and Nagai, 1956; 
Hayashi, 1956). L-glutamic acid decarboxylase is an enzyme that promotes the synthesis 
of GABA in presynaptic neurons which is stored in synaptic vesicles (Jin et al., 2003). GABA 
is released at the synapse from vesicles upon neuronal activation. A number of GABA are 
released from a single vesicle fusion into synaptic cleft, raising the concentration of GABA 
in millimolar range (Mody et al., 1994; Mozrzymas et al., 2003; Mozrzymas 2004) which can 
act either on post synaptic receptors or on extra synaptic receptors by diffusing to 
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extracellular space. GABA transporters take up GABA away from postsynaptic receptors 
(Cherubini 2001; Deken et al., 2003). The balance between GABA release from synaptic 
vesicles and uptake of GABA by transporters regulate the extracellular GABA levels (Deken 
et al., 2003). Mode of action of GABA can be via fast acting ionotropic GABAA and GABAC 
receptors or slow acting metabotropic GABAB receptors (Bormann 2000). Ionotropic GABAA 
receptors are predominant type of GABAARs (Bowery et al., 1987) which are known to 
constitute about 20-50% synapses in the brain (Nutt and Malizia, 2001). 
  
1.13.2 GABAAR are pentameric ion channels consisting of 21 distinct subunits (α1-8, β1-3, 
γ1-3, δ, ε, π, θ and ρ1–3) and a central pore which is permeable to anions (Cl- and HCO3+) 
(Bormann, 1987; Kaila, 1994; Wafford et al., 1996; Whiting et al., 1997; Wafford et al., 2005; 
see figure 1.10). The combination of various subunit binding sites creates ligand specific 
sites for benzodiazepines and barbiturates (Mohler, 1992; Wafford et al., 1993; Graham et 
al., 1996).  GABAARs have been identified both pre-and post-synaptic neurons in various 
regions in the brain. In rats these receptors are found more in Lll/lll than in LV and are 
implicated to play a role in cortico-cortical connections (Jones and Wise, 1977; Jones et al., 
1986). Moreover, GABAAR expression was found to be denser in sensory regions than 
motor regions (Zilles et al., 1995). 
In most mature neurons, equilibrium potential of Cl- becomes more negative than resting 
membrane potential via KCC2 (potassium chloride co transporter) activity which enables 
receptor activation with an influx of Cl- and response is measured as IPSP (inhibitory post 
synaptic potential). This hyperpolarisation effect and increase in conductance shunt 
excitatory inputs which in turn decreases the probability of action potential generation 
(Payne et al., 2003; Farrant and Nusser, 2005). However, hyperpolarising GABA input is 
not always functionally inhibitory as recovery from deep hyperpolarisation may sometimes 
activate excitatory conductances which generate rebound spikes (Chavas et al., 1994; 
Llinas et al., 1988). Similarly, when the concentration of Cl- is higher inside the cell, opening 
of GABA receptors may cause efflux of the anion, thereby generating action potentials 
(Staley, 1992; Owens et al., 1996). Interestingly, GABA response is depolarising in most 
immature neurons due to the lack of KCC2 and presence of NKCC1 (sodium and potassium 
coupled co-transporter) (Riwera et al., 1999; Riwera et al., 2005). The depolarising action 
of GABA is also seen in some mature neurons (Chavas et al., 2003; Stein et al., 2003), 
however, in mature cells under normal circumstances activation of GABAAR generates 
inhibition in two ways described below.  
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Figure 1.10 Representation of a typical GABAAR structure. 
A pentameric structure which consists of two GABA binding sites (black) between α and β 
subunits whilst the benzodiazepine site (grey) exists between α and γ subunits with a central 
pore for Cl- transmission. 
1.13.3 Types of Inhibition 
1.13.3.1 Phasic Inhibition 
Phasic inhibition is rapid (short lasting) and precise transmission mediated by synchronous 
activation of small number of GABAAR at synapses. The mechanism involves the 
presynaptic calcium influx which initiates the fusion of vesicles that contain GABA upon 
arrival of an action potential. Each vesicle is known to release several thousand GABA 
molecules (with a synaptic concentration in mM) onto a few hundred receptors located on 
post synaptic neurons. These receptors witness large number of molecules for a short 
duration enabling synchronous opening of the pore for Cl- travel across the membrane 
generating IPSPs (Edwards et al., 1990; Mody et al., 1994; Nusser et al., 1997; Brickley et 
al., 1999). Studies using low affinity competitive antagonist revealed that decay of GABA 
concentration and GABA binding occurs at time constants of < 500 µs (Overstreet, 2002) 
and about 100 µs (Mozrzymas et al., 2003; Mozrzymas et al., 2004) respectively which 
inputs to short duration and fast diffusion from synapse. The occupancy of various receptors 
varies between synapses on a single neuron or on multiple neurons. Vesicle size, nature of 
fusion, geometry of synapse, arrangement of GABA transporters and postsynaptic receptor 
expression and conformational changes of receptors during ion transition are the various 
factors that contribute to phasic inhibition (Frerking et al., 1996; Nusser et al., 1997; Perrais 
et al., 1999; Hajos et al., 2000; Mozrzymas et al., 2003) leading to decrease in number of 
IPSCs and amplitude.  
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1.13.3.2 Tonic Inhibition 
Tonic inhibition is long lasting transmission by activating non-synaptic GABAAR (Connolly 
and Wafford, 2004), often via spilling of extracellular GABA causing diffusion away from the 
synaptic cleft which then activates receptors on extra- and peri-synaptic sites that contain 
alpha6 or delta subunits, which display a high affinity for GABA binding (Farrant and Nusser, 
2005). This type of inhibition was reported in rat cerebellar granule cells in voltage clamp 
recording (Kaneda et al., 1995a), then in hippocampus (Semyanov et al., 2003), dentate 
gyrus (Nusser and Mody, 2002), pyramidal cells in LV of somatosensory cortex (Keros and 
Hablitz et al., 2005; Yamada et al., 2007). It was identified that pyramidal neurons may 
require an additional increase in GABA concentrations whilst interneurons are thought to 
display tonic inhibition without any external GABA (Seymanov et al., 2003; Scimemi et al., 
2005). It was evident that tonic activation was noticed in embryonic neurons prior to synapse 
formation (Valeyev et al., 1993; LoTurco et al., 1995; Owen et al., 1999; Demarque et al., 
2002). Several studies revealed that reduction of spontaneous IPSCs as well as decrease 
in holding current suggesting the reduction in conductance due to the decrease in open 
GABAAR channels (Kaneda et al., 1995b; Brickely et al., 1996; Tia et al., 1996; Wall et al., 
1997). Ambient GABA may be enough to activate persistent tonic conductance which was 
thought to be nM to mM concentration range (Tossman, 1986; Lerma et al., 1986; Kennedy 
et al., 2002; Xi et al., 2003). Tonic currents play a role in setting the frequency of neuronal 
network oscillations, hence tonic NMDAR activity on interneurons in mouse CA3 increase 
the frequency of gamma oscillations while delta subunit containing GABAAR mediated tonic 
inhibition decreases gamma frequency (Mann and Mody, 2010). Therefore, the balance 
between tonic inhibition and tonic excitation is critical for modulating gamma oscillations via 
progressive interneuronal synchronisation (Mann and Mody, 2010). 
 
1.13.4 GABABR are G-protein coupled metabotropic receptors (Hill and Bowery, 1981, 
Bowery et al., 1983, Bowery, 2002) which acts via intracellular transduction cascades by 
regulating calcium and potassium channels and are expressed in both presynaptic and 
postsynaptic neurons (Axmacher and Draguhn, 2004). Reversal potential of slow IPSP 
mediated by GABABR is -100 mV. Pre-synaptically, they have been implicated in inducing 
membrane hyperpolarisation or shunting the action potential by inhibiting the opening of 
voltage gated Ca+ channels leading to inhibition of GABA release. Post-synaptically, they 
generate long lasting hyperpolarisation by activating inwardly rectifying K+ channels (GIRK 
channels) (Gage, 1992; Kulik, 2006). GABABRs can be pharmacologically isolated by 
activation via baclofen and blocked by 2-OH-saclofen (Terunuma et al., 2010). 
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1.14 Glutamate 
Glutamate is a crucial excitatory neurotransmitter in CNS and has been known to play a 
significant role in several functions (Hollmann and Heinemann, 1994; Monaghan et al., 
1989). Glutamate acts on two different type of receptors: ionotropic and metabotropic (Pin 
and Duvosin, 1995). Ionotropic receptors (iGluR) are further divided (based on the agonist 
sensitivity) in to AMPA (α-amino- 3-hydroxy-5-methyl-4-isoxazole-propionic acid), NMDA 
(N-methyl-d-aspartate) and KA (Kainate) receptors (Watkins and Evans, 1981). 
Metabotropic receptors (mGluR) are categorised to three groups (l, ll and lll) which are G-
protein coupled receptors (Nakanishi, 1994).   
1.14.1 AMPAR are tetrameric, either homo or heteromeric (Nakanishi et al., 1990; 
Rosenmund et al., 1998) structures formed of different combination of subunits: GluA1-4 
(Keinanen et al. 1990; Hollmann, 1999; Dingledine, 1999). AMPARs are activated directly 
by glutamate leading to postsynaptic membrane potential by allowing the influx of Na+ and 
K+. Therefore, the reversal potential EPSP mediated via non-NMDAR (AMPA) is 0 mV. 
Different combinations of AMPAR subunits have significant impact on receptor functions as 
the receptor kinetics and ion selectivity are dependent on subunit compositions (see review 
Traynelis et al., 2010). For instance, slow gating properties have been identified in a 
receptor containing GluA2 subunit compared to one that lack GluA2 subunit (Lomeli et al., 
1994; Swanson et al., 1997) and increased receptor kinetics was identified in receptors 
containing GluA4 subunit (Swanson et al., 1997). PV-positive hippocampal interneurons are 
known to express low GluA2 and high GluA4 (Geiger et al., 1995; Pelkey et al., 2015) 
resulting in rapid EPSPs and high Ca2+ permeability (Geiger et al., 1995; Lawrence and 
McBain, 2003) when compared to pyramidal cells (Hestrin, 1993). GluA2 subunit containing 
AMPAR have been found to be Ca2+ impermeable whilst the other subunits combine to form 
a Ca2+ permeable receptors (Hollmann et al., 1991; Verdoorn et al. 1991). The expression 
of fast acting Ca2+ permeable AMPAR on fast spiking interneurons was found to be a 
requirement for control of oscillatory activity (Bartos et al., 2007, Hu et al., 2014). Also, PV-
positive interneurons of cortex have shown a correlation between action potential timing 
and EPSCs which are AMPAR mediated (Helm et al., 2013). Moreover, over expression of 
GluA2 subunit in GAD67-positive interneurons has shown significant disruption in long 
range synchronization (Fuchs et al., 2001). Furthermore, GluA1 and A4 subunit KO on PV-
positive interneurons altered gamma oscillations and hippocampal memory (Fuchs et al., 
2007). These studies (above) suggest a role of subunit combination in network entrainment 
and a need for new subunit specific targets. 
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Rapid kinetics of AMPAR produces fast EPSPs which enables rapid synaptic transmission 
in CNS. Gamma oscillations have been found to decrease in power in rats upon the 
application of AMAPAR antagonists or by genetically reducing AMPA currents implying a 
significant role of this receptor in the maintenance of gamma oscillations (Cunningham et 
al., 2003, 2004; Palhalmi et al., 2004; Fuchs et al., 2007). In contrast, a study by Fisahn et 
al., (2004) on mice demonstrated that AMPAR antagonist did not alter oscillation suggesting 
AMPAR do not contribute to gamma oscillations. These contradicting reports of AMPAR 
sensitivity could be due to the species like rat vs mouse, the area of experiment: 
hippocampus (AMPAR-sensitive) or entorhinal cortex (insensitive) and AMPAR antagonists 
used (SYM2206, GYKI 53655). 
1.14.2 NMDAR are tetramers, consists of GluN1 and GluN2 (A-D) subunits (Hollmann, 
1999; Dingledine, 1999) with GluN1 being the obligatory subunit for functional receptors 
and most receptors comprising combinations of GluN1 and GluN2 subunits of various 
subtypes. When the pore is open, Ca2+ influx is initiated by which various intracellular 
process such as second messenger signalling cascades in the post-synaptic neuron are 
activated due to rather slow activation and deactivation kinetics of NMDARs when 
compared to AMPAR. But, the permeability of these receptors at hyperpolarised 
membranes (negative membrane potentials) is limited due to the block of the receptor pore 
by Mg2+. Hence, the activation of NMDAR requires depolarisation (>40 mV) (Mayer, 1984; 
Nowak, 1984). NMDAR expression varies across various brain regions and is known to be 
regulated by development and disease conditions (Watanabe et al., 1992; Monyer et al., 
1994; Akbarian et al., 1996; Purcell et al., 2001; The pharmacological properties of these 
receptors have been known to be determined by subunit compositions (McBain and Mayer, 
1994; Traynelis et al., 2010). NMDARs containing GluN2A generate rapid kinetics whilst 
those containing GluN2B have slower kinetics and GluN2C and GluN2D even slower 
kinetics. The slowest decay (τ ~ 2s) was identified in receptors with di-heteromeric receptors 
of GluN1 and GluN2D subunits (Vicini et al., 1998). Knockout mice studies revealed that 
slow gating GluN2B and GluN2D are highly expressed in early development stages, whilst, 
GluN2A is highly expressed at later stages which enhance the synaptic responses in 
hippocampus (von Engelhardt et al., 2015).  
Earlier findings assumed that NMDARs have minimal contribution to fast synaptic 
transmissions in interneurons when compared to pyramidal cells. However, various studies 
after extensive research suggested that NMDAR contribution depend on subunit 
composition and type of interneuron. NMDAR mediated EPSPs have been documented at 
low levels of Mg2+ (Bekkers and Stevens, 1989; Watt et al., 2000; Myme et al., 2003) or at 
depolarised potentials (McBain and Dingledine, 1992).  It is interesting to note that NMDAR 
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correlates with AMPAR expressed on same neuron (McBain and Dingledine, 1993, Monyer 
et al., 1994; Matta et al., 2013; von Engelhardt et al., 2015). When NMDA mediated currents 
were pharmacologically blocked synapses containing AMPA/NMDAR has shown a 
significant decrease in summation of EPSPs and hence reduction in action potential firing 
irrespective of ratios of AMPA/NMDARs (Lei and McBain, 2002). Augmented activation of 
NMDAR has been observed in stroke and trauma (Nicoletti et al., 1996) also in neuro-
degenerative disease like Parkinson`s and Huntington`s (Shaw, 1993).  
 
1.14.3 KAR are homo or heteromeric structured, consisting of following subunits: GluK1 
(GluR5) (Bettler et al., 1990), GluK2 (GluR6) (Egebjerg et al., 1991), GluK3 (GluR7) (Bettler 
et al., 1992), GluK4 (KA1) or GluK5 (KA2) (Werner et al., 1991; Herb et al., 1992, Lerma, 
2001; for review see Traynelis et al., 2010 and Akgul and McBain, 2016). KARs were 
expressed widely in the brain both on pyramidal neurons and interneurons (Wisden and 
Seeburg, 1993). Higher expression of GluK1, 2 and 4 have been identified on interneurons 
that regulate both pre- and post-synaptic activity (Fisahn et al., 2004; Lein et al., 2007; see 
review Carta et al., 2014). Post-synaptic KAR are known to modulate neuronal excitability 
by integrating only excitatory synapses, due to their slow kinetics (Frerking and Nicoll, 2000; 
Pinheiro et al., 2013). However, KARs located pre-synaptically regulate NT release at both 
inhibitory and excitatory synapses (Cossart et al., 2001; Lerma and Marques, 2013). 
Exogenous application of micromolar concentration of KA pre-synaptically reduced 
inhibitory effects of CA1 interneurons on to principal cells (Fisher and Alger, 1984; Kehl et 
al., 1984; Rodriguez-Moreno et al., 1997). Various pharmacological and genetic 
experiments have revealed conflicting results due to poor receptor specific pharmacology 
as well as lack of specific targets (Mulle et al., 2000; Fishan et al., 2004). KAR, like AMPAR 
are activated by glutamate release but are known to have much slower kinetics (decay t 
~10 ms) and low amplitude EPSCs (Cossart et al., 2002; Goldin et al., 2007). KAR, 
sometimes act via metabotropic mechanisms without depending on depolarisation 
(Rodriguez-Moreno and Lerma, 1998; Frerking et al., 2001). In a study by Frerking and 
Ohliger-Frerking (2002) revealed that AMPAR induce transient, variable membrane 
depolarisations, whilst KARs trigger tonic depolarisations with low variability.  
Application of nano molar concentration of KA (and/or CCh) has generated persistent 
gamma oscillations in vitro in primary motor cortex (Johnson, 2016), somatosensory cortex 
(Buhl et al., 1998; Cunningham et al., 2003), hippocampus (Hajos et al., 2000, Hormuzdi et 
al., 2001, Fisahn et al., 2001, Modebadze, 2014). GluK1 and K2 KO mice experiments 
performed have revealed a critical role of these subunits since it was not possible to induce 
gamma oscillations (Fisahn et al., 2004). It was assumed in this study that GluK1 KARs 
were localised on the axons of interneurons and did not contribute to oscillatory activity 
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whilst GluK2 subunit containing KARs were located on somato-dendritic area of 
interneurons and pyramidal cells which enhanced action potential firing upon activation, 
which enabled GABA and glutamate release. However, it was not possible to induce 
oscillatory activity in the presence of GluK1 antagonists suggesting the role of this subunit 
in maintaining gamma oscillations (Stanger et al., 2008). Moreover, KARs have been 
implicated in spike entrainment at theta frequencies in oriens lacunosum-moleculare (OLM) 
cells (Goldin et al., 2007) suggesting a significant role of KARs in oscillatory activity. 
Furthermore, KARs have implicated to contribute to slow wave oscillations SWO, as SWO 
was abolished upon the application of the GluK1-slective KAR antagonist, UBP302 
(Cunningham et al., 2006; Sheroziya et al., 2009). Interestingly, KAR  also plays a critical 
role in epilepsy since systemic administration of KA has been used as a widely accepted 
model for investigating seizures like those observed in temporal epilepsy (TLE) (Ben-Ari et 
al., 1985). 
iGluRs are known to play a significant role in synchronising network activity by recruiting 
inhibitory interneurons. Recent subunit knockout studies (Akgul and McBain et al., 2016) 
revealed the sub-unit composition expressed on type of interneurons were involved in the 
network oscillations (some examples are shown in table below). 
48 
sub-unit 
knockout 
Interneuron 
subtype 
physiological effect oscillatory effect reference 
AMPAR 
(GluR1-4) 
PV (PV-
Cre), 
GAD67 
decrease in AMPA 
mediated EPSPs, 
altered firing 
altered gamma 
oscillations, 
disrupted long range 
synchrony 
Fuchs et 
al., 2007 
NMDAR 
(N2C, N2D) 
GAD67, 
Ppp1r2-Cre 
increased EPSP 
amplitude,decreased 
frequency 
Reduced 
synchronous activity 
Kelsch et 
al., 2012, 
Belforte et 
al., 2010 
KAR 
(GluK1-2) 
Global does not increase 
IPSC frequency 
disrupted/enhanced 
kainate induced 
gamma oscillations 
Mulle et al., 
2000, 
Fishan et 
al., 2004 
Table 1.2 Role of iGluR subunits in various physiological and oscillatory activity 
Adapted from Akgul and McBain et al., 2016 
1.14.4 mGluR are classified in to three groups based on the subunit sequence homology. 
Postsynaptically expressed, group l (mGluR1, mGluR5) are positively coupled to 
phosphoinositide (PI) which increases cyclic AMP (cAMP) via second messenger cascades 
and are known to enhance neuronal excitation. In contrast, presynaptically expressed group 
ll (mGluR2, mGluR3) and lll (mGluR4, mGluR6, mGluR7, mGluR8) mGluRs are negatively 
coupled to adenylyl cyclase and inhibits cAMP which accounts for the reduction in synaptic 
transmission (decrease in excitation). Group ll and lll also regulate glutamate release by 
acting as auto receptors in presynaptic neurons (Schoepp et al., 1992; Shigermoto et al., 
1997) playing a role in both LTP (upregulate glutamate release) and LTD (downregulate 
glutamate release) (Holscher et al., 1999). However, peri-synaptic expression of group l 
mGluR often regulate the excitability of neurons via iGluR channels (Shigermoto et al., 
1993; Baude et al., 1993; Shigermoto et al., 1997). mGluRs have been implicated in many 
process like neuronal development, neurodegeneration, synaptic plasticity, learning and 
memory (Nakanishi, 1994; Pin and Bockaert, 1995; Pin and Duvosin, 1995; Conn and Pin, 
1997; Dale et al., 2003). 
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1.15 Dopamine 
Dopamine (DA), a catecholamine present in the brain, was identified as a neurotransmitter 
in 1972 (Brown and Maknman, 1972; Kebabian et al., 1972). Pharmacological evidence 
revealed the presence of more than one binding sites for DA DA receptors can be classified 
as D1-like and D2-like based on their differential coupling to AC (Kabebian and Calne, 
1979). D1 (D1 and D5) receptors activate Gαs/olf family of G-proteins and thus enhance 
cAMP. (Dearry et al., 1990; Monsma et al., 1990; Zhou et al., 1990) and D1R are found 
exclusively on post synaptic neurons such as medium spiny neurons (MSNs) in striatum. 
D2 (D2, D3, D4) receptors unlike D1, are expressed in both pre- and postsynaptic terminals 
and known to be negatively coupled to AC via Gαi/o family of G proteins (Sokoloff et al., 
2006; Rankin et al., 2010; Rondou et al., 2010). It is evident that DA induces long lasting 
effect via different mechanisms (reviewed in Jay 2003; Luft and Schwarz, 2009) which 
include: intracellular Ca2+ levels (via L-type channels) increase and decrease upon 
activation of D1 and D2 receptors respectively (Neve et al., 2004), increased cAMP due to 
the activation of D1R (but not D2R) activates (protein kinase A) PKA which in turn enhances 
the currents mediated by AMPA and NMDA receptors (Snyder et al., 1998; Gurden et al., 
2000; Wang and O`Donell, 2001) as illustrated in the figure 1.10. 
Figure 1.11 Representation of various signal transduction mechanisms of action D1-
like and D2-like receptors. 
D1-like receptors are positively coupled to AC whilst the opposite is true for D2-like 
receptors and their corresponding effects on K+ channels, Arachinoid acid, Na+/H+ 
exchange, Na+-K+-ATPase. + indicates positively coupled and – indicates negative 
coupling, AC-adenylate cyclase, PLC- phospholipase C (adapted from Missale et al., 1988). 
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The physiological roles of DA include (but are not limited to) sleep, immune system, renal 
functions and sympathetic regulatory function (Snyder et al., 1970; Missale et al., 1998; 
Sibley, 1999; Carlsso, 2001; Iversen and Iversen 2007). On the other hand, several studies 
have implicated a role of DA in pathological conditions such as Parkinson`s disease from 
loss of dopaminergic innervation (Ehringer and Hornykiewicz, 1960), Schizophrenia 
(Snyder et al., 1970; Creese et al., 1976; Seeman et al., 1976; Carlsson et al., 2001) and 
associated with drug abuse (Hyman et al., 2006; Di Chiara and Bassareo, 2007; Koob and 
Volkow, 2010). 
Network activity in primary motor cortex (M1) has been shown to be modulated by DA 
(Alexander et al., 1986). D1 and D2 receptors have a crucial role in direct and indirect 
pathways associated with Parkinson`s disease (Ueki et al., 2006). D1R is more abundant 
than D2R in rat cortex (Boyson et al., 1986). M1 and PFC (pre-frontal cortex) show similar 
organization of DR although M1 expresses fewer DR than PFC (Lidow et al., 1989). The 
laminar distribution of both receptors is found to correspond to dopaminergic terminals in 
M1 which are predominately in deep layers (LV and LVl) (Martes et al., 1985; Dawson et 
al., 1986). 
Additionally, recent studies have indicated that DA modulates tonic currents in various 
regions of brain (Aman et al., 2006; Yague et al., 2013; Liang et al., 2014) and may directly 
inhibit GABA-R (Hoerbelt et al., 2015). These novel activities of DA may impel new 
definitions of dopaminergic signalling in the brain. 
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1.16 Aims and Objectives 
The primary objective of this thesis is to explore the oscillatory cortical dynamics at different 
frequencies that were induced by various pharmacological manipulations. Given the 
inadequate in vitro research, we aimed to explore delta, nested theta and gamma 
oscillations in primary motor and sensory cortices in rat brain slices. Studies have implicated 
M1 in execution of voluntary movements and S1 in sensory information from both local 
network in vitro and whole brain in vivo perspectives and interactions between these two 
regions are known to play critical roles in motor learning and control skills (Asanuma and 
Arissian, 1984; Asanuma and Pavlides, 1997) which forms the basis for choosing M1 and 
S1 in our study. 
Objectives: 
 To explore oscillatory activity in primary motor cortex (M1) and primary sensory 
cortex (S1) using KA and CCh using extracellular, local field potential (LFP) 
recordings from control rats. 
 To induce and characterise the origin and mechanisms involved in delta oscillations 
in M1 and S1 using pharmacological manipulations. 
 To investigate interactions between rhythms in M1 and S1.  
 To examine the role of dopamine in tonic and phasic inhibition by using single cell 
patch clamp technique. 
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2 Methods 
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2.1   Animals and ethical approval 
All the experiments were carried out in accordance with  the Animals (Scientific Procedures) 
Act 1986 UK, European Communities Council Directive 1986 (86/609/EEC) and the Aston 
University ethical review document. 
2.2   Slice preparation 
Sagittal slices containing primary motor cortex (M1) and somatosensory cortex (S1) were 
obtained from male Wistar rats (50-70 g). Initially, rats were anesthetized by placing them 
in a chamber containing 2% Isoflurane and N2/O2 and then by injecting pentobarbital (600 
mg/kg) subcutaneously (SC). Xylazine (100 mg/kg) was administered through the 
intramuscular route and when pedal reflexes were completely lost transcardial perfusion 
was performed with ice-cold sucrose based artificial cerebrospinal fluid (aCSF). aCSF 
contained (mM): 180 sucrose, 2.5 KCl, 10 MgSO4, 25 NaHCO3, 1.25 NaH2PO4, 0.5 CaCl2, 
10 glucose, 1 L-ascorbic acid, 2 N-acetyl-L-cysteine, 1 taurine, 20 ethyl pyruvate. 
Neuroprotectants such as 0.04 indomethacin, 0.3 uric acid and 0.2 aminoguanidine were 
also added and aCSF was saturated with carbogen (95% O2, 5% CO2). The brain was 
carefully extracted and sagittal slices of 450 µm thickness for extracellular recordings and 
350 µm thickness for intracellular recording were prepared using a vibrating microtome 
(Campden Instruments, UK) using the same solution at room temperature. Prepared slices 
for extracellular recording were then stored in an interface chamber (Scientific System 
Design Inc., Canada) whereas slices for intracellular recording were submerged in aCSF 
which was constantly bubbled with carbogen at room-temperature and was composed of 
glucose-based aCSF containing (mM): 126 NaCl, 3 KCl, 1.6 MgSO4, 26 NaHCO3, 1.25 
NaH2PO4, 2 CaCl2, 10 glucose. 0.04 of indomethacin (a cyclooxygenase inhibitor) and 0.3 
of uric acid were added as neuro-protectants to improve cell viability (Pakhotin et al., 1997; 
Rice et al., 1994). Slices for extracellular recordings were then immediately transferred 
carefully unto a recording chamber (Scientific System Design Inc., Canada), where they 
were perfused with glucose-based aCSF at a flow rate of 2 ml/min for an hour before 
recording. PTC03 proportional temperature controller (Scientific System Design Inc., 
Canada) was used to maintain 33-34 °C. Slices for intracellular recording were placed in 
submerged holding chamber for an hour prior to being placed into a submerged recording 
chamber and allowed to settle for 15 minutes prior to recording. 
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Figure 2.1 Representation of various types of rat brain slice preparations used for extracellular and intracellular recordings. 
Nissl stained sagittal sensory motor slice locating Primary motor cortex (M1) and primary somatosensory cortex (S1). Adapted from The Rat Brain Atlas 
(Paxinos and Waston, 1998). A) Sensory motor sagittal slice with both M1 and S1 intact, areas of each region were represented by lines. B) Sensory 
motor sagittal slice with a micro-cut made between M1 and S1 regions only, which was represented by a dashed line. C) Primary motor cortex sagittal 
slice (boxed area) segregated from sensory motor slice. D) Primary somatosensory cortex (boxed area) segregated from sensory motor slice. Cut was 
made all through the slice separating M1 and S1 which was represented by dashed line in C and D. E) micro slice with just M1 and S1, isolated from 
rest of the slice (boxed area). F) M1 slice isolated from a sensory motor slice with surroundings intact. This type of slice was used for intracellular 
recordings whereas all the other types of slices were used for extracellular recordings. 
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The M1 region of the cortex was identified as being dorsal to the lateral ventricle and the 
caudal extent of the striatum and S1 being adjacent to M1 dorsal to hippocampus. With the 
aid of The Rat Brain Atlas (Paxinos and Waston, 1998) various types of slices were 
prepared based on regions of interest as illustrated in figure 2.1. These different types of 
slices were used to perform region-specific studies and correlation studies. Type A slices 
were 450 µm in thickness used for extracellular recordings. This type of slice contain intact 
M1 and S1 and recordings were made from one region or simultaneously from both regions. 
Type B slices are the same as type A except a cut (dashed line in figure 2.1) was made 
between M1 and S1 using a surgical scalpel blade and were carefully transferred on to the 
recording chamber where they were settled for an hour before recording. Simultaneous 
recordings were made from this type of slice which was used to determine the correlation 
between rhythms in the two regions. Type C slices were again 450 µm thick and were used 
for extracellular recordings. M1 was isolated from sensory motor slice by cutting all through 
the slice and boxed region from the figure C was used for region-specific recording. Type 
D slices were same as type C but this type has S1 isolated (boxed region) from the sensory 
motor slice. Type E slices were also 450 µm thick and were used for extracellular recordings 
but this type is a micro slice with just M1 and S1 isolated from rest of the sensory motor 
slice. This isolation was made diligently with surgical scalpel blade and were transferred to 
the recording chamber. Type F slices were 350 µm thick and were used for intracellular 
recordings. This type of slice had M1 with surroundings intact (boxed region in figure 2.1). 
These slices were carefully transferred to and submersion chamber to settle before 
experiments. All the recordings were made from layer V of both M1 and S1 (unless 
otherwise stated) which was located through visual inspection using microscope (Olympus 
BX51W1, Japan) unless otherwise stated. 
2.3   Extracellular recordings 
Local Field Potentials (LFPs) of neuronal network activity were recorded using an 
extracellular field potential technique. LFPs reflect local neuronal network mechanisms of a 
specific brain region and are known to arise from activity within approximately 250 µm at 
the tip of electrode. These recordings are often used to investigate synchronous activity of 
neuronal networks (Logothesis, 2003; Mitzdorf, 1985; 1987; Rasch et al., 2007). A Flaming-
Brown micropipette puller (Sutter Instruments, CA) was used to pull borosilicate glass 
microelectrodes with open tip resistance of 2-3 MΩ which were placed into Layer V of M1 
and/or S1 using the rat brain atlas of Paxinos and Watson (Paxinos and Waston, 2012) as 
a reference by viewing under a LEICA MZ6 field microscope. The activity was recorded 
using an EXT amplifier head-stage (NPI electronics GMBH, Germany) mounted on to a 
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manually operated micromanipulator (MM-33; Narishige, Japan). The signal was amplified 
10 x using an LHBF-48X preamplifier/signal conditioner (NPI, Germany) set to band-pass 
filter between 700 Hz and 0.1 Hz and then amplified a further 100 times using EXT-102F 
amplifier (NPI, Germany). Humbugs (Quest Scientific, Canada) signal conditioners were 
used to eliminate low amplitude (<100 μV p-p) 50 Hz noise. The signal was simultaneously 
digitised using a CED 1401 digital converter in to a disk using Spike2 software (figure 2.2). 
Figure 2.2 The extracellular local field potential recording setup 
The signal from micro-electrode which was mounted onto head stage was amplified 100x 
by EXT 10-2F amplifier (1), 50 Hz noise was eliminated by humbugs (2), signal was further 
amplified (x10) and high and low pass filtered by LHBF-48X amplifiers (3) signals was then 
converted from analogue to digital signal by CED 1401 digitizer (4) recordings were made 
and saved on a PC (5). 
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2.3   Intracellular recordings 
Patch clamp technique was used to make whole cell recordings of synaptic currents. A 
Flaming-Brown micropipette puller (Sutter Instruments, CA) was used to pull borosilicate 
glass microelectrodes of 4-6 MΩ. The tip of the electrode filled with internal solution 
(composition below) was then carefully placed on the surface of the neurons located visually 
using infra-red video microscopy with differential inference contrast (DIC) optics (Olympus, 
BX51WI) which enabled the visibility of neurons located in deep surface of the slice. Cells 
with smooth edges tends to give successful patch recordings. Slight positive pressure was 
applied from inside the electrode to maintain the resistance of the electrode by keeping off 
contamination. The tip of the electrode was advanced onto the chosen cell. Pipette offset 
was reset to zero and signs for slight rise in resistance and indentation of the cell membrane 
were examined, which indicates the electrode tip was on the neuron surface. As soon as 
the tip was confirmed to have contacted the membrane, positive pressure was turned off 
and a natural suction was noticed, after which gentle mouth suction was applied to seal the 
tip onto the membrane. At this stage pipette capacitance was compensated. When gigaseal 
(>1 GΩ as measured using a 5 mV step injected at line frequency) was observed, a gentle 
suction was applied to rupture the membrane under the patch electrode tip, with the pipette 
holding current set to -70 mV. A sudden appearance of large capacitance transients at the 
leading and trailing edges of the pulse is an indication of successful breakthrough.  
2.3.1 Voltage clamp  
Voltage clamp technique was used to characterise phasic and tonic inhibitory currents in 
the layer V of M1 the rat brain atlas of Paxinos and Watson as a reference. In this technique 
membrane potential was held constant (-70 mV) so that the current flow resulting from ion 
channel opening was measured in pA in the form of Inhibitory Post Synaptic currents 
(IPSCs). Electrodes used for this purpose were filled with internal solution containing (in 
mM): 100 CSCl (blocks K+ channels), 40 HEPES (buffering agent, maintains pH), 1 Qx-314 
(voltage activated Na+ channel blocker), 0.6 EGTA (calcium chelator), 5 MgCl2 (salt), 10 
TEA-Cl (blocks K+ channels), 80ATP-Na, GTP-Na and 1 IEM 1460 (AMPA blocker) (titrated 
with CsOH (to adjust pH =7.25) at 290-295 mOsm. This solution was maintained in ice-cold 
conditions as ATP and GTP degrade at room temperature and was stored at -20 degrees 
in aliquots until required. This chloride based solution (which has a Cl- equilibrium potential 
around 0 mV) enables the IPSCs to be recorded as apparent inward currents at -70 mV 
using Axopatch 700A amplifier (Molecular Devices, USA). Frequent measurements of 
series resistance (Rs) were made using the capacitance transient on a line-frequency 
voltage step (5 mV) during recording. Sampling rate of the recording was 10 KHz, filtered 
(8-pole low-pass Bessel filter) at 2 KHz which was digitised using a Digidata 1440A (figure 
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2.3). Under these conditions of high internal Cl- concentration, IPSCs were recorded as 
downward deflections ranging in amplitude from 10-500 pA. Since IPSC parameters were 
only compared prior to and following drug addition, whole cell capacitance and electrode 
series resistance were monitored, but not compensated. Recording in which series 
resistance (as measured at the peak of the capacitance transient recorded in response to 
seal test at 5 mV) changed by >25% were routinely rejected from analysis. 
Figure 2.3 The patch clamp recording setup. 
Slices were observed under microscope with differential interference (Nomarski) optics and 
a contrast enhancer (BRSL CE-4) (1), cells were visualised on a basic video monitor 
(Panasonic) (2), head stage on which microelectrode was mounted was connected to a 
manipulator which enables movement (Scientifica device) (6), Axopatch 700A amplifier 
(Molecular Devices, USA (4), signal was digitised using Digidata 1440A (Axon Instruments, 
Molecular devices) (5). Digitised data were recorded and saved on a standard PC (3). Water 
heater circulator C-85A (7). 
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2.5   Drugs 
All drugs were obtained from Tocris, Sigma-Aldrich, Abcam, Actavis, Thermo Fisher 
Scientific and Sigma-Aldrich. Powdered drugs were diluted into 1-100 mM stock solutions 
using suitable solvents which were then stored at -20oC until use. Depending on the 
experimental design the drugs were added directly to perfusing aCSF in required amounts 
at desired concentration. The concentrations used throughout this thesis are both empirical 
and theoretical (literature). 
2.6   Data collection and analysis 
2.6.1   Extracellular (LFP) analysis 
Data were analysed offline using Spike2 v7.1 software (Cambridge electronic design). To 
reconstruct the original signal below 200 Hz, the sampling rate was chosen to be 10 KHz 
based on Nyquist sampling theorem (Axon guide). The sampling frequency must be more 
than twice the frequency of the input signal to enable proper reconstruction of digital signal. 
Time-frequency analysis was performed to create power spectra using Fast Fourier 
Transform (FFT) algorithm where the waveform was divided to frequency components 
against power. The FFT block size used for theta and gamma oscillations was 8192 (0.983 
s), results showed frequencies 0 to 4166.67 Hz in 4096 bins with a resolution of 1.01 Hz. 
For delta oscillations, 16384 (1.966 s), results showed frequencies 0 to 4166.67 Hz in 8192 
bins with a resolution of 0.050 Hz. The obtained data were copied to Graph-Pad Prism 5 
and 7 (GraphPad Software, Inc. USA) for further analysis. 60 second epochs were used to 
analyse rhythms. 2 seconds’ raw data presented in the figures throughout this thesis was 
filtered using a band pass second order Infinite impulse response (IIR) Bessel digital filter 
between 1 and 6 Hz for delta, between 5 and 13 Hz for theta, between 4 and 8 Hz for slow 
theta, between 22 and 30 Hz for beta and between 30 and 40 Hz for gamma oscillations. 
Filtering was performed on wider range for example in between 1 and 6 Hz for delta than 
corresponding frequency range (2-4 Hz) so that the data were not lost due to `rolling off` 
effect from using IIR filters.  
2.6.2   Intracellular analysis 
Spontaneous IPSCs (sIPSCs) were recorded using Clampex10.2, viewed using Clampfit 
10.2 (Molecular Devices, USA) and were analysed in the Mini-analysis programme 
(synaptosoft, USA). 
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2.6.3.1 Tonic current analysis 
The method of Nusser and Mody (2002) was used to measure tonic currents to exclude 
confounding effects of IPSCs overlapping. A baseline current amplitude (pA) of a 5-ms 
epoch was taken every 100 ms. The mean and SD of the averaged baseline points were 
calculated for 10 s (~100 averaged baseline points) at three distinct times of the recordings 
(for example: periods A, B, and C). Two changes in the baseline current were calculated 
between the three periods. The first (DBL) was the value of the difference during recording 
periods A and B, both taken during the control period and reflecting baseline fluctuation. 
The second (DDrug) was the value of the difference during recording periods C and B, and 
reflecting drug induced changes to the holding current. The two baseline changes (DBL and 
DDrug) were then statistically compared (paired t-test).  Raw traces were shown to illustrate 
changes in baseline in control and drug conditions which were made using PowerPoint. 
2.6.3.2 Phasic current analysis 
The Mini Analysis programme (synaptosoft, USA) was used. Minimum 200 events were 
taken from the recordings to calculate the amplitude and the inter event interval of the 
IPSCs. Double events were also scanned and were considered in analysis. The cumulative 
probability distributions were plotted for sIPSC amplitude and inter event interval (IEI) to 
compare control and drug conditions using Graph Pad Prism 5 and 7 (GraphPad Software, 
Inc. USA). Raw traces were shown to illustrate the changes in IPSCs amplitude and IEI in 
control and drug conditions (after 15 min of drug application) which were made using 
PowerPoint. 
2.6.1   Statistical analysis 
For extracellular recordings, pooled data are presented as mean ± SEM. Wilcoxon (non-
parametric) signed rank test (ns, not significant, p>0.05; * significant 0.05>p>0.01; ** very 
significant, 0.01>p>0.001, *** extremely significant) was used to determine statistical 
significance for one drug (example: PTX). The Friedman test (*p>0.05, **p>0.01, ***p> 
0.001) was used to detect significant differences for multiple drug applications (example: 
Zolpidem). 
For intracellular recordings, pooled data are presented as mean ± SEM. Significance of 
changes in tonic currents were determined using paired t-tests and Dunn`s multiple 
comparisons using Graph Pad prism software and are designated by p values and *. 
For Phasic currents, a cumulative probability distribution was plotted for sIPSC amplitude 
and inter event interval (IEI) during control and drug conditions. The significance between 
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these two distributions are determined by two sample Kolmogorov-Smirnov test using 
Graph Pad prism software. 
2.6.2   Correlation analysis 
Correlation analysis is a measure of linear relationship of variables with correlation 
coefficient values in between -1 and 1 which was performed in Spike2. 
Auto correlation function of a signal is defined with respect to the signal itself. This means 
that the signal is being compared (for similarity) with a time shift. Mathematically, its function 
is the average of the sequence x(t) with a time shift of m within itself which measure 
periodicity of a signal in time domain format. This analysis was used to identify signals at 
various frequency bands (delta, theta, and gamma) to determine the level of correlation. 
Cross correlation function of a signal is correlation of two independent signals with a time 
shift in one of the two independent signals. This analysis was used to determine temporal 
relationship between two independent signals x(t) and y (t) to estimate the degree to which 
two waveforms are correlated which ranges from -1 to +1. +1 indicates positive correlation, 
-1 indicated negative correlation whilst zero (0) implies no correlation. 
 
2.6.3   Linear regression analysis 
Linear regression is the most commonly used predictive analysis.  Regression analyses are 
used to describe data and to explain the relationship between a dependent variable and 
one or more independent variables. This analysis assembles the data as a single line 
through a scatter plot.  The simplest form with one dependent and one independent variable 
is defined by the formula y = c + b*x (y = estimated dependent, c = constant, b = regression 
coefficients, and x = independent variable). Linear regression analysis was performed in 
Graph Pad Prism software to determine the significance of the elevation or trend (y-
intercepts) of two data sets. 
 
2.6.4   Phase amplitude coupling analysis 
Phase amplitude coupling (PAC), is a type of cross frequency coupling (CFC). PAC analysis 
was performed to determine the coupling of phase of low frequency oscillations and 
amplitude of high frequency oscillations by using a customised MATLAB script 
‘CalleRoutine3’ developed by Tort et al., 2010. To measure PAC, the low (theta) and high 
(gamma) frequency data of 60 s with a sampling rate of 1000 Hz were band pass filtered in 
the range of 3-15 Hz and 30-45 Hz respectively. To remove any phase distortion, the filters 
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were applied to the original time series in the forward and then the reverse direction using 
MATLAB’s function ‘filtering.m’. These zero-phase filtered data were then used to conduct 
PAC studies based on a Hilbert transform. Amplitudes were normalized by subtracting the 
temporal mean and dividing the result by the temporal standard deviation to create the set 
of normalized band-passed signals. Normalization was performed to facilitate comparison 
between different frequency bands (Tort et al., 2010). 
The degree of PAC between theta and gamma oscillations were measured by modulation 
index (MI) in the desired frequency bands: (theta) phase modulating and (gamma) 
amplitude modulated and was represented by bi-dimensional cross-frequency coupling in 
frequency domain in which high coupling was represented by hot (red) colours. Several 
other hotspots observed in some PAC plots could account for harmonic activity or artefacts. 
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3 Characterisation of pharmacologically 
induced theta and gamma oscillations in 
LV of M1 and S1 
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3.1 Introduction 
3.1.1 Oscillations in M1 and S1 
The use of in vitro electrophysiological techniques has enabled a greater understanding of 
neuronal activity, primarily through the use of the brain slice preparation (Yamamoto and 
Mcllwain, 1966; Andersen et al., 1972). Over the last 20 years, this preparation has provided 
insight into the mechanisms underlying oscillations at various frequency ranges. 
Understanding the electrical and neuropharmacological properties of brain networks using 
selective receptor modulators in native tissue enables comparison with such properties with 
those in disease models (e.g. epilepsy and PD). In vivo and in vitro studies have reported 
M1 in execution of voluntary movements and, from both local network in vitro and whole 
brain in vivo perspectives, M1 has shown to generate oscillatory activity at beta frequency 
(Murthy and Fetz, 1992; Baker et al., 1997, Jensen et al., 2005; Yamawaki, 2008, Prokic, 
2011, 2015). However, MEG studies in human have also revealed nested rhythms at theta 
and gamma frequencies (Cheyne et al., 2008) like those of rat hippocampus (Bragin et al., 
1995) and in vivo studies also confirm slow wave oscillations in somatosensory cortex 
including delta and theta band activity (Steriade, 2006). Whilst gamma oscillations have 
been reported in vitro in somatosensory cortex (Buhl et al., 1998), this has not since been 
followed up with detailed mechanistic studies. To date, rhythms in other bands, such as 
delta, theta and alpha frequencies, have not been demonstrated in somatosensory and 
motor cortices in vitro and hence their mechanisms remain unexplored. 
Using a modified sagittal plane slice preparation (Prokic et al., 2015; Johnson et al., 2017; 
Ozkan et al., 2017), with aCSF containing neuro-protectants, we have greatly improved 
brain slice viability, enabling the generation and study of dual rhythms (theta and gamma 
oscillations) in the in vitro sensorimotor slice in the presence of KA and CCh (Johnson et 
al., 2017) and enabling production of theta-gamma and delta waves in vitro for the first time. 
Over the next 3 chapters, this thesis describes the physiology and pharmacology of these 
various rhythms in rat sensorimotor cortex in vitro. 
3.1.2 Significance of gamma oscillations 
Gamma oscillations have been identified to play critical role in cognitive integration in brain 
(Herrmann et al., 2004). They have found to be involved in attention (Tiitinen et al., 1993) 
sensory and motor functions, learning and memory (Hopfield et al., 1995; Lisman and Idiart, 
1995; Buzsaki and Chrobak, 1995; Lisman, 1999) arousal (Struber et al., 2000), language 
perception, focussed attention, recognition (Bouyer et al., 1981; Sheer et al., 1989; Murthy 
and Fetz, 1992; Pfurtscheller and Neuper, 1992) and memory formation, processing and 
retrieval (Buzsaki, 1989; Fell et al., 2001; Kaiser et al., 2003). Besides these role of gamma 
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oscillations in healthy brain, they have been implicated too in disease conditions such as 
hyperactivity disorder (Yordanova et al., 2001), Alzheimer`s disease (Stam et al., 2007) and 
epilepsy (Willoughby et al., 2003), autism (Brock et al., 2002). Gamma oscillations have 
also been found to be profoundly altered in schizophrenia (Moghaddam et al., 2003; Lewis 
et al., 2005) and high-frequency gamma oscillations were reported in cortex before and 
after the onset of epileptic seizures (Allen et al., 1992; Fisher et al., 1992).  
3.1.3 Significance of theta oscillations 
The occurrence of theta rhythm is mostly associated with REM sleep, locomotor activity 
(Jouvet, 1969; Vanderwolf, 1969) and learning and memory (Vertes, 1997; Buzsaki, 2002; 
kowalczyk et al., 2013). It has been suggested that theta oscillations play a major role in 
synchronising long-range circuits, facilitating transfer of information between distant brain 
regions (Sirota et al., 2008; Gordon, 2011; Buzsaki and Watson, 2012). Theta oscillations 
are known to be synchronised with the activity in amygdala, pre frontal cortex, and medial 
septum during cognitive functions (Seidenbecher et al., 2003; DeCoteau et al., 2007; 
Adhikari et al., 2010; Benchenane et al., 2010; Hernandez-Perez et al., 2015) and 
furthermore, gamma oscillations in hippocampus and other cortical regions like M1 are often 
phase-locked to theta rhythm (Bragain, 1995; Canolty et al., 2006; Sirota et al., 2008; 
Montgomery et al., 2009; Colgin et al., 2009; Johnson et al., 2017), suggesting functional 
interactions between theta and gamma rhythms. Hence, theta oscillations contribute to both 
local network function as well as widely dispersed cortico-cortical, and sub-cortical circuits 
(Hernandez-Perez et al., 2015). In vitro studies demonstrate that theta can be 
pharmacologically induced in hippocampus (Kowalczyk et al., 2013) and in cortex (Lukatch 
and Maclver, 1997) using CCh. 
3.1.4 Significance of theta and gamma coupling 
Neuronal network oscillations do not function as single-frequency representations of 
network states, rather, they exist as complex activity patterns that appear to code 
information in cross-frequency relationship between the phase, amplitude and frequency 
components of the various waves. For example, evidence exists that phase-amplitude 
coupling (PAC) contributes to sensory signal detection (Handel and Haarmeier, 2009), and 
memory processes (Tort et al., 2009; Axmacher et al., 2010), maintenance of working 
memory (Lisamn and Idiart, 1995), sequential memory organisation (Lisamn, 2005), 
attentional selection (Schroeder and Lakatos, 2009). According to theoretical models 
(Lisman, 2005), PAC has a functional role in cognitive functions (Lakatos et al., 2008; Tort 
et al., 2008, 2009; Cohen et al., 2009a, b; Axmacher et al., 2010). PAC has been reported 
in vivo in rodent hippocampus (Bragin et al., 1995; Buzsaki et al., 2003; Hentschke et al., 
2007; Tort et al., 2008; Tort et al., 2009; Wulff et al., 2009), rodent basal ganglia (Tort et al., 
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2008), macaque neocortex (Lakatos et al., 2005) and in various cortical and sub-cortical 
regions in humans (Bragin et al., 1995; Buzsaki et al., 2003; Bruns and Eckhorn, 2004; 
Vanhatalo et al., 2004; Mormann et al., 2005; Canolty et al., 2006; Hentschke et al., 2007; 
Demiralp et al., 2007; Osipova et al., 2008; Monto et al., 2008;Tort et al., 2008; Penny at 
al., 2008; Wulff et al., 2009; Tort et al., 2009; Cohen et al., 2009a, 2009b; 2009c; Handel 
and Heermeier, 2009; He et al., 2010; Axmacher et al., 2010; Sadaghiani et al., 2010; 
Voytek et al., 2010). A recent study in our own laboratory, (Johnson et al., 2017) has 
reported PAC in primary motor cortex slices of rats in vitro and this is the first demonstration 
of PAC in cortex in vitro. 
 
3.1.5 M1 and S1 interactions 
Both regions (M1 and S1) have similar laminar structure, though some studies suggest 
absence of LIV in M1 (Donoghue and Wise, 1982; Beaulieu, 1993; Zilles et al., 1995) which 
makes it unique compared to other cortical regions. However, several studies (Krieg, 1946; 
von Bonin, 1949; Caviness, 1975; Deschênes et al., 1979; Skoglund et al., 1997; Cho et 
al., 2004, Kuramoto et al., 2009; Rowell et al., 2010; Mao et al., 2011; Kaneko, 2013; 
García-Cabezas and Barbas, 2014; Yamawaki et al., 2014) suggest the existence of 
connection patterns that are similar to that of LlV in other sensory regions. Topographic 
maps of both M1 and S1 are well established (Brooks et al., 1961, Woolsey 1952, Li and 
Waters 1991) and interactions between these two regions are known to play critical roles in 
motor learning and control skills (Asanuma and Arissian, 1984; Asanuma and Pavlides, 
1997). Recovery of motor function after a brain injury requires changes in structure and 
function (Bornschlegl and Asanuma, 1987) and these changes may be mediated by inter-
cortical interactions between M1 and S1 (Paperna and Malach, 1991). Changes in motor 
function due to the projections from S1 have been reported in several species and vice 
versa. In cats, LTP in M1 is generated by exciting the neurones that project from S1 and 
thalamus to M1 (Iriki et al., 1989). In humans and rodents, somatosensory entrainment 
enhances the excitability of M1 (Luft et al., 2002; Kaelin and Lang et al., 2002). Disrupting 
S1 projections in primates causes disturbances in chewing (Lin et al., 1993, 1998; Hiraba 
et al., 2000), muscle contraction, motor coordination and ability to carry heavy objects 
(Rothwell et al., 1982; Johansson and Westling, 1984; Hikosaka et al., 1985; Brochier et 
al., 1999). It is evident that neurones in S1 fire prior to the onset of actual movement in 
rhesus macaques (Soso and Fetz, 1980) and also in non-human primates (Nelson, 1987). 
This phenomenon, in which somatosensory integration plays a critical role in voluntary 
movements, is termed as efference copy (EC) which was used to distinguish between 
sensory inputs obtained from internal and external stimuli (Wolpert et al., 1995; Helmholtz, 
2011). Physiological properties of individual regions have been well characterised but inter-
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cortical connectivity remains less explored despite its clear functional significance. 
Sensorimotor integration has been studied in-vivo (Wannier et al., 1991; Smith et al., 1983) 
but this does not enable a full understanding of the pathways and local network interactions. 
We have recently developed a novel slice preparation method (details in section 3.3) based 
upon use of numerous neuroprotectants to aid preservation of inhibitory neurons critical for 
maintenance of rhythmic network activity. Using this modified preparation, dual theta-
gamma oscillations could reliably be induced in M1 (Johnson et al., 2017.) and S1. We 
determined to use the same slice preparation to induce theta-gamma activity and to explore 
rhythms generated in both M1 and S1, with a view to exploring potential interactions 
between M1 and S1 in the functionally connected sagittal cortical slice.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
68 
 
3.2 Results 
3.2.1 Induction of theta and gamma oscillations in M1 and S1 
M1 and S1 are adjacent to each other and when simultaneous extracellular LFP recordings 
were performed in deep layers of M1/S1 in the absence of exogenously applied neuronal 
excitants we found no spontaneous oscillatory activity. Subsequently, KA and CCh were 
used to induce oscillations both in M1 and S1. Sagittal sensory motor slices were used in 
these experiments as it was easy to locate M1 and S1 and functional connectivity is well 
preserved (Woodhall, unpublished observations). Since there seems to be greater 
oscillatory power in deeper layers (Yamawaki, 2008) than in superficial, recordings were 
made from LV of both M1 and S1 simultaneously or non-simultaneously from slice type A 
in this section 3.2 (unless otherwise stated) located using the rat brain atlas of Paxinos and 
Watson (Paxinos and Waston, 2012). 
Co-application of 150 nM of KA and 10 µM CCh reliably induced theta (6-11 Hz) and gamma 
(30-40 Hz) oscillations in both M1 and S1 (figure 3.1) which were stable for 3-4 hrs. Mean 
values: theta (M1 7.5 ± 0.2 Hz; S1 7.7 ± 0.3 Hz, n=40) and gamma (M1 33.4 ± 1.2 Hz; S1 
33.7 ± 1.8 Hz, n=40). Whilst, most of the recordings have high gamma power but there are 
some recordings with high theta power (example: Figure 3.10). Therefore, noemalised 
values are used for analysis. Various receptor modulators were bath applied to perform 
pharmacological studies to determine the mechanisms involved in these oscillations. 
`Control` (normalised to 100%) in experiments in this chapter indicates stable theta and 
gamma oscillations where there was no change noticed in frequency and amplitude over 
20 min period. The effect of drug was measured after 40 min of bath application (unless 
otherwise stated) which was compared with control.  
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Figure 3.1 Theta and gamma oscillations were induced both in M1 and S1 in the 
presence of KA and CCh. 
(Ai) raw data of 60 s LFP recording of theta and gamma oscillations in LV of M1 (scale: 20 
μV vs 200 ms) (Bi) in LV of S1 filtered using Bessel IIR filter (scale: 20 μV vs 200 ms). (ii) 
A typical representative power spectrum of 60 s extracellular recording of M1 and S1 (8 Hz 
and 32 Hz) and S1 (7 Hz and 33 Hz). 
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3.2.2 GABAAR modulation of theta and gamma oscillations in M1 and S1 
To uncover the dependence of theta and gamma oscillations on inhibitory mechanisms, 
gabazine (GBZ), a competitive GABAAR antagonist was applied to the solution perfusing 
the slices. 250 nM GBZ significantly attenuated the synchronous activity of gamma 
oscillations but increased the amplitude of theta oscillations both in M1 and S1. In M1, GBZ 
increased the power of theta oscillations to 146 ± 9% of control (n=8, p<0.01 and 
significantly decreased the power of gamma oscillations to 38 ± 2% (n=8, p<0.001) (figure 
3.2A). In S1, GBZ increased the power of theta oscillations to 122 ± 4% of control (n=8, 
p<0.05) and significantly decreased the power of gamma oscillations to 24 ± 3% (n=8, 
p<0.001) (figure 3.2B). 
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Figure 3.2 GABAAR receptor block increases theta oscillatory power whilst 
decreasing gamma oscillatory power in M1 and S1. 
(A) Effect of gabazine (250 nM) on theta and gamma oscillations in M1 (i) Raw data showing
the changes in oscillatory activity before (black) and after (red) drug application of theta
(top) and gamma (bottom) (scale: 20 μV vs 200 ms) (iii) Representative power spectra of
60s of extracellular recording showing peak power before (black) and after (red) gabazine
(iv) Bar graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red
bars) oscillations normalised to control (**p<0.01, *** p<0.001; n=8).
(B) Effect of gabazine (250 nM) on theta and gamma oscillations in S1 (i) Raw data showing
the changes in oscillatory activity before (black) and after (red) drug application of theta
(top) and gamma (bottom) (scale: 10 μV vs 200 ms) (iii) Representative power spectra of
60s of extracellular recording showing peak power before (black) and after (red) gabazine
(iv) Bar graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red
bars) oscillations normalised to control (*p<0.05, *** p<0.001; n=8).
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3.2.3 iGluR modulation of theta and gamma oscillations 
3.2.3.1 AMPAR modulation of theta and gamma oscillations in M1 and S1 
To investigate whether AMPAR are involved in the generation of theta and gamma 
oscillations in M1 and S1, SYM2206 (a specific AMPAR antagonist) was applied to bath. 20 
µM of SYM2206 decreased the gamma activity whilst increasing theta activity both in M1 
and S1. In M1, SYM2206 increased theta activity to 225 ± 12% of control (n=8, p<0.001) 
and significantly decreased gamma oscillations to 32 ± 2% of control (n=8, p<0.001) (figure 
3.3A). In S1, theta oscillations were significantly increased to 301 ± 8% of control (n=8, 
p<0.001) and decreased gamma oscillations to 41 ± 6% (n=8, p<0.01) (figure 3.3B). 
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Figure 3.3 AMPA receptor block increases theta oscillatory power whilst increasing 
gamma oscillatory power in M1 and S1. 
(A) Effect of SYM2206 (20 μM) on theta and gamma oscillations in M1 (i) raw data showing
the changes in oscillatory activity before (black) and after (red) drug application of theta
(top) and gamma (bottom) (scale: 10 μV vs 200 ms) (iii) Representative power spectra of
60s of extracellular recording showing peak power before (black) and after (red) SYM2206
(iv) Bar graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red
bars) oscillations normalised to control (**p<0.01, *** p<0.001; n=8).
(B) Effect of SYM2206 (20 μM) on theta and gamma oscillations in S1 (i) raw data showing
the changes in oscillatory activity before (black) and after (red) drug application of theta
(top) and gamma (bottom) (scale: 10 μV vs 200 ms) (iii) Representative power spectra of
60s of extracellular recording showing peak power before (black) and after (red) SYM2206
(iv) Bar graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red
bars) oscillations normalised to control (**p<0.01, *** p<0.001; n=8).
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3.2.3.2 KA/AMPAR modulation of theta and gamma oscillations in M1 and S1 
After confirming the significance of AMPAR in generation of theta and gamma oscillations 
in M1 and S1 by using SYM2206, CNQX (a KAR/AMPAR antagonist) was used to examine 
the combined impact of KAR and AMPAR on these oscillations.  25 µM of CNQX decreased 
the gamma activity whilst increasing theta activity both in M1 and S1. In M1, CNQX 
increased the power of theta oscillations to 189 ± 14% of control (n=8, p<0.001) and 
significantly decreased the power of gamma oscillations to 44 ± 4% (n=8, p<0.01) (figure 
3.4A). In S1, CNQX increased the power of theta oscillations to 194 ± 16% of control (n=8, 
p<0.001) and significantly decreased the power of gamma oscillations to 58 ± 3% of control 
(n=8, p<0.01) (figure 3.4B) suggesting a role of both KA and AMPA receptors. Specific KAR 
antagonists, UBP 304 and UBP 310 would be beneficial. 
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Figure 3.4 AMPA/KA receptor block increases theta oscillatory power whilst 
increasing gamma oscillatory power in M1 and S1. 
(A) Effect of CNQX (25 μM) on theta and gamma oscillations in M1 (i) raw data showing
the changes in oscillatory activity before (black) and after (red) drug application of theta
(top) and gamma (bottom) (scale: 10 μV vs 200 ms) (iii) Representative power spectra of
60s of extracellular recording showing peak power before (black) and after (red) CNQX (iv)
Bar graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red
bars) oscillations normalised to control (**p<0.01, *** p<0.001; n=8).
(B) Effect of CNQX (25 μM) on theta and gamma oscillations in S1 (i) raw data showing the
changes in oscillatory activity before (black) and after (red) drug application of theta (top)
and gamma (bottom) (scale: 10 μV vs 200 ms) (iii) Representative power spectra of 60s of
extracellular recording showing peak power before (black) and after (red) CNQX (iv) Bar
graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red bars)
oscillations normalised to control (**p<0.01, *** p<0.001; n=8).
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3.2.3.3 NMDAR modulation of theta and gamma oscillations in M1 and S1 
To investigate the dependence of theta and gamma oscillations on NMDAR mechanisms, 
2-AP5, a competitive NMDAR antagonist was applied to bath solution perfusing the slices. 
50 µM of 2-AP5 significantly enhanced the synchronous activity of gamma oscillations but 
had differential effects on amplitude of theta oscillations in M1 and S1. In M1, 2-AP5 had 
no significant effect on the power of theta oscillations (n=8, p>0.05) but significantly 
increased the power of gamma oscillations to 174 ± 7% of control (n=8, p<0.001) (figure 
3.5A). In S1, 2-AP5 decreased the power of theta oscillations to 80 ± 3% of control (n=8, 
p<0.05) and significantly increased the power of gamma oscillations to 180 ± 8% (n=8, 
p<0.001) (figure 3.5B). Although the power spectrum in the figure (Aiii) shows a decrease 
in peak frequency it is not significant when data were pooled. 
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Figure 3.5 NMDA receptor block has differential effects on theta oscillatory power 
whilst increasing gamma oscillatory power in M1 and S1. 
(A) Effect of -2-AP5 (50 μM) on theta and gamma oscillations in M1 (i) raw data showing
the changes in oscillatory activity before (black) and after (red) drug application of theta
(top) and gamma (bottom) (scale: 10 μV vs 200 ms) (iii) Representative power spectra of
60s of extracellular recording showing peak power before (black) and after (red) 2-AP5 (iv)
Bar graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red
bars) oscillations normalised to control (**p<0.01, *** p<0.001; n=8).
(B) Effect of -2-AP5 (50 μM) on theta and gamma oscillations in S1 (i) raw data showing
the changes in oscillatory activity before (black) and after (red) drug application of theta
(top) and gamma (bottom) (scale: 20 μV vs 200 ms) (iii) Representative power spectra of
60s of extracellular recording showing peak power before (black) and after (red) 2-AP5 (iv)
Bar graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red
bars) oscillations normalised to control (*p<0.05, *** p<0.001; n=8).
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3.2.4 Dopamine modulation of theta and gamma oscillations in M1 and S1 
3.2.4.1 DAR modulation of theta and gamma oscillations 
DA was bath applied along with 250 µM ascorbic acid to prevent DA oxidation (Hastings et 
al., 1996) to determine the effect of DAR in generation of theta and gamma oscillations in 
M1 and S1. 30 µM DA enhanced the synchronous oscillatory activity of theta and gamma 
oscillations both in M1 and S1. In M1 DA increased theta to 120 ± 2% of control (n=8, 
p<0.01) and gamma to 148 ± 4 % of control (n=8, p<0.001) (figure 3.6A). In S1, DA 
significantly increased the theta activity to 153 ± 5% of control (n=8, p<0.01) and gamma 
oscillation to 160 ± 6 % of control (n=8, p<0.01) (figure 3.6B) suggesting a role in these 
oscillations. 
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Figure 3.6 Dopamine increases both theta and gamma oscillatory power in M1 and 
S1. 
(A) Effect of DA (30 μM) on theta and gamma oscillations in M1 (i) raw data showing the
changes in oscillatory activity before (black) and after (red) drug application of theta (top)
and gamma (bottom) (scale: 10 μV vs 200 ms) (iii) Representative power spectra of 60s of
extracellular recording showing peak power before (black) and after (red) DA (iv) Bar
graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red bars)
oscillations normalised to control (**p<0.01, *** p<0.001; n=8).
(B) Effect of DA (30 μM) on theta and gamma oscillations in S1 (i) raw data showing the
changes in oscillatory activity before (black) and after (red) drug application of theta (top)
and gamma (bottom) (scale: 10 μV vs 200 ms) (iii) Representative power spectra of 60s of
extracellular recording showing peak power before (black) and after (red) DA (iv) Bar
graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red bars)
oscillations normalised to control (**p<0.01; n=8).
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3.2.4.2 AMPH modulation of theta and gamma oscillations in M1 and S1 
It may be argued that application of micromolar concentrations of dopamine is not 
physiological, and we decided to investigate the effect of endogenously released DA. To 
this end, we applied amphetamine sulphate, which is known to release DA from vesicles by 
direct displacement, as well as to block DA transport across the neuronal membrane. 20 
µM of AMPH was bath applied. AMPH in M1 enhanced the synchronous oscillatory activity 
of theta and gamma oscillations both in M1 and S1. In M1, AMPH had significantly increased 
theta to 171 ± 11% of control (n=8, p<0.001) and gamma to 213 ± 5 % of control (n=8, 
p<0.001) (figure 3.7A). In S1, AMPH significantly increased the theta activity to 196 ± 8% 
of control (n=8, p<0.001) and gamma oscillation to 164 ± 15 % of control (n=8, p<0.001) 
(figure 3.7B). 
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Figure 3.7 AMPH increases both theta and gamma oscillatory power in M1 and S1 via 
DA release. 
(A) Effect of AMPH (20 μM) on theta and gamma oscillations in M1 (i) raw data showing 
the changes in oscillatory activity before (black) and after (red) drug application of theta 
(top) and gamma (bottom) (scale: 20 μV vs 200 ms) (iii) Representative power spectra of 
60s of extracellular recording showing peak power before (black) and after (red) AMPH (iv) 
Bar graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red 
bars) oscillations normalised to control (*** p<0.001; n=8). 
(B) Effect of AMPH (20 μM) on theta and gamma oscillations in S1 (i) raw data showing the 
changes in oscillatory activity before (black) and after (red) drug application of theta (top) 
and gamma (bottom) (scale: 10 μV vs 200 ms) (iii) Representative power spectra of 60s of 
extracellular recording showing peak power before (black) and after (red) AMPH (iv) Bar 
graphs showing pooled peak oscillatory power of theta (grey bars) and gamma (red bars) 
oscillations normalised to control (***p<0.001; n=8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
88 
3.2.5 Summary of results 
The pharmacology of theta and gamma oscillations in M1 and S1 is summarised in the table 
below. 
Drug 
(concentration) 
Region % Change in Control N Significance 
Theta gamma 
gabazine (250 nM) 
[GABAR 
antagonist] 
M1 146 ± 9 38 ± 2 8 **,*** 
S1 122 ± 4 24 ± 3 8 *,*** 
SYM2206 (20 µM) 
[AMPAR 
antagonist] 
M1 225 ± 12 32 ± 2 8 ***,*** 
S1 301 ± 8 41 ± 6 8 ***,** 
CNQX (25 µM) 
[KAR+AMPAR 
antagonist] 
M1 189 ± 14 44 ± 4 8 ***,** 
S1 194 ± 16 58 ± 3 8 ***,** 
2-AP5 (50 µM)
[NMDAR 
antagonist] 
M1 ns 174 ± 7 8 ns, *** 
S1 80 ± 3 180 ± 8 8 *,*** 
Dopamine (30 µM) M1 120 ± 2 148 ± 4 8 **,*** 
S1 153 ± 5 160 ± 6 8 **,** 
AMPH (20 µM) 
[endogenous DA 
release 
M1 171 ± 11 213 ± 13 8 ***,*** 
S1 196 ± 8 164 ± 15 8 ***,*** 
Table 3.1 Pharmacology of theta and gamma oscillations in LV of M1 and S1 
Peak power changes after application of various receptor modulators is represented as 
mean ± SEM when compared to control (normalised to 100%). N= number of recordings 
(obtained from 3 different animals), significance: ns, p>0.05, * p<0.05, **p<0.01, ***p<0.001. 
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3.3 Correlation and Phase-amplitude coupling studies 
As noted above, oscillations at different frequencies coexist and interact with each other                                                                       
in in vivo networks. The ability to investigate such interaction in the in vitro slice preparation 
would, therefore, be invaluable in answering mechanistic questions about cross-frequency 
interactions. To this end, correlation analysis was performed to determine the relation 
between theta and gamma activity in M1 and S1 in vitro, to examine intra and inter regional 
interactions across and between different frequency bands. Auto-correlation analysis was 
conducted for theta and gamma oscillations in M1 and S1 to determine the frequency of 
oscillations. To explore the potential for cross-frequency interactions, cross-correlation 
analysis was performed between theta in M1 and theta in S1, between gamma in M1 and 
gamma in S1 and between theta and gamma oscillations. Analysis of phase-amplitude 
coupling (PAC) was performed between theta and gamma oscillations, with theta frequency 
(3 –12 Hz) as phase and gamma frequency (25-50 Hz) as amplitude that was driven by low 
frequency using a script developed by Tort et al., 2010. PAC was performed on 60 s epochs 
of data in various slice types (refer methods section) and was represented as Modulation 
Index (MI) which indicates the degree of coupling that existed between two oscillations. As 
shown above, results obtained from autocorrelation, as expected, revealed the frequency 
of low frequency in theta range and high frequency in gamma range explaining internal 
positive correlation between each frequency range in a time series. Cross correlation 
analysis showed that theta and gamma oscillatory activity was phase delayed by 5.5 ± 1 
ms and 1 ± 0.3 ms respectively to that of in S1. Average MI of theta and gamma oscillations 
in M1 was found to be 1.6 x 10-4 ± 0.8 x 10-4 (n=5) whilst in S1 it is 1.1 x 10-4 ± 0.5 x 10-4 
(n=5). MI in M1 was higher than of S1 in this intact slice preparation (figure 3.8). However, 
there is no correlation within theta or gamma oscillations between M1 and S1 in slice type 
B (figure 3.10) in which there was a cut made between two regions. Average MI of theta 
and gamma oscillations in M1 was found to be 2.4 x 10-4 ± 1.4 X 10-4 z (n=5) whilst in S1 it 
was 2.1 x 10-4 ± 1.3 x 10-4 (n=5). MI was found to be slightly higher in M1 than in S1 (figure 
3.11). 
Phase lag that was noticed in M1 with reference to S1 in intact slice suggests that theta and 
gamma oscillations originated in S1 (figure 3.8 G, H), however, further investigations 
revealed that when M1 was isolated from S1, both regions produced theta and gamma 
oscillations suggesting the existence of independent local rhythm generators (figures 3.12, 
3.14). In slice type C, the average MI of theta and gamma oscillations was found to be 4.2 
x 10-4 ± 1 x 10-4 (n=5) (figure 3.13). In slice type D, average MI of theta and gamma 
oscillations was found to be 3.6 x 10-4 ± 0.9 x 10-4 (n=5) (figure 3.15). Overall, high coupling 
was found in slice types C and D in which M1 and S1 are isolated along with adjacent 
regions.  
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3.3.1 Correlation and PAC studies of theta and gamma oscillations in slice type A 
Figure 3.8 Theta and gamma oscillations are phase delayed in M1 when compared to 
S1 in slice type A. 
(A) Representative power spectrum of theta and gamma oscillations of 60 s extracellular
recording from LV of M1 and (B) of S1 (C) auto-correlation analysis of theta oscillation in
M1 and (D) in S1 (E) auto-correlation analysis of gamma oscillations in M1 and (F) in S1.
(G) cross-correlation analysis of theta oscillations between S1/S1 (black) and M1//S1 (red)
(H) cross-correlation analysis of gamma oscillations between S1/S1 (black and M1/S1 (red).
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Figure 3.9 Phase amplitude coupling exists between theta and gamma oscillations 
both in M1 and S1 in slice type A 
(Ai) pooled phase amplitude coupling (PAC) graph of theta and gamma oscillations in M1 
(Bi) of S1 (Aii), (Bii) representative comodulogram showing the cross frequency coupling 
in frequency domain, areas of high modulation are in red in M1 (MI=4.08x10-4) and S1 
(MI=1.3x10-4) respectively. 
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3.3.2 Correlation and PAC studies of theta and gamma oscillations in slice type B 
Figure 3.10 No correlation exists between theta and gamma oscillations between M1 
and S1 in slice type B. 
(A) Representative power spectrum of theta and gamma oscillations of 60 s extracellular
recording from LV of M1 and (B) of S1 (C) auto-correlation analysis of theta oscillation in
M1 and (E) in S1 (D) auto-correlation analysis of gamma oscillations in M1 and (F) in S1.
(G) cross-correlation analysis of theta oscillations in M1 and S1 (H) cross-correlation
analysis of gamma oscillations in M1 and S1.
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Figure 3.11 Local phase amplitude coupling exists between theta and gamma 
oscillations both in M1 and S1 in slice type B 
(Ai) pooled phase amplitude coupling (PAC) graph of theta and gamma oscillations in M1 
(Bi) of S1 (Aii), (Bii) representative comodulogram showing the cross frequency coupling 
in frequency domain, areas of high modulation are in red in M1 (MI=6.06x10-4) and S1 
(MI=1.4x10-4) respectively. 
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3.3.3 Correlation and PAC studies of theta and gamma oscillations in slice type C 
Figure 3.12 No correlation exists between theta and gamma oscillations in (M1) slice 
type C 
(A) Representative power spectrum of theta and gamma oscillations of 60 s extracellular
recording from LV of M1 (B) cross-correlation analysis of theta and gamma oscillations. (C)
auto-correlation analysis of theta oscillation in M1 (D) auto-correlation analysis of gamma
oscillations in M1.
Figure 3.13 Local phase amplitude coupling exists between theta and gamma 
oscillations in M1 slice type C 
(A) pooled phase amplitude coupling (PAC) graph of theta and gamma oscillations in M1
(B) representative comodulogram showing the cross-frequency coupling in frequency
domain, areas of high modulation are in red (MI=3.19x10-4).
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3.3.4 Correlation and PAC studies of theta and gamma oscillations in slice type D 
Figure 3.14 No correlation exists between theta and gamma oscillations in (S1) slice 
type D 
(A) Representative power spectrum of theta and gamma oscillations of 60 s extracellular
recording from LV of S1 (B) cross-correlation analysis of theta and gamma oscillations. (C)
auto-correlation analysis of theta oscillation in S1 (D) auto-correlation analysis of gamma
oscillations in S1.
Figure 3.15  Local phase amplitude coupling exists between theta and gamma 
oscillations in S1 slice type D 
(A) pooled phase amplitude coupling (PAC) graph of theta and gamma oscillations in S1
(B) representative comodulogram showing the cross-frequency coupling in frequency
domain, areas of high modulation are in red (MI=1.62x10-4).
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3.3.5 Correlation and PAC studies of theta and gamma oscillations in slice type E 
In this type of micro slice where only M1 and S1 were isolated from rest of the regions, there 
was no activity noticed in the presence of KA (150 nM) and CCh (10 µM). Application of 
double concentrations of KA and CCh also did not induce any oscillatory activity, probably 
because of many cuts that were made in slice preparation as well as suggesting local 
networks are essential for neuronal activity within M1 or/and S1 (data not shown). 
3.3.6 Comparison of modulation index in various slice types 
Bar graph below represents MI in various slice types. Note the significant differences 
between M1 in intact slice (A) and M1 only slice (C)  (**, p<0.01, n=5), S1 in intact (A) and 
S1 only slice (D) (**, p<0.01, n=5), S1 in intact (A) and M1 only slice (C) (***, p<0.001, n=5), 
S1 in cut slice (B) and M1 only slice (C)  (*, p<0.05, n=5). 
Taken together (table below), high percentage (74%) of coupling was observed in slice type 
C, then in slice type D (66%) followed by slice type B (41%) and A (36%). This could 
probably mean the biological differences in each slice obtained daily however needs further 
investigations of the mechanisms behind the coupling. 
Figure 3.16 Bar chart representing modulation index (MI) in various slice types. 
97 
MI (Mean+SEM) of theta and gamma oscillations coupling in M1 and S1 in slice types A, B, 
C and D. 
Slice preparation 
type 
Modulation Index (MI) x 10-4 
mean+SEM (n=5) 
  M1                         S1 
% of slices 
showing 
coupling 
(A) Intact M1&S1 1.6 ± 0.8 1.1 ± 0.5 36 
(B) Cut M1/S1 2.4 ± 1.4 2.1 ± 1.3 41 
(C) only M1 4.2 ± 1 - 74 
(D) only S1 - 3.6 ± 0.9 66 
Table 3.2 Mean modulation index of theta and gamma oscillations in M1 and S1 and 
the percentage of coupling in various slice types. 
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3.3 Discussion 
Initial investigations in the lab (Yamawaki, 2008) using coronal sensorimotor slices that are 
obtained from decapitated animals using standard storage glucose-based aCSF and the 
cutting aCSF was sucrose-based (Aghajanian and Rasmussen, 1989). aCSF in these 
studies contained neuro-protectants such as indomethacin (cyclooxygenase inhibitor, 450 
µM) (Pakhotin et al., 1997). There was no spontaneous activity in these slices, however, 
bath application of KA (400 nM) and CCh (50 µM) (as used by Buhl et al., 1998) induced 
beta oscillations with a mean frequency of 27.8 ± 1.1 Hz which was in consistent with 
previous in vivo studies (Murthy and Fetz, 1992; Baker et al., 1997; Jensen et al., 2005). 
Beta oscillations in M1 were reported to originate in layer V and were dependent on GABAR, 
NMDAR, M1R as well as gap junctions (Yamawaki, 2008). It was only in subsequent years 
it was identified that the slices were less viable and only a very low percentage of slices 
showed oscillatory activity (Prokic, 2011), possibly due to the damage that occurred during 
preparation of slices. Numerous studies have explored this issue and it was indicated that 
addition of neuro-modulators to standard sucrose-based aCSF solutions would enable 
increased viability of slices (Hajos and Mody, 2006). Ascorbic acid is known to be abundant 
in cerebral cortex (up to 500 µM) (Rice, 2000) which was found to be depleted during slice 
preparation. Hence, addition of 1 mM Ascorbate was used to compensate any loss. Taurine 
has been identified to play a role in cell viability (Boldyrev et al., 1999), mitochondrial 
function (Palmi et al., 1999) and intracellular calcium levels (Wu and Prentice, 2010) and 
NAC has been suggested to revive the functioning of mitochondria during brain injury 
(Xiong, Peterson and Lee 1999). Therefore, we (Prokic et al., 2011) decided to modify the 
standard aCSF (see methods chapter for full composition of modified aCSF) by adding 
ascorbate (1 mM), taurine (1 mM) and NAC (2 mM). Also, indomethacin (22.5 µM), uric acid 
(400 µM) and ascorbic acid (300 µM) and aminoguanidine (200 µM) were added to modified 
aCSF as neuro-protectants (Griffiths et al., 1993; Rice et al., 1994; Pakhotin et al., 1997). 
Storage aCSF also contained indomethacin (22.5 µM) and uric acid (400 µM). Slices were 
stored on a storage chamber before recording to enable the above-mentioned neuro-
protectants to be washed off. Also, several studies in the past have suggested that slices 
required an hour of recovery period due to the structural damage that occurred during slicing 
(Hajos et al., 1989; Kirov et al., 1999). Recordings made from slices immediately after slicing 
did not enable the generation of oscillatory activity even in the presence of KA and CCh 
confirming the need for recovery period before recording. 
Pietersen et al., has showed that trans-cardial perfusion using sucrose-based aCSF has 
increased the generation of spontaneous gamma oscillations in hippocampus (Pietersen et 
al., 2009). These modifications and additions to aCSF along with trans-cardial perfusion 
has enabled a better cell viability and improved oscillatory activity to greater extent (about 
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60%) (Prokic, 2011) when compared to original work in the lab (Yamawaki, 2008). 
Recordings made from these slices revealed no spontaneous activity. However, an increase 
in frequency to 29.9 ± 1.0 Hz in coronal plane whilst, 32.66 ± 0.89 Hz in sagittal plane in the 
presence of KA (100-150 nM) and CCh (5-10 µM) was observed since high concentration 
used previously (400 nM) and CCh (50 µM) (Buhl et al., 1998; Yamawaki, 2008) induced 
seizure like activity. This reduced requirement of KA and CCh could be accounted for by 
the modified solutions as well as sagittal plane slicing which aided in better preservation of 
network connections (Prokic, 2011; Johnson, 2016). 
3.3.1 KA and CCh induced oscillations in M1 and S1 
KA has been shown to induce oscillatory activity in sensory cortex (Roopun et al., 2006), 
hippocampus (Fishan et al., 1998; Modebadze, 2014) and entorhinal cortex (Cunningham 
et al., 2003). Wang and Buzsaki have reported that increasing excitatory drive by application 
of KA or CCh induced high power and high frequency gamma oscillations when compared 
to spontaneous gamma in hippocampus (Wang and Buzsaki, 1996). KA alone failed to 
induce oscillations in mouse somatosensory cortex (Buhl et al., 1998). However, co-
application of muscarinic receptor agonist in micro-molar concentration has enabled 
oscillatory activity at gamma frequency (Buhl et al., 1998). Various concentrations of CCh 
(4-60 µM) has enabled the generation of delta, theta and gamma oscillations (Fellous and 
Sejnowski, 2000; Tiesinga et al., 2001). Currently, nested rhythms have become of more 
interest in electrophysiology and may have a role in memory processing, sensory 
information and coding (Lisman and Jensen, 2013). Theta and gamma oscillations were 
observed previously in hippocampus (Soltesz and Deschenes, 1993; Bragin et al., 1995; 
Colgin et al., 2009; Belluscio et al., 2012). Co-application of KA and CCh was found to be 
essential to generate oscillatory activity in M1 (Yamawaki, 2008, Prokic, 2011, Johnson, 
2017).  
Co-application of KA and CCh reliably induced theta and gamma oscillations in both M1 
and S1 and which were stable for 3-4 hrs in line with other in vitro studies (Dickinson et al., 
2003). Beta was initially defined as 25-35 Hz (Murthy and Fetz, 1992) but was redefined as 
20-40 Hz (Murthy and Fetz, 1996 a, b), then as 20-30 Hz (Baker et al., 1999) and the others 
defined as 15 Hz (Traub et al., 1996). It was then considered as low (15-20 Hz) and high 
beta (20-30 Hz). These frequencies overlap with gamma which is either 25 Hz above or 35 
Hz and above (Whittington et al., 1995). The classification of frequency ranges has always 
been in conflict between several studies. Nevertheless, theta was defined as 6-10 Hz and 
gamma as 30-40 Hz in this study. 
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3.3.2 Role of KA and CCh in oscillatory activity 
KA enables neuronal excitation and synaptic transmission (Contractor et al., 2011). It was 
established that KA acts via direct pre-synaptic effect (Cossart et al., 2001) as it enhances 
AP-independent miniature (m) IPSC frequency (Cossart et al., 1998; Frerking et al., 1998). 
Moreover, KA was known to activate KAR by resulting in enhancing the excitability of 
neurons. Furthermore, nanomolar concentrations of KA have been identified to increase 
both sEPSPs and mEPSPs recorded from pyramidal cells (Campbell et al., 2007) by 
postsynaptic depolarisation of excitatory synapses. Nevertheless, in vivo studies in rats 
revealed that low concentrations of KA cause a reduction in GABA mediated inhibition 
(Lerma, 1997) and KA when used in higher concentration can induce seizures (Smolders 
et al., 2002). 
CCh was co-applied along with KA to induce oscillatory activity in M1 and S1. CCh activates 
muscarinic mACh receptors. These receptors are known to be post synaptically expressed 
and are G-protein coupled (Muller and Misgeld, 1986). This receptor depolarises by 
regulating various K+ channels which include leak K+ current (IK-leak), Ca2+ dependent K+ 
current (IAHP), rectifying outward current (IM) (Lucas-Meunier et al., 2003). Moreover, mAchR 
modulates Ih currents which are known to play a critical role in oscillatory activity (Traub et 
al., 2000; Fishan et al., 2002). Furthermore, CCh acts by increasing glutamate release first 
in interneurons by fast hyperpolarisation and then in pyramidal cells via slow depolarisation 
(McCormick and Prince, 1986; Lucas-Meunier et al., 2003). Pirenzepine, a mAChR 
antagonist, was found to abolish CCh induced gamma oscillations (Fishan et al., 1998; 
Fishan et al., 2002).  
3.3.3 GABAAR modulation 
GABAA receptors are ligand gated ion channels. These receptors act by increasing the 
membrane permeability of anions (Cl- and HCO3- ions) which hyperpolarises the membrane 
resulting in inhibition (Rivera et al., 1999). Theta oscillations and gamma oscillations have 
suggested to be dependent on GABAR in several studies (Gokebiewski et al., 1996; 
Konopacki et al., 1997; Buhl et al., 1998; Fisahn et al., 1998; Cunningham et al., 2003; 
Cardin et al., 2009) Theta oscillations were increased upon application of gabazine. The 
increase in power of theta oscillations could attributed to disinhibition (inhibiting the 
inhibitory inputs) generated by theta-off neurons in cortex (Lukatch and Maclver, 1997). 
Gamma oscillations were abolished upon the application of GABAR antagonists in line with 
previous studies in hippocampus, CA3 and cortex (Fisahn et al., 1998; Fisahn et al., 2004; 
Palhalmi et al., 2004; Cunningham et al., 2003; Pietersen et al., 2009). Frequency of gamma 
oscillations were known to be dependent on decay time constant of GABAAR mediated 
IPSCs (Traub  
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et al., 1996). Pentobarbital has shown a decrease in hippocampal gamma frequency owing 
to prolonged IPSC decay kinetics (Segal and Barker, 1984; Modebadze, 2014). Moreover, 
fast spiking interneurons are known to be essential for gamma oscillations in cortex (Cardin 
et al., 2009). However, it was not possible to investigate interactions between pyramidal 
neurons and adjacent interneurons due to experimental limitations in the current study. 
Dependence of theta and gamma oscillations on GABAAR implies the requirement of 
inhibitory currents in M1 and S1 like in hippocampal brain regions (Whittington et al., 1995; 
Fishan et al., 1998, Modebadze, 2014). It is however assumed from the above results that 
gamma oscillations may originate from synaptic mechanisms whilst theta oscillations reflect 
non-synaptic mechanisms since the power of theta increased upon application of GABAAR 
antagonist unlike gamma oscillations (decreased in power). A colleague in the lab has 
recently reported that high concentration (2.5 µM) of GBZ has shown a similar effect as low 
concentration (Johnson et al., 2017) implying the blockade of synaptically driven oscillations 
enhances the non-synaptically driven oscillation (Roopun et al.,2006). 
3.3.4 Glutamate modulation 
Excitatory currents have been identified to contribute to network oscillatory activity in M1 
including delta, theta, gamma and beta oscillations (Yamawaki, 2008; Prokic, 2011; 
Johnson, 2016, Carrecedo et al., 2013), somatosensory cortex of mouse (Buhl et al., 1998) 
and in hippocampus (Fisahn et al., 1998; Modebadze, 2014).  
SYM2206, an AMPAR antagonist (Pelletier et al., 1996) abolished gamma oscillations, 
whilst increasing theta oscillations in M1 and S1. When CNQX, a KAR/AMPAR antagonist 
was bath applied, similar effects to that of SYM2206 were observed. Requirement of KAR 
and AMPAR mediated excitation for the generation of gamma oscillations has been 
previously reported in various studies in hippocampus (Whittington et al., 2000; 
Cunningham et al., 2003; Pietersen et al., 2009). Gamma oscillations in M1 and S1 
represent PING-like oscillations based on their reliance on phasic excitatory transmission 
(Whittington et al., 2000) and are not comparable to beta oscillations in M1 which were 
insensitive to AMPAR block (Yamawaki, 2008). Gamma oscillations have been shown to 
be altered upon the reduction of AMPAR mediated EPSPs in GluA3 and A4 subunits 
(expressed on PV+ interneurons) KO experiments suggesting a role of specific sub-unit 
expression on interneurons in oscillatory activity (Fuchs et al., 2007). Increases in the power 
of theta oscillations is in consistent with a study performed in the conditions of decreased 
AMPAR activity in hippocampus (Gillies et al., 2002) and it was suggested that a subset of 
interneurons have set this theta frequency. This could mean the existence of neuronal 
population with similar intrinsic properties to that of in hippocampus that are being recruited 
in the conditions suppressing AMPA currents. Further investigations of neuronal 
populations in M1 and S1 using optogenetic or labelling studies would be beneficial. 
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It was previously reported that NMDAR blockade induced an increase of beta frequency 
oscillatory power in M1 (Yamawaki, 2008). We found the NMDAR antagonist, 2-AP5, 
increased gamma oscillations in M1 and S1 whilst decreasing theta power in S1, but no 
effect on theta oscillations in M1. NMDAR have shown differential effect on gamma 
oscillations in various studies. For instance, no significant change was identified in KA 
induced gamma oscillations (Fishan et al., 2004). In contrast, spontaneous gamma 
oscillations were decreased, and KA induced activity was increased in the presence of 
NMDAR antagonist, AP-5 (Pietersen et al., 2009). CCh induced gamma oscillations have 
been reported to be enhanced upon NMDAR suppression (Modebadze, 2014) in 
hippocampal slices. Similar results were identified with NMDAR modulators at delta 
frequency in M1 and S1 as well (see chapter 4 and 5). GluN1 subunit played a significant 
role in neuronal activity as knocking out this specific subunit has increased firing rate of 
pyramidal neurons and decreased synchrony in cortex (Belforte et al., 2010). It was also 
evident that, increase in theta oscillations, decrease in the gamma oscillations and altered 
theta and gamma coupling have been identified in PV+ interneurons using GluN1 KO mice 
experiments (Korotkova et al., 2010) suggesting NMDAR that is localised on GABAergic 
interneurons drive them to spike at gamma frequency (Borgers and Kopell, 2003). Increase 
in theta power in S1 could mean that there are more cells available to entrain at theta 
frequency and no change in M1 could be attributed to the region-specific organisation 
suggesting a need for various subunit expression investigations using KO studies. However, 
theta oscillations were found to be increased when non-competitive antagonists MK-801 
and ketamine were bath applied by a colleague in lab (Johnson et al., 2017) which contrasts 
with an in vivo study in hippocampus has shown a reduction of theta oscillations using 
ketamine (Sabolek et al., 2009) in accordance with Gillies et al., (2002) suggesting a need 
for further studies using various receptor modulators.  
 
3.3.5 DA and AMPH modulation 
D1-like receptors have identified to be abundantly expressed on pyramidal neurons in deep 
layers of M1 (Vitrac et al., 2014) with D1R located on soma and D5R on apical dendrites 
(Awenowicz and Porter, 2002). However, Both D1 and D2 like receptors are known to be 
localised on PV+ interneurons that are present in deep layers (Le Moine and Gasper, 1995). 
DA plays a critical role in network activity in M1 (Alexander et al., 1986). Exaggerated beta 
oscillations (12-30 Hz) have been reported in DA depleted conditions associated with PD 
(Bevan et al., 2002). DA is known to oxidise which was noticed by colour change. Hence, 
Ascorbic acid was added to prevent this. Ascorbic acid on it own at the concentrations used 
in our study did not affect oscillations. Ozkan et al., (2017) demonstrated that “bath 
application of DA resulted in a decrease in gamma power with no change in theta power. 
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However, application of either the D1-like receptor agonist SKF38393 or the D2-like agonist 
quinpiroleco increased the power of both theta and gamma suggesting that the DA-
mediated inhibition of oscillatory power is by action at other sites other than classical DA 
receptors”. In the current study, when DA was bath applied, it increased the power of both 
theta and gamma in M1 and S1 respectively. There could be several possible mechanisms 
as to why DA enabled the excitation as following: In vivo studies have revealed that 
administration of DA in to M1 of awake rat enhanced excitability (Storozhuk et al., 2004) in 
accordance with previous work in LV of primate M1 in which DA increased the spontaneous 
activity of the neurons (Sawaguchi et al., 1986). Activation of D1 receptors on pyramidal 
neurons or D2 receptors in interneurons (by inhibiting the inhibitory drive) could be the basis 
for excitation. Similarly, there is evidence that D2 antagonists, but not D1 receptor 
antagonists decreased the excitability of pyramidal neurons in motor cortex of rats (Hosp et 
al., 2009). Also, α-adrenergic receptors have shown to contribute to DA mediated responses 
(Yang et al., 2014). Moreover, D1R, via PKA cascades has reported to directly influence 
the function and trafficking of iGluRs. For instance, PKA increases the surface expression 
of NMDA and AMPA receptors (Snyder et al., 2000; Hallett et al., 2006) trafficking could be 
a result of direct interaction between D1 and NMDAR (Lee et al., 2002; Scott et al., 2006). 
Furthermore, it was evident from recent years that DA directly modulates GABAAR (Hoerbelt 
et al., 2015) which could form the grounds for increase in power of theta and gamma 
oscillations in M1 and S1. The mechanism involved here could be disinhibition in which 
increase in GABA would increase inhibiton on inhibitory interneurons which is enhancing 
the power through consequent increased excitation of principal cells. Given the ubiquity of 
GABAARs, it might be beneficial to perform investigations using selective and specific drugs 
that target DA-GABA mechanisms. Amphetamine sulphate, a potent CNS stimulant, when 
bath applied has shown a significant increase in power of theta and gamma oscillations to 
in M1 and S1 similar to that was observed upon DA application.  AMPH enhances DA levels 
by inhibiting DA uptake via (dopamine transporter) DAT, facilitates the release of DA from 
vesicles to cytoplasm and by enabling the DAT mediated reverse transit from cytoplasm to 
extracellular space (synaptic cleft) independent of action potential mediated vesicular 
release (Richfield et al., 1989; Fleckenstein et al., 2007) which was termed as DA efflux 
enabling increased locomotion (German et al., 2015; Kopra et al., 2017) in line with a study 
suggesting extracellular dopamine levels have indicated to be higher after AMPH 
administration in rats (O`Leary et al., 2016.). This may explain DA mediated effects of 
AMPH. Auto-radiographic investigations have shown that deep layers (LV and LVI) of motor 
areas (M1 and S1/2) have been identified to be innervated by dopamine (Descarries et al., 
1987; Berger et al., 1988) which may suggest a robust disruption of M1 and S1 interactions 
in PD pathophysiology caused due to DA depletion suggesting a requirement for further 
research. 
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3.3.6 Possible mechanism of theta and gamma oscillations in M1 and S1. 
Co-application of KA and CCh at very low concentrations (150 nM and 10 µM CCh) 
compared to earlier studies (Buhl et al., 1996, Yamawaki, 2008) reliably induced theta and 
gamma oscillations both in M1 and S1. Basic pharmacology performed using various 
receptor modulators has revealed the contribution of GABAAR, NMDAR, AMPAR as well as 
DAR. Gamma oscillations were decreased by GABAAR antagonists (gabazine and 
picrotoxin) and also by AMAPAR antagonist (SYM2206), whilst increasing theta power in 
these cases. GABABR antagonist (CGP55845), GABA positive modulators such as 
diazepam, zolpidem, NMDAR antagonist (MK 801) and mGluR antagonists have shown an 
increase in both oscillations (Johnson et al., 2017). Theta and gamma oscillations were 
found to be reliant on gap junctions as the activity was abolished when carbenoxolone, a 
gap junction blocker was bath applied (Johnson et al., 2017) which in consistent with beta 
oscillations in M1 (Yamawaki et al., 2008) and delta oscillations (chapter 4). Dependence 
of oscillatory activity of mAchR in M1 reflects the incidence of oscillatory activity using CCh 
(Johnson et al., 2017) along with KA and was proved by bath application of mAchR 
antagonist. Atropine abolished both theta and gamma oscillations (Johnson et al., 2017) in 
consistent with various studies (Konopacki et al., 1987; Lukatch and MacIver, 1997; Buhl et 
al., 1998; Fisahn et al., 1998). 
 
3.4 M1 and S1 interactions in various types of slice preparations 
3.4.1 Correlation studies 
It is evident that the relation between sensory inputs and movements is facilitated by 
interactions within primary motor and primary sensory cortices. Exploration of environment 
by whisker movements and this feedback from sensory inputs aids further movements as 
seen in rodents (Nguyen and Kleinfeld, 2005) as well as in primates (Murthy and Fetz, 1996) 
suggesting a critical role of sensory motor circuits in integration and synchronising activity. 
Sensorimotor areas also show an association with several other regions like cerebellum 
(Popa et al., 2013), cerebral cortex, spinal cord and basal ganglia in order to aid voluntary 
movements (Wichmann and DeLong, 1999). Anatomical studies have reported that M1 
receives sensory input from S1 and thalamus (Zin-Ka-Leu and Arnault, 1998; Miyachi et al., 
2005).  The reciprocal connections between M1 and S1 have been known to be well 
preserved by optimum plane sensorimotor slice preparation developed by Rocco et al., 
(2007). Auto correlation studies revealed the frequencies of the above described dual 
rhythm to be in theta and gamma range. Theta in between two regions have shown a 
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significant correlation and so did gamma between M1 and S1. However, both theta and 
gamma frequencies have revealed a significant phase delay in M1 to that of S1 suggesting 
S1 to be the possible origin of oscillatory activity of this dual rhythm (theta and gamma). 
This is in accordance with several electrophysiological investigations which suggested that 
neuronal network activity of M1 was regulated by S1 (Kosar et al., 1985; Zarzecki et al., 
1989; Kaneko et al., 1994; Farkas et al., 1999; Kelly et al., 2001). Interestingly, cross-
correlation studies performed in M1 and S1 at beta frequency (Prokic, 2011) has revealed 
near synchrony since there were no significant phase differences. However, there was a 
delay in desynchronising oscillatory activity in M1 suggesting that activity in S1 preceded 
that of M1 based on the fact that sensory information is being transferred to M1 from S1 
(Ferezou et al., 2007) and that the connections from S1 to M1 dominate (Izraeli and Porter, 
1995; Welker et al., 1998). It was found that oscillatory activity in S1 was first abolished 
followed by M1 when zolpidem was bath applied reflecting the dominant projections from 
S1 to M1 and could also mean that S1 sets the rhythm and M1 follows (Prokic, 2011).  
Interestingly, in slice type B, there was absolutely no correlation between M1 and S1 
suggesting the loss of crucial connections between M1 and S1 with the cut made in this 
type of slice between two regions based on the fact that there are direct connections 
between the two regions in rodents and cats (Asunama et al., 1981; Donoghue and Parham, 
1983; Porter and Sakamoto, 1988; Izraeli and Porter, 1995). Although there were intra and 
inter-cortical connections between M1 and S1, those between LVa of S1 to L2/3 and LVa 
of M1 and reciprocal connections to S1 from LVa and LVb are probably the two most 
important connections (Mao et al., 2011) and the cut that was made was is assumed to 
have disrupted these connections. It was suggested that onset of movements have 
occurred upon S1 stimulation, both in healthy and pathological states (Johansson et al., 
1993; Hamdy et al., 1998; Kaelin-Lang et al., 2002) as well as prevention of sensory inputs 
using local anaesthesia has disrupted motor control (Edin and Johansson, 1995) and 
complex motor skills (Sakamoto, 1989). Also, activity in M1 was eliminated upon the 
inactivation of S1 (Anderson, 1995) suggesting that connections between M1 and S1 has 
functional significance. In isolated slice types C (M1 only) and D (S1 only), dual oscillations 
(theta and gamma) have been induced using KA and CCh suggesting the ability of individual 
regions to generate oscillatory activity independent of each other. The local networks seem 
to be sufficient for this dual rhythm generation. However, these slices were intact with 
neighbouring regions and to investigate the role of regions surrounding both M1 and S1, 
slice type E was used. This slice is a segregated micro slice of just M1 and S1 isolated from 
every possible surrounding region, which did not enable any oscillatory activity probably 
due to several cuts made to obtain this slice or the involvement of sub cortical connections 
in generating oscillatory activity, which may need further exploration. 
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3.4.2 Phase-amplitude coupling (PAC) studies 
Interactions between two different types of oscillations is defined as cross-frequency 
coupling (CFC) and has been identified in EEG, ECog and LFP recordings (Bragin et al., 
1995; Lakatos et al., 2005; Canolty et al., 2006; Demiralp et al., 2007; Jensen and Colgin, 
2007; Cohen, 2008; Kramer et al., 2008; Young and Eggermont, 2009). Phase amplitude 
coupling between theta and gamma oscillations, where the phase of low frequency (theta) 
oscillations modulates the amplitude of high frequency (gamma) oscillations has been of a 
particular interest in recent years (Bragin et al., 1995; Canolty et al., 2006; Demiralp et al., 
2007; Hentschke et al., 2007; Jensen and Colgin, 2007; Kramer et al., 2008; Cohen, 2008; 
Cohen et al., 2009a,b; Handel and Haarmeier, 2009; Lakatos et al., 2005, 2008; Schroeder 
and Lakatos, 2009; Tort et al., 2008, 2009; Wulff et al., 2009; Young and Eggermont, 2009; 
Axmacher et al., 2010; McGinn and Valiante, 2014; Lega et al., 2016; Sotero, 2016; 
Chehelcheraghi et al., 2017; Johnson et al., 2017).  
In the current study, PAC was performed between theta and gamma oscillations, with theta 
frequency (3 –14 Hz) as phase and gamma frequency (25-50 Hz) as amplitude that was 
driven by low frequency using a MATLAB script developed by Tort et al., 2010. PAC was 
performed on 60 s epochs of data in various slice types (refer methods section) and was 
represented as Modulation Index (MI) which indicates the degree of coupling that existed 
between two oscillations. It was interesting to note that not every slice has shown a coupling 
and the percentage of slices that exhibited coupling varied according to slice type. High MI 
was found in slice types C and D in which M1 and S1 are isolated along with adjacent 
regions. Low MI was observed intact slice (type A) than in cut slice (type B) suggesting that 
there are connections between two regions in intact slices that are involved in suppression 
of PAC. Although the MI equation was first applied (to our knowledge) to neuroscience 
studies in 1998 (Tass et al., 1998), it was not until 2008 that it was applied to phase-
amplitude coupling analysis (Tort et al., 2008) in which the phase-amplitude distributions 
were analysed. Comodulograms is a bidimensional colour map used to measure coupling 
as described by Tort et al., (2010) and was previously performed by various studies (Canolty 
et al., 2006; Tort et al., 2008; Tort et al., 2009; Colgin et al., 2009). Coupling was found to 
vary with each slice. This could probably mean the biological differences such as viability 
of each slice, receptor expression, interneurons and pyramidal cell expression in each slice 
obtained daily however, the need for further investigations is high to uncover possible 
mechanisms behind the coupling. 
Modulation of gamma oscillations by theta oscillations has been reported previously in 
hippocampus in in vitro (Fisahn et al., 1998) and in vivo studies (Bragain et al., 1995; 
Penttonen et al., 1998; Csicsvari et al., 2003) and this may be due to the contribution of two 
distinct sets of interneurons. A study reported that, during gamma oscillations O-LM cells 
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fire at theta frequency (every 4-5 gamma periods), whereas basket cells fire at each gamma 
cycle (Gloveli et al., 2005b).  
PV+ interneurons could form the basis for high coupling in M1 based on the evidence that 
PV+ interneurons contribute to generation and coupling of theta and gamma oscillations 
since selective removal of fast synaptic inhibition from PV+ cells using transgenic mouse 
protocols (Wulff et al., 2009) effectively abolished theta-gamma rhythmogenesis. This 
suggests fast synaptic inhibition could form the basis for cross frequency coupling (Bragin 
et al., 1995; Buzsaki et al., 2002; Bartos et al., 2002; Gloveli et al., 2005a; Tort et al., 2007). 
Since each subtype fire at distinct patters (phase) each subtype of interneurons probably 
has a unique role in entraining nested rhythms in various regions. 
Moreover, McGinn and Valiante have reported that inter-laminar (deep and superficial 
layers) synchrony within human cortex is linked to the degree of coupling between the theta 
and gamma oscillations (PAC) (MacGinn and Valiante, 2014) which is inconsistent with a 
study in rat cortex and striatum (von Nicolai et al., 2014). Theta frequency displays phase 
differences between deep and superficial layers which are not uniform (Florez et al., 2013) 
and these oscillations are coordinated between layers. To further investigate this, McGinn 
and Valiante performed phase-dependent power correlations, and phase coherence 
(PDPC) studies (Womelsdorf et al., 2007) which revealed that “both theta power and theta 
synchrony are related to one another between [deep and superficial] cortical laminae. At 
the population level, increases in theta power within the LFP may arise from increased 
synchrony and/or number of theta generating elements (i.e., neurons or small circuits; 
Buzsaki et al., 2012) and possibly increased spiking (Reimann et al., 2013)” (MacGinn and 
Valiante, 2014). They have also demonstrated that significant correlation existed between 
PAC and PDPC mostly within theta band (4-12 Hz) and is particularly strong in deep layers 
suggesting PAC increases with increase in theta synchrony between the layers. Given the 
dominance of cortico-cortical projections (Douglas and Martin, 2004) in superficial layers 
and output to subcortical regions in deep layers, theta oscillations may repesent a 
mechanism of coordinating cortical outputs. Inter-laminar synchrony at theta frequency may 
have been well preserved in slices with isolated cortical regions such as M1 and S1 (sub-
cortical connections being cut off) and this could probably reflect high coupling in isolated 
slices compared to intact slices and also providing scope for further investigations. 
Pharmacological agents such as ketamine have been reported to influence PAC (Caixeta 
et al., 2013). In their study, an NMDAR antagonist, ketamine, has shown a dose dependent 
effect on theta and gamma coupling with an increase in PAC at low dose and decrease in 
PAC at high doses. Therefore, it is essential to perform PAC before and after various 
receptor modulators or even throughout the recording to identify how various receptors are 
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contributing to PAC. This is not explpored in our study but gives plenty of room for future 
work.  
Interestingly, human hippocampus and cortex exhibited different properties in that PAC in 
hippocampus was the strongest at the phase of slow theta band (2.5-5 Hz) and both low 
(35-70 Hz) and high gamma (70-130 Hz) whilst, the phase of high theta band (4-9 Hz) was 
preferred with low gamma exhibiting greater coupling in cortex (Lega et al., 2016). This 
observation may prove the difference between hippocampal theta oscillations among 
humans (< 5Hz) and rats (6-12Hz) (Lega et al., 2012; Watrous et al., 2013; Jacobs et al., 
2014). It would be beneficial to apply these frequency specific studies in the PAC data that 
was observed in M1 and S1 of rat slices. 
 
3.5 Final conclusions 
Trans-cardial perfusion, sagittal slice preparation, modified aCSF solution as well as 
addition of neuro-protectants have greatly increased slice viability. Co-application of KA and 
CCh induced persistent theta and gamma oscillations. This dual rhythm was identified to be 
led by S1 in an intact slice but both M1 and S1 have individual rhythm generators. These 
nested oscillations seem to have distinct mechanisms and were identified to be coupled 
from PAC analysis. However, the percentage of coupling varied in various types of slice 
preparations with high modulation index (MI) in M1 only slice followed by S1 only slice when 
compared to intact slice preparations. 
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4 Characterisation of pharmacologically 
induced delta oscillations in LV of primary 
motor cortex (M1) 
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4.1 Introduction  
4.1.1 Neurochemical aspects of the sleep-wake cycle 
The sleep-wake cycle is associated with electrical and chemical changes that enable the 
transition between various sleep and awake states. However, overall orchestrated co-
ordination of these electrical and chemical processes in specific brain regions have yet to 
be explored. We now know that neurons in various regions in the brain such as 
hypothalamus and brain stem undergo transitions between states via regulated release of 
various neuromodulators in cortex and thalamus and these are discussed below: 
Acetylcholine (ACh) has been identified to play a role in both sleep and awake states. 
Cholinergic neurons fire at high frequency in the awake state whilst showing no activity in 
REM sleep. The NREM state has been shown to have an intermediate cholinergic tone 
(Hobson et al., 2003; Espana and Scammell, 2004; Jones, 2005). Interestingly, ACh 
neurons in pedunculopontine (PPN), have been identified to have high firing rates both in 
wake and REM sleep (Wake-ON) more in REM than wake or non-REM sleep (REM-ON) in 
which the increased firing was observed 20-60 s prior to state change. This shift in patterns 
has been suggested to underpin the role of PPN in desynchronizing the cortex during awake 
and REM states (Steriade et al., 1990). 
Dopamine (DA) plays a key role in arousal and sleep states. DA has been implicated in 
awake-associated behaviours such as movement, cognition and arousal as lesioning 
dopaminergic innervations has shown to decrease arousal. In Parkinson’s, a neuro-
degenerative disease with symptoms caused by depletion of DA, sufferers show difficulty 
in active awake-state maintenance. CNS stimulants such as amphetamines and cocaine 
act on dopaminergic systems which enhances arousal, increased vigilance and attention 
either by stimulating DA release or by inhibiting re-uptake. Interestingly, compounds like 
caffeine, that does not act via DA systems, may also influence DA release in the synaptic 
cleft (Schultz and Miller, 2004; Boutrel and Koob, 2004; Espana and Scammell, 2004; 
Wisor, 2005; Jones, 2005). Despite the above evidence that DA is critical for arousal, it has 
not traditionally been grouped with the reticular activating system based on the fact that DA 
neurons fire at equal rates both in awake and sleep states (Trulson et al., 1981). 
Histamine (HA) was found to be wake promoting from the fact that histaminergic neurons 
fire at higher rates in awake state while remaining silent during REM and NREM sleep 
(Takahashi et al., 2006), which was revealed in electrophysiological recordings. 
Furthermore, increased sleepiness is an unwanted side effect of some anti-histamines 
(Hobson et al., 2003; Jones, 2005). 
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Serotonin (5-HT) also has been implicated in wake promoting since serotonergic cells fire 
at a maximum rate in awake state with progressive decline in activity in NREM sleep and 
no activity in REM sleep.  However, the activity was found to be resumed prior to the end 
of REM episodes (McGinty and Harper, 1976; Trulson and Jacobs, 1979). Although 
evidence supports the role of 5-HT in the awake state, there is controversy over its role in 
sleep (Jones, 2005; Espana and Scammell, 2004). Studies suggest this confusion is 
probably due to many receptor subtypes as well as many activities attributed to 5-HT 
(Espana and Scammell, 2004; Jones, 2005). 
GABA concentration was found to be the highest in cortex during NREM sleep and is 
reduced in REM sleep in comparison to awake state (NREM>awake>REM) (Vanini et al., 
2011). Increased levels of extracellular GABA may indeed enhance synaptic inhibition 
whereby balancing synaptic inhibition and excitation in slow wave sleep (Haider et al., 2006; 
Rudolph et al., 2007). However, several studies have identified co-release of GABA with 
ACh and HA suggesting decreased levels of GABA in NREM sleep (Saunders et al., 2015; 
Yu et al., 2015). 
4.1.2 Significance of delta oscillations 
Delta oscillations have been implicated both in deep sleep state and awake states 
performing cognitive tasks. This apparent contradiction was explained by the existence of 
some type of inhibition during task that would inhibit the non-relevant neuronal activity 
(Vogel et al., 1968) known as behavioural inhibition (Kamarajan et al., 2004; Knyazev, 2007; 
Putman, 2011). Behavioural studies on humans showed that delta oscillations which are 
prevalent in deep sleep may mediate an enhancement in declarative memory (Huber et al., 
2004; Aeschbach, 2009). Rotation adaption tasks on human subjects performed in this 
study showed a greater correlation between increases in the 1-4 frequency range and 
improved task performance after sleeping in EEG of cerebral cortex (Huber et al., 2004). 
Sleep has been suggested to facilitate memory consolidation by strengthening and 
stabilising memories (Gais et al., 2000; Stickgold et al., 2000; Maquet, 2001; Walker and 
Stickgold, 2006; Rasch and Born, 2013). It was demonstrated that better performance was 
observed in a group that were allowed to sleep after learning compared to a group that were 
awake after learning. Besides consolidation of previously acquired memories sleep also 
plays a role in acquisition of new memories (Van Der Werf et al., 2009) which was proved 
in a study where short period of sleep preceding learning has enabled a greater capacity to 
encode information (Mander et al., 2011). Also, it has been reported that the synaptic 
plasticity associated with low frequency oscillations during sleep contribute to memory 
consolidation processes (Steriade and Timofeev, 2003). Interestingly, some studies have 
suggested a role for the phase component of delta oscillations in decision making and signal 
detection (Basar-Eroglu et al., 1992) by rhythmically modulating the rate of sensory 
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information received over time (Wyart et al., 2012) and in many cognitive processes (Basar 
et al., 2001). Delta oscillations are also known to play a critical role in pathological 
conditions: decreased synchronous delta activity was observed in schizophrenic patients 
(Ford et al., 2008), reduced delta amplitude and coherence in Alzheimer’s patients 
(Guntekin et al., 2008; Yener and Basar et al., 2010) increased delta power in Parkinson`s 
patients under medication (Kryzhanovskii et al., 1990) and disrupted delta activity in 
epilepsy (Tao et al., 2011; for review see Harmony, 2013). 
Despite its functional significance, cellular mechanisms of cortical delta rhythmogenesis and 
its mechanistic origin have not yet been explored. There is a hypothesis that the cortical 
delta rhythm was mediated by intrinsically bursting neurons (Amzica and Steriade, 1998) 
however, in that study the usage of depolarising current pulse (intercellular injections) did 
not match with long lasting hyperpolariaation conditions during sleep reported in cortex 
(Steriade et al., 2001; Timofeev et al., 2000). This leads to further discrepancies regarding 
the mechanism underlying cortical delta rhythm. A recent study in slices containing 
secondary somatosensory/parietal area (S2/Par2) has revealed generation of delta 
oscillations in vitro by maintaining neuro-modulatory state equivalent to deep sleep state 
(Carracedo et al., 2013). Our current study performed on LV of M1 demonstrates the 
generation of delta oscillations by pharmacological manipulations and investigates the 
contribution of various receptors involved in the rhythm generation and the pharmacological 
equivalent awake state. Characterisation of delta rhythm in control slice preparations may 
facilitate understanding of the mechanisms underlying various pathological conditions like 
Alzheimer’s disease. 
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4.2. Pharmacology of delta oscillations in M1. 
4.2.1 Pharmacological induction of delta oscillations in M1 
It is evident that there was no spontaneous activity in M1, however, it was possible to induce 
activity by pharmacological manipulations. Theta (6-10 Hz) and gamma (30-37 Hz) 
oscillations were induced by co-application of 150 nM of KA and 10 µM of CCh (see chapter 
3 for details). Delta (2-4 Hz) oscillations were induced by mimicking the neuromodulatory 
state of deep sleep via low dopaminergic and cholinergic tone. KA (150 nM) and CCh (10 
µM) was added half an hour prior to recording as this gave time for slices to settle into 
rhythmic activity. Theta (6-10 Hz) and gamma (30-37 Hz) oscillations emerged after half an 
hour. At this point, a bath solution (aCSF) which contained KA (150 nM) and CCh (10 µM) 
was changed to the one that contained: KA (150 nM), CCh (2 µM), SCH23390 (10 µM) and 
Haloperidol (10 µM). Application of either D1 or D2 antagonist along with low CCh did not 
induce delta oscillations indicating the need for both D1 and D2 receptor antagonists to 
induce delta activity. There was a transition from fast oscillations: Theta (6-10 Hz) and 
gamma (30-37 Hz) to slow oscillations: slow theta (5-7 Hz) and beta oscillations (25-30 Hz) 
before a high amplitude delta oscillation (2-4 Hz, ~400 μV2, n=200) with mean frequency 
3.1 ± 0.2 Hz emerged (figure 4.1, 4.2). 
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Figure 4.1a Pharmacological induction and transition of delta oscillations (2-4 Hz). 
(A) Representative extracellular voltage recordings of activity during development of delta
rhythm in SCH23390 & haloperidol. Gamma (30-40 Hz), beta (25-29 Hz), theta-1 (6-10 Hz),
theta-2 (5-7 Hz) and delta (2-4 Hz) oscillations (scale: 20 μV x 500 ms). (B) Power spectra
of oscillatory activity during application of SCH23390 & haloperidol in 30 min (dotted line),
in 60 min (red line). Note how gamma-theta activity gradually shifted into beta and slow
theta (5-7 Hz) oscillations (dotted), before a high amplitude (20-400 µV2) delta rhythm (red)
emerged.)
Figure 4.1b. Representative typical delta oscillation in LV of M1 (2-4 Hz) 
(A) Raw data of an example typical delta oscillation recorded from LV of M1 (B)
representative power spectrum of pharmacologically induced delta activity in
neuromodulatory state (low dopaminergic and low cholinergic tone).
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At the beginning of this project, low cholinergic and low dopaminergic states were induced 
only after prior induction of theta and gamma oscillations, hence, delta oscillations appeared 
relatively late into experiments. In order to save time and to keep slices viable, later 
experiments were started off by bath application of low CCh, KA, D1 and D2 antagonists 
and this was also found to reliably induce delta oscillations (stable for 2-3 hr) in 73% of 
slices. This approach enabled me to perform pharmacological studies using various 
receptor modulators. In the following report, ‘control’ (normalised to 100%) refers to a period 
where stable delta oscillations were present and there was no change noticed in frequency 
and amplitude over 20 min period. The effect of drug was then measured after 40 min of 
bath application (unless otherwise stated) which was then compared with control. 
4.2.2 Laminar studies of delta oscillations through M1 
Investigations were performed in sagittal slice preparation as it contained intact M1-S1 
connections as well as easily identifiable gross anatomy. All layers except Ll showed delta 
activity however, relative power reduced from deep to superficial layers. To address this, 
simultaneous recordings across the layers (Lll, Llll, LV, LVI) were examined. Figure 4.2 A, 
B shows the power in various layers with LV being normalised to 100%. To further 
investigate if LV was the source of origin for delta oscillatory activity, recordings were made 
by placing a reference electrode in LV and ‘walking’ a second electrode up the layers V to 
ll. The data obtained from each layer were analysed by performing cross-correlation 
analysis with data from LV as reference point. These cross-correlation studies showed that 
oscillatory activity in LII and Lllll was phase delayed to that of LV. The average time lag was 
found to be 2.4 ± 0.4 and 2.3 ± 0.6 ms for Lll and Llll respectively. However, delta oscillatory 
activity in LVI was found to precede to that of LV by 2.1 ± 1 ms. (figure 4.2 C, D, E). Due to 
the difficulty in identifying the exact boundary between LV and LVI, cross correlation 
analysis was performed between deep (LV/LVI) and superficial layers (LII/LIII) in which 
superficial layers showed an average phase lag of 2.6 ± 0.7 ms (figure 4.2 F). This suggests 
the origin of delta oscillations to be deep layers and hence the subsequent recording were 
being made from deep layers especially from LV due to its salient feature of the presence 
of Betz cells.   
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Figure 4.2 Deep layers are the origin of delta oscillation in M1 
(A) Relative peak power changes in LII, LIII, LVI (grey) with respect to LV (black) activity
(normalised to 100%) (B) Power spectrum of normalised oscillatory activity in each layer,
LII, LIII, LVI, LV (100%) in a single slice. (C) cross-correlation analysis between LII/LV (red)
and LV/LV (black). (D) cross-correlation analysis between LIII/LV (red) and LV/LV (black).
(E) cross-correlation analysis between LVI/LV (red) and LV/LV (black). (F) cross-correlation
analysis between superficial (red) and deep layers (black).
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4.2.3 Cholinergic modulation of delta oscillations 
To determine the role of CCh in delta oscillations whether it is via muscarinic acetylcholine 
receptors, general mAChR antagonists, atropine (AT) and pirenzepine (PIR) were bath 
applied. AT (5 µM) significantly desynchronised delta activity and the amplitude was 
decreased to 23.8 ± 5% of control (p< 0.001, n=8). PIR (10 µM) also significantly decreased 
delta power to 21.5 ± 7.5% of control (p< 0.001, n=8) indicating the action of muscarinic 
receptors is M1 specific. PIR showed significant reduction in power within 10 min of bath 
application (figures 4.3A-B) implying delta oscillations are reliant on M1 mAChRs. 
Figure 4.3 Muscarinic receptor block decreases delta oscillatory power 
(A) Effect of atropine (10 µM) on delta oscillations. (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 20 μV vs 1 min). (ii)
Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) AT (iii) Bar graphs showing peak oscillatory power
of oscillations before (grey) and after (red) drug application normalised to control. ** p<0.01,
n=8. (B) Effect of pirenzepine (10 µM) on delta oscillations. (i) Raw data showing the
changes in oscillatory activity before (black) and after (red) drug application (scale: 20 μV
vs 1 min). (ii) Representative power spectra of 60s of extracellular recording demonstrating
peak responses before (black) and after (red) PIR (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey) and after (red) drug application normalised to control. **
p<0.01, n=8.
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4.2.4 Gap junction modulation of delta oscillations 
To examine the involvement of gap junctions in incidence of delta oscillations, the gap 
junction blocker, carbenoxolone (CBNX) was added. CBNX (200 µM) abolished the 
synchronous activity after two hours of application. Peak power was reduced to 4.5 ± 0.5% 
of control (n=6, P<0.01) suggesting a significant role of gap junctions in delta oscillation 
generation in Layer 5 of M1 (figure 4.4) 
Figure 4.4 Gap junction block decreases delta oscillatory power 
(A) Effect of carbenoxolone (200 µM) on delta oscillations (i) Raw data showing the changes
in oscillatory activity before (black) and after (red) drug application (scale: 50 μV vs 500
ms). (ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) CBNX (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey) and after (red) drug application normalised to control. **
p<0.01, n=8
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4.2.5 GABAAR modulation of delta oscillations 
Contribution of GABAAR on pharmacologically induced delta oscillations in layer V of M1 
was investigated by perfusing GABAAR agonists and antagonists and comparing the activity 
before and after the application of drug.  
Zolpidem, a benzodiazepine site agonist was bath applied at a concentration of 10 nM, 30 
nM and 50 nM. As Fig. 4.5 shows, delta activity is exquisitely sensitive to benzodiazepine 
site modulation. Hence, 10 nM of Zolpidem increased the peak power of delta oscillations 
to 123 ± 9 % of control whilst at 30 and 50 nM peak power of delta activity was reduced to 
44 ± 4% and 11 ± 3% respectively.  
Figure 4.5 GABAAR receptor agonist shows concentration dependent differential 
effects on delta oscillatory power 
(A) Effect of Zolpidem (10 nM, 30 nM and 50 nM) on delta oscillations (i) Raw data showing
the changes in oscillatory activity before (black) and after (red) drug application (scale: 50
μV vs 500 ms). (ii) Representative power spectra of 60s of extracellular recording showing
peak power before (black), after 10 nM (red), 30 nM (dotted line) and 50 nM (solid line) of
Zolpidem. (ii) Bar graphs showing peak oscillatory power of oscillations before (grey) and
after 10 nM (red), 30 nM (lined) and 50 nM (lined) of drug application normalised to control.
*** p<0.001, p<0.01, n=8.
In order to investigate the role of the GABA at the orthosteric binding site of the GABAAR, 
gabazine (GBZ), a competitive GABAAR antagonist was applied at 250nM and 2.5 μM 
concentrations. Both concentrations significantly reduced synchronous delta activity to 
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26.50 ± 5% and 11.7 ± 4% of control respectively (n=8, p<0.001) (figure 4.6A), suggesting 
roles for both synaptic and extra-synaptic receptors. The effect of picrotoxin (PTX), a non-
competitive channel blocker which acts by preventing the entry of Cl- ions into the neuron 
was examined. 5 μM PTX significantly reduced the synchronous activity to 25.50 ± 13% of 
control (n=8, P<0.01) (figure 4.6B). Taken together, these data suggest delta activity 
depends on inhibitory GABAAR receptors in layer V of M1. 
Figure 4.6 GABAA receptor block decreases delta oscillatory power 
(A) Effect of gabazine (250 nM and 2.5 μM) on delta oscillations (i) Raw data showing the
changes in oscillatory activity before (black) and after (red) drug application (scale: 40 μV
vs 500 ms) (ii) Representative power spectra of 60s of extracellular recording showing peak
power before (black) and after 250 nM (red) and 2.5 μM (dotted line) gabazine. (ii) Bar
graphs showing peak oscillatory power of oscillations before (grey) and after (red) drug
application normalised to control. *** p<0.001, n=8.
(B) Effect of picrotoxin (50 µM) on delta oscillations (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 20 μV vs 500 ms).
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black red) and after picrotoxin (red) (iii) Bar graphs showing peak
oscillatory power of oscillations before (grey) and after (red) drug application normalised to
control. **p<0.01, n=8.
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4.2.6 GABABR modulation of delta oscillations 
To investigate if pharmacologically induced delta oscillations require the activation of 
GABABR, CGP55845, a competitive GABABR antagonist was bath applied. 5 μM of 
CGP55845 significantly decreased the delta synchronisation to 71.50 ± 14% of control (n=8, 
P<0.01) suggesting a small but significant GABABR contribution to the power of delta 
oscillations (figure 4.7). 
Figure 4.7 GABAB receptor block decreases delta oscillatory power 
(A) Effect of CGP55845 (5 µM) on delta oscillations (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 30 μV vs 500 ms).
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after CGP55845 (red) (iii) Bar graphs showing peak
oscillatory power of oscillations before (grey) and after (red) drug application normalised to
control. **p<0.01, n=8.
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4.2.7 iGluR modulation of delta oscillations 
KAR modulation of delta oscillations: To investigate the role of kainate receptors and to 
confirm the action of KA is through kainate receptors, UBP310 (a GluK1/3 antagonist) and 
UBP 304 (a GluK1-selective antagonist) were bath applied. 10 μM of UBP304 and 3 μM of 
UBP310 significantly decreased the power of delta activity to 14.50 ± 4% of control (n=8, 
p<0.01) and 29.0 ± 0.5% of control (n=8, p<0.001) respectively (figures 4.8A-B). These data 
suggest an important role for KAR in delta oscillogenesis given that KA is used to evoke 
oscillations. 
Figure 4.8 Kainate receptor block decreases delta oscillatory power 
(A) Effect of UBP310 (3 µM) on delta oscillations (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 30 μV vs 500 ms).
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) UBP310 (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey) and after (red) drug application normalised to control. ***
p<0.001, n=8. (B) Effect of UBP304 (10 µM) on delta oscillations (i) Raw data showing the
changes in oscillatory activity before (black) and after (red) drug application (scale: 20 μV
vs 1 min). (ii) Representative power spectra of 60s of extracellular recording demonstrating
peak responses before (black) and after (red) UBP304 (iii) Bar graphs showing peak
oscillatory power of oscillations before (grey) and after (red) drug application normalised to
control. **p<0.01, n=8.
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4.2.7.1 AMPAR modulation of delta oscillations 
The dependence of delta oscillations on AMPAR was investigated by using SYM2206, a 
specific AMPAR antagonist. Application of 20 μM of SYM2206 significantly desynchronised 
the delta activity. It reduced the power to 29.50 ± 6% of control (n=8, p<0.01) (figure 4.9A). 
In order to assess the contribution of combined AMPAR/KAR activity, we applied 25 μM 
CNQX, a KAR/AMPAR antagonist. CNQX significantly reduced the synchronous delta 
activity (figure 4.9B) to 15.50 ± 6% of control (n=8, P<0.001) revealing the role of both KA 
and AMPA receptors in generation of delta oscillations but stronger role for KAR. 
Figure 4.9 AMPA receptor block decreases delta oscillatory power 
(A) Effect of SYM2206 (20 µM) on delta oscillations (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 70 μV vs 500 ms).
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) SYM2206 (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey) and after (red) drug application normalised to control.
**p<0.01, n=8.
(B) Effect of CNQX (25 µM) on delta oscillations (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 40 μV vs 500 ms).
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) CNQX (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey) and after (red) drug application normalised to control. ***
p<0.001, n=8
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4.2.7.2 NMDAR modulation of delta oscillations 
The role of NMDA receptors was tested using 2-AP5, a competitive NMDAR antagonist. 50 
μM 2-AP5 did not alter the delta peak (95.5 ± 17 % of control, n=8, P>0.05) (figure 4.10A). 
To confirm this lack of reliance of delta oscillations on NMDAR, a selective non-competitive 
antagonist, MK-801 was bath applied. Application of MK-801 had no significant effect on 
peak delta power (n=8, P>0.05, figure 4.10B) 
 
 
Figure 4.10 NMDA receptor block has no effect on delta oscillatory power 
(A) Effect of 2-AP5 (50 µM) on delta oscillations (i) Raw data showing the changes in 
oscillatory activity before (black) and after (red) drug application (scale: 60 μV vs 500 ms). 
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak 
responses before (black) and after (red) 2-AP5 (iii) Bar graphs showing peak oscillatory 
power of oscillations before (grey) and after (red) drug application normalised to control. ns 
p>0.05, n=8. (B) Effect of MK801 (10 µM) on delta oscillations (i) Raw data showing the 
changes in oscillatory activity before (black) and after (red) drug application (scale: 20 μV 
vs 500 ms). (ii) Representative power spectra of 60s of extracellular recording 
demonstrating peak responses before (black) and after (red) MK801 (iii) Bar graphs 
showing peak oscillatory power of oscillations before (grey) and after (red) drug application 
normalised to control. ns p>0.0, n=8. 
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4.2.8 mGluR modulation of delta oscillations 
The contributions of mGluR to delta activity was investigated by using positive and negative 
receptor modulators of group l, group ll and group lll mGluRs. Agonists generally decreased 
the peak power whilst antagonists increased peak delta power. 
Group I modulation of delta oscillations: Application of the mGluR group l agonist DHPG 
(10 µM) did not show any significant effect (p>0.05, n=8). Consistently, the non-competitive 
mGluR1 antagonist CPCCOet (25 µM) had no effect on delta oscillations (p>0.05, n=8) 
whereas as mGluR5 specific antagonist MPEP (20 µM) and potent mGluR5 antagonist 
MTEP (100 nM) significantly increased the activity to 187 ± 22.5% of control and 189 ± 29% 
(n=8, p<0.01) of control (n=8, p<0.01) respectively (figures 4.11 A-D), suggesting a role for 
mGluR5, rather than mGluR1 in modulation of delta power. 
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Figure 4.11 Effect of group I, mGlu receptor modulators on delta oscillatory power 
(A) Effect of DHPG (10 µM) on delta oscillations (i) Raw data showing the changes in 
oscillatory activity before (black) and after (red) drug application (scale: 50 μV vs 500 ms). 
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak 
responses before (black) and after (red) DHPG (iii) Bar graphs showing peak oscillatory 
power of oscillations before (grey) and after (red) drug application normalised to control. ns 
p>0.05, n=8. 
(B) Effect of cpccoet (25 µM) on delta oscillations (i) Raw data showing the changes in 
oscillatory activity before (black) and after (red) drug application (scale: 50 μV vs 500 ms). 
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak 
responses before (black) and after (red) cpccoet (iii) Bar graphs showing peak oscillatory 
power of oscillations before (grey) and after (red) drug application normalised to control. ns 
p>0.05, n=8. 
(C) Effect of MTEP (100 nM) on delta oscillations (i) Raw data showing the changes in 
oscillatory activity before (black) and after (red) drug application (scale: 30 μV vs 500 ms). 
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak 
responses before (black) and after (red) MTEP (iii) Bar graphs showing peak oscillatory 
power of oscillations before (grey) and after (red) drug application normalised to control. ** 
p<0.01, n=8. 
(D) Effect of MPEP (20 µM) on delta oscillations (i) Raw data showing the changes in 
oscillatory activity before (black) and after (red) drug application (scale: 40 μV vs 500 ms). 
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak 
responses before (black) and after (red) MPEP (iii) Bar graphs showing peak oscillatory 
power of oscillations before (grey) and after (red) drug application normalised to control. ** 
p<0.01, n=8. 
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Group II modulation of delta oscillations: The group ll (mGluR3) agonist, LY379268 (1 μM) 
showed a significant reduction in synchronous delta activity to 41.80 ± 10 % of control 
(p<0.01, n=8). mGluR2 antagonist LY341495 (100 nM) and mGlu-R2/3 antagonist 
LY341495 (1 µM) did not show any significant effect on peak power of delta oscillations 
(p>0.05, n=8) (figure 4.12 A-B). Please note that the figure Aii shows an effect on frequency 
however this effect was not significant when data were pooled. 
 
 
Figure 4.12 Effect of group II, mGlu receptor modulators on delta oscillatory power 
(A) Effect of LY379268 (1 µM) on delta oscillations (i) Raw data showing the changes in 
oscillatory activity before (black) and after (red) drug application (scale: 40 μV vs 500 ms). 
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak 
responses before (black) and after (red) LY379268 (iii) Bar graphs showing peak oscillatory 
power of oscillations before (grey) and after (red) drug application normalised to control. ** 
p<0.01, n=8. 
(B) Effects of LY341495 (100 nM and 1 μM) on delta oscillations (i) Raw data showing the 
changes in oscillatory activity before (black) and after (red) drug application (scale: 100 μV 
vs 500 ms). (ii) Representative power spectra of 60s of extracellular recording showing 
peak power before (black) and after 100 nM (red) and 1 μM (dotted line) LY341495. (ii) Bar 
graphs showing peak oscillatory power of oscillations before (grey) and after (red) drug 
application normalised to control. ns p>0.5, n=8. 
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Group III modulation of delta oscillations: L-AP4 (50 µM), an agonist and an antagonist 
CPPG (10 µM), an antagonist, did not show any significant effect on peak power of delta 
oscillations (p>0.05, n=8) (figures 4.13 A-B). 
Figure 4.13 Effect of group III, mGlu receptor modulators on delta oscillatory power 
(A) Effect of L-AP4 (50 µM) on delta oscillations (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 40 μV vs 500 ms).
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) L-AP4 (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey bars) and after (red bars) drug application normalised to
control. ns p>0.05, n=8. (B) Effect of CPPG (10 µM) on delta oscillations (i) Raw data
showing the changes in oscillatory activity before (black) and after (red) drug application
(scale: 30 μV vs 500 ms). (ii) Representative power spectra of 60s of extracellular recording
demonstrating peak responses before (black) and after (red) CPPG (iii) Bar graphs showing
peak oscillatory power of oscillations before (grey) and after (red) drug application
normalised to control. ns p>0.05, n=8.
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4.2.9 Pharmacological equivalent awake state: delta reversal protocol 
Having investigated the pharmacology of persistent delta activity in M1, we determined to 
attempt to mimic the switch to awake-state neurochemistry. This section details the various 
pharmacological equivalent awake state protocols that were used to try and reverse the 
delta which was pharmacologically induced. All the recordings form this section were made 
from LV of M1.  
4.2.9.1 Effect of KA+CCh (wash) on delta oscillations: 
To investigate if delta induced by bath application of KA (150 nM), CCh (2 µM), SCH23390 
(10 µM) and Haloperidol (10 µM), perfusing solution (aCSF) was changed to the one that 
contained KA (150 nM), CCh (10 µM). There was no significant change either in power or 
in frequency. Concentrations of KA and CCh were doubled to observe any change but there 
was not any change confirming the stable and persistent nature of the delta oscillations 
(p>0.05, n=8) (figure 4.14). 
 
 
 
Figure 4.14 No significant change was noticed in frequency and power of delta 
oscillations in wash 
(A) Effect of wash (150 nM KA+10 µM CCh) on delta oscillations (i) Raw data showing the 
changes in oscillatory activity before (black) and after (red) wash (scale: 70 μV vs 500 ms). 
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak 
responses before (black) and after (red) wash (iii) Bar graphs showing peak oscillatory 
power of oscillations before (grey) and after (red) wash normalised to control. ns p>0.05, 
n=8. 
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4.2.9.2 Effect of high KA on delta oscillations 
To determine the effect of high concentrations of KA on delta oscillations, 250 nM, 350 nM, 
500 nM KA were bath applied. Since all the concentrations showed similar effect, only the 
highest is reported here. KA at 500 nM induced seizure like activity with very high power 
1350 ± 600% of control with frequency range of 0.5-1 Hz (n=8, figure 4.15) which is different 
to that of induced delta oscillations of 2-4 Hz frequency range. However, delta oscillations 
were found to be intact when traces were filtered but were potentially masked by high 
amplitude and low frequency activity. The power of the activity was reduced to 69 ± 4 % of 
control.  
 
 
Figure 4.15 Seizure like activity was induced in the presence of high KA with intact 
delta 
(A) Effect of high KA (500 nM) on delta oscillations (i) Raw data showing the changes in 
oscillatory activity before (black) and after (red) high KA (scale: 150 μV vs 500 ms). (ii) 
Representative power spectra of 60s of extracellular recording demonstrating peak 
responses before (black) and after (red) wash (iii) Bar graphs showing delta oscillatory 
power of oscillations before (grey) and after (red) high KA normalised to control. ns p>0.05. 
The boxed area represents the expanded graph at 2-5Hz. 
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4.2.9.3 Effect of high CCh on delta oscillations 
To investigate if enhancing the cholinergic drive (dominance in awake state) would enable 
the reversal of induced delta oscillation, high concentrations of CCh were bath applied. 
When 100 µM was bath applied, seizure activity was induced with a high power 2150 ± 
300% of control with low frequency of about 0.5-1 Hz, different to actual delta oscillations 
(2-4 Hz) (figure 4.16). Interestingly, delta oscillations were found to be intact but were 
possibly masked by high amplitude and low frequency oscillations similar to that of high KA. 
The power of delta oscillations was significantly reduced to 52 ± 3 % of control.  
Figure 4.16 Seizure like activity was induced in the presence of high CCh with delta 
intact 
(A) Effect of high CCh (100 µM) on delta oscillations (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) high CCh (scale: 200 μV vs 500 ms). (ii)
Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) wash (iii) Bar graphs showing delta oscillatory
power of oscillations before (grey) and after (red) high CCh normalised to control. ns p>0.05,
n=8. The boxed area represents the expanded graph at 2-5Hz.
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4.2.9.4 Effect of DA on delta oscillations 
To examine if dopaminergic drive would reverse slow oscillations (2-4 Hz) to faster 
oscillations since low dopaminergic state was used to induce delta oscillations. DA was bath 
applied along with 250 µM of ascorbic acid to prevent DA from oxidising (Hastings et al., 
1996) since DA is an unstable molecule (Graham, 1978). 30 µM DA (data not shown) did 
not show any significant effect in terms of amplitude and frequency whilst 50 µM of DA 
slightly enhanced the power of delta oscillations to 110 ± 10% (p<0.05) but showed no effect 
on frequency (figure 4.17). 
 
 
Figure 4.17 DA increases the power of delta oscillations but no effect on frequency 
(A) Effect of DA (50 µM) on delta oscillations (i) Raw data showing the changes in oscillatory 
activity before (black) and after (red) DA (scale: 60 μV vs 500 ms). (ii) Representative power 
spectra of 60s of extracellular recording demonstrating peak responses before (black) and 
after (red) wash (iii) Bar graphs showing peak oscillatory power of oscillations before (grey) 
and after (red) DA normalised to control. ns p<0.05, n=8. 
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4.2.9.5 Effect of HA on delta oscillations 
Histamine (HA) was bath applied to investigate if histaminergic drive (associated with awake 
state) would change the low frequency delta oscillations to faster oscillations. 200 µM of 
HA, when applied to bath, significantly increased the peak power to 116 ± 4% (p<0.05, n=8) 
but frequency range remained the same (figure 4.18). 
 
Figure 4.18 HA increases the power of delta oscillations but no effect on frequency 
(A) Effect of HA (200 µM) on delta oscillations (i) Raw data showing the changes in 
oscillatory activity before (black) and after (red) HA (scale: 70 μV vs 500 ms). (ii) 
Representative power spectra of 60s of extracellular recording demonstrating peak 
responses before (black) and after (red) wash (iii) Bar graphs showing peak oscillatory 
power of oscillations before (grey) and after (red) HA normalised to control. ns p<0.05, n=8. 
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4.2.9.6 Effect of combined awake-state drugs on delta oscillations 
Neuromodulators (without any dopamine antagonists) (KA (150 nM), CCh (10 µM), GABA 
(1 µM), DA (50 µM), HA (200 µM) and 5-HT (1 µM) that are prevalent in awake state are 
bath applied to examine if this mixture would enable the reversal of pharmacologically 
induced delta oscillations. Ascorbic acid (250 µM) was bath applied along with the mixture 
above to prevent DA oxidation (Hastings et al., 1996). When bath was applied with this 
mixture, delta peak power was increased significantly to 170 ± 9% of control (n=8, p<0.01) 
but again wihtout change in frequency range (figure 4.19). 
 
 
 
Figure 4.19 Awake drug mixture increases the power of delta oscillations but no 
effect on frequency 
(A) Effect of awake drug mixture ((KA (150 nM), CCh (10 µM), GABA (1 µM), DA (50 µM), 
HA (200 µM), 5-HT (1 µM)) on delta oscillations (i) Raw data showing the changes in 
oscillatory activity before (black) and after (red) awake mixture (scale: 70 μV vs 500 ms). 
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak 
responses before (black) and after (red) awake drug mixture (iii) Bar graphs showing peak 
oscillatory power of oscillations before (grey) and after (red) awake mixture normalised to 
control. ns p<0.001, n=8. 
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4.2.9.7 Effect of waking-state pharmacology before inducing delta oscillations 
To investigate if this drug mixture ((KA (150 nM), CCh (10 µM), GABA (1 µM), DA (50 µM), 
HA (200 µM), 5-HT (1 µM), Ascorbic acid (250 µM)) had any impact on induction of delta 
oscillations, this mixture was bath applied on theta and gamma oscillations which were 
induced when bath applied KA and CCh. This drug mixture significantly increased the power 
of theta and gamma oscillations. These fast oscillations graduated to slow oscillations and 
to delta oscillations upon application of KA (150 nM), CCh (2 µM), SCH23390 (10 µM) and 
Haloperidol (10 µM) (n=8, figure 4.20)  
Figure 4.20 Induction of delta oscillations in the presence of awake drug mixture 
(A) Effect of awake drug mixture ((KA (150 nM), CCh (10 µM), GABA (1 µM), DA (50 µM),
HA (200 µM), 5-HT (1 µM), Ascorbic acid (250 µM)) on induction delta oscillations (i)
Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) awake drug mixture on theta and gamma
oscillations (iii) Representative power spectrum illustrating the transition of fast oscillations
(black) to slow oscillations (dotted line) and to delta oscillations (red)  in the presence of
awake drug mixture (n=8).
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4.2.9.8 Effect of AMPH on delta oscillations 
To investigate if CNS stimulants would change the frequency range, amphetamine sulphate 
(AMPH) was bath applied. Application of 20 µM and 40 µM increased the peak delta power 
to 123 ± 6% of control (n-8, p<0.01) but no effect on frequency range (figure 4.21). 
Figure 4.21 AMPH increases the power of delta oscillations but no effect on frequency 
(A) Effect of AMPH (20 µM) on delta oscillations (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) AMPH (scale: 50 μV vs 500 ms). (ii)
Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) wash (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey) and after (red) AMPH normalised to control. ns p<0.05,
n=8.
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4.2.9.9 Effect of AMPH before inducing delta oscillations 
The effect of AMPH on induction of delta oscillations was examined by bath application of 
AMPH on theta and gamma oscillations. When 20 µM of AMPH was bath applied, there 
was a significant increase in the peak power of theta and gamma oscillations. However, 
there is no transition to delta oscillations upon application of KA (150 nM), CCh (2 µM), 
SCH23390 (10 µM) and Haloperidol (10 µM) even after 2 hours of observation. (n=8, figure 
4.22) but to our surprise it revealed an increase in theta power (mean frequency: 7.9 ± 0.6 
Hz). 
Figure 4.22 Delta was not induced in the presence of AMPH 
(A) Effect of AMPH (20 µM) on induction delta oscillations (i) Representative power spectra
of 60s of extracellular recording demonstrating peak responses before (black) and after
(red) AMPH on theta and gamma oscillations (iii) Representative power spectrum
illustrating the transition of fast oscillations (black) to slow oscillations (dotted line) and to
theta oscillations (red) in the presence of awake drug mixture (n=8). Note: No delta was
induced in the presence of AMPH.
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4.2.10 Summary of results  
Pharmacology of delta oscillations in LV of M1 was summarised in table below. 
Drug (concentration) % Change of 
Control 
 N Signifi 
cance 
atropine (5 µM) [mAch antagonist] 23.8 ± 5 8 ** 
pirenzepine (10 µM) [mAch antagonist] 21.5 ± 7.5 8 ** 
Carbenoxolone (200µM) [Gap junction 
blocker] 
4.5 ± 0.5 8 ** 
zolpidem (10 nM,30 nM,50 nM) [GABAAR 
agonist] 
123±9,41±4,11±3 8 **, ***, *** 
gabazine (250 nM,25 µM) [GABAAR 
antagonist] 
26.6 ± 5, 11.7 ± 4 8 *** 
picrotoxin (5 µM) [GABAAR antagonist] 25.9 ± 13 8 ** 
CGP55845 (5 µM) [GABABR antagonist] 71.48 ± 14 8 ** 
UBP310 (3 µM) [KAR antagonist] 29.27 ± 4 8 *** 
UBP304 (10 µM) [KAR antagonist] 14.5 ± 4 8 ** 
SYM2206 (20 µM) [AMPAR antagonist] 29.15 ± 6 8 ** 
CNQX (25 µM) [KA/AMPAR antagonist] 15.77 ± 6 8 *** 
2-AP5 (50 µM) [NMDAR antagonist] N/A 8 ns 
MK801 (10 µM) [NMDAR antagonist] N/A 8 ns 
DHDG (10 µM) [groupl mGluR agonist] N/A 8 ns 
cpccoet (25 nM) [gl mGluR antagonist] N/A 8 ns 
MTEP (100 µM) [gl mGluR antagonist] 187 ± 23 8 ** 
MPEP (20 µM) [gl mGluR antagonist] 189 ± 29 8 ** 
LY 379268 (1 µM) [groupll mGluR agonist] 41.8 ± 11 8 ** 
LY 341495 (100 nM,1 µM) [gll mGluR 
antagonist] 
N/A 8 ns 
L-AP4 (50 µM) [grouplll mGluR agonist] N/A 8 ns 
CPPG (10 µM) [glll mGluR antagonist] N/A 8 ns 
Table 4.1 Pharmacology of delta oscillations in LV of M1 
Peak power changes after application of various receptor modulators is represented as 
mean ± SEM when compared to control (normalised to 100%). N= number of recordings 
(obtained from 3 different animals), significance: ns p>0.05, * p<0.05, **p<0.01, ***p<0.001. 
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Delta reversal protocol was summarised in table below. Note delta was found to be 
irreversible as there was no change in frequency of the oscillations but there was changes 
in peak power of delta oscillations. 
Drug  (concentration) %Change 
of Control 
N significance 
KA (150 nM)+CCh (10 µM) ns 8 Ns 
high KA (500 nM) ns 8 Ns 
high CCh (50 µM) ns 8 Ns 
dopamine (50 µM) 110 ± 10 8 * 
histamine (200 µM) 116 ± 4 8 * 
amphetamine Sulphate (20 
µM) 
123 ± 6 8 ** 
awake mixture (150 
nMKA+10 µM CCh+1 µM 
GABA+1 µM 5HT+50µM 
DA+200 µM HA+250 µM 
Ascorbic Acid) 
170 ± 9 8 *** 
Table 4.2  Various delta reversal protocols 
Peak power changes after application of various receptor modulators is represented as 
mean ± SEM when compared to control (normalised to 100%). N= number of recordings 
(obtained from 3 different animals), significance: ns p>0.05, * p<0.05, **p<0.01, ***p<0.001. 
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4.3 Discussion 
Initial LFP recordings revealed the absence of spontaneous oscillatory activity in M1 and 
S1 in consistent with previous work (Yamawaki, 2008; Johnson, 2016). Co-application of 
KA and CCh reliably induced beta oscillations (Yamawaki, 2008; Prokic, 2011) in old slice 
preparations whereas, theta and gamma oscillations were identified both in M1 and S1 
(Johnson et al., 2016) with new slice preparation (refer chapter 3 for details). To further 
investigate the low frequency neuronal network activity in M1 and S1, experiments were 
performed to induce delta (2-4 Hz) oscillations which are known to be associated with deep 
sleep stages especially NREM3 and NREM4 stages. Although a number of studies 
demonstrated the origin of delta oscillations (1-4 Hz) in thalamus (Amzica et al., 1992), 
relatively less is known about cortical based delta oscillations. A delta rhythm of purely 
cortical origin has been implicated in in vivo studies (Amzica and steriade, 1998; Fell et al., 
2002) but the mechanisms underlying were not as clear as those in thalamic origin (Pirchio 
et al., 1997; Hughes et al., 1999; 2002). Additionally, it has been suggested that cortical 
delta oscillations are generated in a use-dependent manner, in that the cortical circuits that 
are active during awake states generate these oscillations in the succeeding sleep (Kattler 
et al., 1994; Huber et al., 2004) and in a region specific way, implying a self-organising 
property of local neuronal networks (Krueger and Oba´l, 1993; Vassalli and Dijk, 2009; 
Vyazovskiy et al., 2011). Frontal and parietal cortical regions are known to be delta 
generators in human cortex during sleep with a possibility of local delta generators for each 
region (Mormann et al., 2008; Ioannides et al., 2009). A recent in vitro study has indicated 
delta oscillations in secondary somatosensory cortex/parietal area, S2/Par2 slices prepared 
from male Wistar rats (Carracedo et al., 2013). None of these studies have indicated the 
mechanisms and origin of cortical delta rhythm probably because it is challenging to induce 
delta oscillations unlike gamma oscillations, which can be identified spontaneously or with 
minimal pharmacological manipulations in regions like CA3, M1, S1, V1 etc. A recent study 
has revealed that transition of NREM2 to NREM3&4 stages required the neuromodulatory 
action of cortex itself but not thalamus (Krishnan et al., 2016).  We have assumed that the 
origin of delta oscillations could possibly be primary motor and sensory cortices with these 
regions being primary projection sites for thalamus, hence the term ‘primary’.  
4.3.1 Generation of delta oscillations 
Induction of delta oscillations requires a state that mimics the physiologically equivalent 
deep sleep state. In order to achieve this neuromodulatory state we have tried various 
protocols using sleep related neurochemicals. Initially 150 nM KA and 10 µM CCh was bath 
applied to activate the slices since there is no spontaneous activity observed in M1 and S1. 
Co-application of KA and CCh induced theta and gamma oscillations (see chapter 3). When 
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GABAA positive modulator, pentobarbital (10-30 µM) was bath applied at this stage, the 
oscillations have been desynchronised and very slow oscillations (< 1Hz) were identified 
which was different to what was expected (2-4 Hz) (data not shown). It was not surprising 
to see pentobarbital affect frequency with no change in power based on the fact that it acts 
via phasic inhibition, by opening GABAAR for longer time. Increased IPSC decay has 
enabled the decrease in frequency (Segal and Baker, 1984). The reciprocal interaction 
model suggested that the awake state has aminergic dominance and REM sleep state has 
cholinergic dominance whereas NREM state of sleep has intermediate tone (McCarley and 
Hobson, 1975). To investigate if low cholinergic tone would induce delta oscillations, aCSF 
with standard KA (150 nM) and CCh (10 µM) was replaced to that which contained same 
KA but low concentration of CCh (2 µM – 1/5th of what is generally required for cortical 
activation). Reduction in ACh levels has shown increased excitatory connection strength 
via AMPA conductance, as well as increased leak (K+) currents. This decreased ACh levels 
have proved to be essential for transition to deep sleep stages (Krishnan et al., 2016). There 
has been research that suggests CCh when injected bilaterally promoted sleep in vivo 
(George et al., 1964). This has decreased the power of theta and gamma oscillations but 
did not induce delta oscillations probably because low cholinergic tone alone was not 
enough. Since dopamine plays a critical role in promoting arousal, it was suspected whether 
ambient dopamine in the slices was too high to enable delta induction. This was examined 
by perfusing the slices with D2 antagonist (Haloperidol 10 μM) besides KA and CCh based 
on the evidence that D2 blocking properties has enabled NREM 3 and 4 sleep whilst 
decreasing awake state (Monti and Monti, 2007). This still did not induce delta oscillations 
but reduced the frequency of oscillations. To mimic low cholinergic and low dopaminergic 
state, 150 nM KA, 2 μM of CCh, D2 antagonist; Haloperidol and D1 antagonist; SCH23390 
was bath applied simultaneously. In this condition, it was possible to induce persistent delta 
oscillations at 2-4 Hz frequency. Interestingly, delta oscillations were not generated either 
by blocking D1 receptors or D2 receptors on their own which is contrary to recent in vitro 
work on delta rhythm in rat slices containing secondary somatosensory/parietal area, 
S2/Par2 (Carracedo et al., 2013) suggesting a physiological difference in the origin of M1 
delta rhythm. Changes in power (increase) and frequency (decrease) in the generation of 
delta meant the involvement pre (phasic) and post-synaptic (tonic) currents. Activation of 
D1 receptors disturbs long-term depression and increases (spike time dependent) long-
term potentiation (Xu and Yao et al., 2010). Furthermore, evidence exists that application 
of D1 antagonist (SCH 23390) prevented arousal (Trampus et al., 1993) hence, the 
decrease in D1 tone may be a critical aspect of the current study.  
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4.3.2 Origin of delta oscillations 
All the layers of M1 exhibited delta activity with same mean frequency but Layer V was 
thought to be the source of origin since the power of delta oscillations was found to be 
progressing from deep to superficial layers. This is consistent with human invasive electrode 
in vivo delta studies (Cserca et al., 2010) and also in vitro delta studies that were carried 
out in rat parietal cortex and human frontal cortical tissue (Carracedo et al., 2013). In vivo 
awake and sleep delta have been thought to originate mostly from the deep layers of frontal 
cortex (Knyazev, 2012). Additionally, beta oscillations (Murthy and Fetz, 1996; Donoghue 
et al., 1998; Yamawaki, 2008) have also been reported to have highest power in Layer V 
as well as theta and gamma oscillations (Johnson et al., 2017). Theta oscillations in human 
neocortex slices have shown temporal delays in superficial layers relative to deep layers, 
suggesting deep layers to be the origin of activity (Florez et al., 2013). In accordance with 
the idea that deep layers drive slow oscillations, RS neurons in LV have been found to drive 
pyramidal neurons in superficial layers at low theta range (Carracedo et al., 2013). Initiation 
of activity in LV was proved by local application of tetrodotoxin (TTX) whilst recording from 
Lll/lll and LV. 10 μM of TTX showed no effect on oscillatory activity of LV when locally 
applied to superficial layers whereas the oscillatory activity was abolished in Lll/lll when TTX 
was locally applied in deep layers (LV) (Yamawaki et al., 2008). Correlation studies were 
performed on simultaneous recordings across each layer (ll, lll, V, Vl) with a reference 
electrode in LV. These revealed that delta band oscillatory activity in Lll and Llll was phase-
delayed compared to that of LV however, delta activity in LVI was found to precede to that 
of LV. As the peak power of delta activity is greater in LV than in LVl, it might be assumed 
that LV would drive the activity, however, the fact that LVI leads LV suggest the latter as a 
driver. Unfortunately, it was not possible to isolate deep layers due to experimental 
difficulties in finding the precise boundary and so we could not directly test the ability of LVI 
alone to generate delta oscillations. There could be several possible grounds as to why LV 
may be assumed to drive oscillatory activity. Firstly, the morphological aspects; as it 
contains high density pyramidal cells in deep layers and also the presence of the Betz cells 
that were characteristic feature of LV of M1. Betz cells in M1 have extensive projections 
across all layers up to LI with a huge cell body (Molnar and Cheung, 2006). Secondly, the 
physiological properties of the interneuron populations that are present in LV which are 
responsible for neuronal oscillatory activity at delta frequency (not explored in this study). A 
strong drive onto vasoactive intestinal peptide-positive (VIP+) cells was identified in M1 and 
S1 (Lee et al., 2013) and these cells have been identified to receive greater input from LV 
(Xu and Callaway, 2009) based on the anatomical evidence that layer V projections are 
more widely diffused than that of superficial layers (Markov et al., 2014). Also, as seen in 
up/down states of mice sleep state in vivo and in vitro studies, network activation involves 
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intrinsically bursting (IB) neurons with cell bodies located in LV (Beltramo et al., 2013; 
Carrecedo et al., 2013). IB cells relate to excitatory synapses and gap junctions which could 
form the basis for high oscillatory activity in LV (Mercer et al., 2006; Lefort et al., 2009). 
Current source density studies in human recordings have revealed more synaptic input in 
superficial layers indicating enhancing the excitation onto distal dendrites in deep layers 
(LV) (Csercsa et al., 2010). This excitatory output to deep layers from superficial layers have
indicated in local circuits (Thomson and Morris, 2002). Previous studies on local circuits 
have suggested the existence of strong excitatory inputs to LV from other layers (Weiler et 
al., 2008; Yu et al., 2008; Anderson et al., 2010; Hooks et al., 2011;). Gap junctions between 
interneurons are known to increase network synchronisation (Gibson et al., 1999; Galarreta 
and Hestrin, 1999; Traub et al., 2000, 2001, 2003). Also, gap junctions between pyramidal 
axons have been implicated to enhance output activity of these cells (Schmitz et al., 2001; 
Traub et al., 2003). Moreover, the existence of most common gap junction subunit, 
connexion 36 was identified to be densely expressed in deep layers when compared to 
superficial layers which could be the basis for high amplitude oscillations in LV (Condorelli 
et al., 2000; LeBeau et al., 2003).  
However, LV can not be considered the sole origin of network activity since LVl also 
contains various cell types that may contribute to generation of oscillatory activity. Cells in 
LVI receive direct thalamo-cortical input as well as forms an output layer to many thalamic 
nuclei.  The major types of pyramidal cells that were identified in LVI which are distinguished 
based on shape include: CT (cortico-thalamus) cells that project to thalamus are short, 
narrow and vertically oriented towards LlV and LV. CC (cortico-cortical) cells that are 
present only within cortical regions with different shapes from short upright to bipolar 
neurons (see review Thompson, 2010). But, the functional characterisation of each type 
remains unexplored (Gonchar et al., 2007). Nevertheless, LVl was reported to provide 
significant excitatory input to LV pyramidal cells in a paired recording study (Mercer et al., 
2005) besides the strong reverse connection from LV to LVl. It is challenging to identify the 
boundary between LV and LVl in our experiments, therefore we have recorded from deep 
layers (LV) with it being large area and was easily identified under microscope. A better way 
to delineate between LV and LVl would be beneficial. 
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4.3.3 Muscarinic receptor modulation 
Application of CCh was essential to induce network activity in M1. Gamma oscillations were 
desynchronised when muscarinic receptor antagonists were bath applied (Fisahn et al., 
1998). Action of CCh was proved to be pre-dominantly via M1 receptors (mACh) as the 
delta oscillations were desynchronised when pirenzepine, an M1 receptor antagonist was 
applied to bath which is similar to delta oscillations in in vitro in other brain region like 
secondary somatosensory/parietal area (S2/Par2) (Carracedo et al., 2013). 
4.3.4 Gap junctions 
Neuronal network activity is known to be dependent on electrical coupling via gap junctions 
(Draguhn et al., 1998; Galarreta and Hestrin, 1999; Traub et al., 2000, 2001, 2003) Gap 
junctions also have a critical role in high frequency oscillations generation and 
synchronization (Buhl et al., 2003; Hormuzdi et al., 2001) especially in the gamma 
frequency range (Kopell and Ermentrout, 2004; Hormuzdi et al., 2001). Investigations of 
(Draguhn et al., 1998) axo-axonal (pyramidal-pyramidal) gap junctions has revealed that 
action potentials propagate from one cell to another (Draguhn et al., 1998; Schmitz et al., 
2001); cortex (Grenier et al., 2001). Connexion-36 subunit knockout experiments revealed 
a role of axonal gap junctions in initiation of oscillatory activity whilst dendritic (interneuron-
interneuron) gap junctions contribute to oscillation coherence (Traub and Bibbig, 2000). 
When gap junctions were blocked using carbenoxolone, delta oscillations were abolished 
in M1 after about 2 hours of drug application. The slow action of carbenoxolone is similar to 
that observed during EEG recordings in vivo, where oscillatory activity at theta frequency 
was only abolished after 60 min of perfusion (Konopacki et al., 2004). Various gap junction 
blockers such as octanol (1 mM), CBX (0.2 mM), quinine (0.2 mM) and 18β-glycyrrhetinic 
acid has shown to decrease or abolish delta oscillations in slices containing secondary 
somatosensory/parietal area (S2/Par2) (Carracedo et al., 2013) as well as gamma 
oscillations in other brain regions (Traub and Bibbig, 2000; Cunningham et al., 2004). This 
evidence suggests the role of gap junction in generation and maintenance of delta 
oscillations. However, it is critical to note that gap junction modulators are non-specific and 
could act through mechanisms that are independent of gap junctions (Nakahiro et al., 1991; 
Rouach et al., 2003). Carbenoxolone is highly non-specific and has indicated to act through 
various mechanisms that include (but not limited to): block post synaptic NMDAR, reduce 
IPSCs via GABAAR, suppress action potentials, blocks calcium channels, and reduces 
seizure activity besides blocking gap junctions (Rekling et al., 2000; Rouach et al., 2003; 
Vessey, 2004; Tovar et al., 2009; Connors, 2012) yet still was used in current experiments 
due to its water-soluble nature and the lack of better alternatives (Konopacki et al., 2004). 
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Further specific subunit KO experiments would be essential as well as developing selective 
blockers. 
4.3.5 GABA modulation 
GABAA receptors are ligand gated ion channels. These receptors act by increasing the 
membrane permeability of anions (Cl- and HCO3- ions) which hyperpolarises the membrane 
resulting in inhibition (Rivera et al., 1999). GABAAR antagonists, GBZ and PTX, reduced 
the power of delta oscillations with no change in frequency range. Dependence of delta 
oscillations on GABAAR implies the requirement of inhibitory currents in M1 like in 
hippocampal brain regions (Whittington et al., 1995). It is known that the competitive 
antagonist, GBZ, at low concentration (250 nM) inhibits phasic synaptic currents but not 
extracellular tonic currents (Farrant & Nusser, 2005) due to the differential affinity of tonic 
(high affinity) and phasic (low affinity) GABAA receptors. Hence, high concentration GBZ 
(2.5 µM) was bath applied to surpass extra-synaptic tonic currents (Stell and Mody, 2002). 
250 nM and 2.5 μM significantly reduced the synaptic synchronous delta activity revealing 
the role of both synaptic and extra-synaptic receptors in delta rhythm generation. Further 
investigations were made using a non-competitive channel blocker. PTX (5 µM) acts by 
binding inside the receptor ionophore which prevents the flow of Cl- (Krishek et al., 1996). 
PTX reduced the power of delta oscillations. Since pharmacological manipulation of IPSC 
kinetics using antagonists has meant the change (reduction) in power, tonic inhibition is 
responsible for delta rhythm initiation (Traub and Whittington, 2010). Surprisingly, these 
results contrasts with that of in rat secondary somatosensory/parietal area whose delta is 
GABAAR insensitive, suggesting a distinct mechanism between two regions (Carracedo et 
al., 2013). This may be due to the subunit expression in various regions that are responsible 
for delta oscillations. 
Zolpidem, a benzodiazepine site agonist showed differential effects at various 
concentrations and was previously demonstrated on beta oscillations in M1 (Prokic et al., 
2015). At beta frequency, Zolpidem stabilises a tonic current in a kinetically-slow state, 
meaning it cannot be desensitised and it therefore acts to hyperpolarise the GABA neurons, 
reducing oscillatory power. At higher concentrations, there is no slow state and zolpidem 
enhances power by augmenting inhibition. Interestingly, delta oscillations have shown an 
increase in delta power at 10 nM and decreased in the power at higher concentrations 
suggesting the GABAAR are not working in the same manner as it they were during beta or 
gamma activity (Prokic et al., 2015). This could depend on the population of cells and 
receptor subtypes with different kinetic properties that are recruited for generation of delta 
oscillations in M1. 
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The GABAB receptors are metabotropic G-protein coupled receptors, which act by inhibiting 
presynaptic calcium release via adenylyl cyclase (Dunlap and Fischbach, 1981; Hill 1985; 
Newberry and Nicoll, 1985). On one hand, a study reported that GABABR do not contribute 
to oscillatory activity induced by CCh (Williams and Kauer, 1997). On the other hand, a 
study by Whittington et al., has revealed the role of these receptors in determining the 
duration of gamma oscillations (Whittington et al., 1995). CGP55845 (5 µM), GABABR 
antagonist reduced the power of synchronous delta oscillations which is in line with 
hippocampal and cortical gamma and beta oscillations (Yamawaki, 2008; Dugladze et al., 
2013) and similar to delta in secondary somatosensory/parietal area (Carracedo et al., 
2013) demonstrating the role of slow acting GABABR in delta rhythm generation. 
4.3.6 Glutamate modulation 
Excitatory currents have been identified to contribute to network oscillatory activity in M1 
including theta, gamma and beta oscillations (Yamawaki, 2008, Prokic, 2011, Nicholas, 
2016). To investigate iGluR involvement in delta rhythm generation, various receptor 
antagonists were bath applied. CNQX desynchronised delta oscillations by blocking both 
KA/AMPAR indicating the requirement of KAR or/and AMPAR. SYM2206, a potent AMPAR 
antagonist reduced the synchronous activity of delta oscillations GluA1-4 (APAMR) subunit 
KO studies revealed decrease in AMPA mediated EPSPs, changes in firing properties 
which in turn disrupted long range synchronisation (Fuchs et al., 2001). KAR antagonists: 
UBP310 (GluK1/3) and UBP304 (GluK1) also blocked the activity. Kainate receptors were 
identified to be critical for rhythm generation as well as stabilisation. However, the delta 
induced in parietal cortex did not show significant effect to AMPA or KA receptors on their 
own but desynchronised the delta power when both receptors were blocked using CNQX 
(KA/AMPA blocker) suggesting a distinct mechanism (Carracedo et al., 2013).  
It is interesting to note that unlike the generation of beta oscillations in LV of M1 (Yamawaki, 
2008), delta oscillations do not require NMDAR, which was in contrast to what was 
demonstrated both in vitro (Carracedo et al., 2013) and in vivo studies (Hunt and Kasicki, 
2013). In vitro studies in rat parietal cortex observed that synchronous delta oscillations 
were reduced when NMDAR antagonist 2-AP5 was added to bath whereas in vivo studies 
on freely moving rats proved that the delta power was increased in various cortical regions 
as demonstrated by various studies in the past (Mattia and Moreton, 1986; Marquis et al., 
1989; Feinberg and Campbell, 1998). These controversial findings imply further 
investigation on NMDAR associated with the delta rhythm. Since 2-AP5 is a competitive 
NMDAR antagonist, MK801 which is a selective non-competitive antagonist was bath 
applied. However, both drugs showed no effect on delta oscillations. There could be several 
reasons as to why pharmacologically induced delta oscillations are NMDA insensitive which 
may include experimental protocol, types of cells expressed in the region recordings were 
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made, receptor subunit composition and neuronal populations recruited for the rhythm. 
Moreover, Specific subunit KO experiments revealed that GluN1 KO increased firing rate 
thereby altering the synchrony (Belforte et al., 2010), GluN2B (Kelsch et al., 2014) KO 
reduced frequency and amplitude of EPSPs and knocking out GluN2C and D (Von 
Engelhardt et al., 2015) had no change in NMDA mediated EPSPs in hippocampal 
interneurons. Therefore, comparatively greater expression of GluN2C and D subunits in 
layer V of M1 could also form the basis for this. Further investigations however are needed 
to address this by using subunit specific receptor modulators and KO studies. 
 
mGluRs are known to influence rhythmic activity of transient gamma oscillations induced by 
tetanic stimulation as demonstrated by Whittington et al., (1995). It has been reported that 
s activation of group l mGluRs by DHPG induced gamma oscillations in CA3 which are 
different to those induced by KA and CCh in CA3 (Palhalmi et al., 2004). However, these 
receptors showed little contributions to synchronous activity of pharmacologically induced 
delta oscillations in M1. Moreover, they showed no contribution on pharmacologically 
induced beta oscillations in same area (Yamawaki, 2008). Only mGlu-R3, mGlu-R5 amongst 
three groups have been found to contribute to delta rhythm generation. None of the other 
receptors appeared to be involved in delta in M1. Minor but significant reduction in 
synchronous delta oscillations was noticed when mGlu-R3 agonist LY379268 was bath 
applied whilst mGlu-R5 antagonists MTEP and MPEP showed a significant increase in delta 
oscillations.  
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4.3.7 Pharmacological equivalent awake state: delta reversal protocol 
Neurotransmitters play a critical role not only in sleep and awake states but also in transition 
state. It was evident that acetylcholine (ACh), histamine (HA), GABA, serotonin (5-HT), 
dopamine (DA) and nor-epinephrine (NE) are involved in sleep wake mechanisms. High 
levels of ACh, HA, NE are found in NREM2&3 stages whilst GABA was found to be lowest 
in these stages when compared to awake state (Aston-Jones and Bloom, 1981; McCormick, 
1992; Vazquez and Baghdoyan, 2001; Lena et al., 2005; Vanini et al., 2011).  It was 
interesting that, in REM sleep, ACh levels were found to increase but HA, NE and GABA 
were observed to decrease (Baghdoyan and Lydic, 2012). The reciprocal interaction model 
suggested that the awake state has aminergic dominance and REM sleep state has 
cholinergic dominance whereas NREM state of sleep has intermediate tone (McCarley and 
Hobson, 1975). Delta oscillations (2-4 Hz) were reliably induced by mimicking 
neuromodulatory deep sleep (low cholinergic and low dopaminergic) state. This state was 
obtained by pharmacological manipulation by bathing the slices in 150 nM of KA, 2 µM CCh, 
10 µM SCH23390, 10 µM Haloperidol. Subsequent experiments were performed to reverse 
this state to a pharmacologically equivalent awake state. Since theta and gamma 
oscillations were identified upon application of KA and CCh, it was assumed that washing 
the slices in the same would reverse delta oscillations to faster frequency range but no 
change was observed confirming the persistent nature of delta oscillations. Increased ACh 
would mean the decrease in AMPA conductance based on experimental findings (Gil et al., 
1997; Kimura et al., 1999; Hsieh et al., 2000) which would not influence frequency of 
oscillations. High concentrations of KA and CCh were bath applied and both lead to seizure 
like activity which was not surprising as KA and CCh increase the rate of firing whereby 
inducing seizure like activity as observed in various studies (Ben-Ari et al., 1985; Brudzynski 
et al., 1995; Stivers et al., 1998; Ben-Ari and Cossart, 2000). Interestingly, when we 
investigated experiments in high KA and CCh, we found delta intact, but masked by very 
low frequency and high amplitude activity. High levels of DA has shown an increase in 
wakefulness in dopamine transporter (DAT) knock out mice (Wiser et al., 2001). Also, 
application of D1 agonist, SKF38393 increased wakefulness and decreased sleep and a 
simultaneous block of D1 receptors using an antagonist (SCH23390) prevented arousal 
(Trampus et al., 1993). Subsequent experiments were carried out using dopamine and 
histamine assuming the increase in aminergic tone would enable the transition from deep 
sleep state to awake state but both HA and DA showed an increase in power with no effect 
on frequency of delta oscillations.  High levels of HA has led to effect Ih current by positively 
shifting activation curve (McCormick and Williamson, 1991) with no effect on network 
activity. Moreover, awake drug mixture [KA (150 nM), CCh (10 µM), GABA (1 µM), DA (50 
µM), HA (200 µM), 5-HT (1 µM), Ascorbic acid (250 µM)] was used but no change in 
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frequency range was noticed. This mixture contains ascorbic acid as a neuro-protectant 
since DA is an unstable molecule (Graham, 1978) and easily gets oxidised to free radicals 
and reactive quinones (Hastings et al., 1996). However, a massive increase in power of 
delta oscillations was observed suggesting all the above wake promoting compounds have 
strengthened the neuronal network synchronisation in M1. Furthermore, amphetamine 
sulphate, a potent CNS stimulant which is critical for monoamine regulation via trace amine-
associated (G-protein coupled) receptor (TAAR1) was bath applied to investigate if this 
would enable wakeful state (Miller, 2011). 
On an interesting note, both awake drug mixture and amphetamine sulphate, when bath 
applied before delta incidence have shown a significant increase in power of theta and 
gamma oscillations yet, only the former has enabled delta induction whilst the latter did not. 
AMPH reverses the DA transit from cytoplasm to extracellular space via DAT which was 
termed as DA efflux enabling increased locomotion (German et al., 2015; Kopra et al., 2017) 
in accordance with a study suggesting extracellular dopamine levels have indicated to be 
higher after AMPH administration in rats (O`Leary et al., 2016). This hyper dopamine levels 
explains the prevention of delta oscillations which requires low dopaminergic state. 
Reduction in power of gamma oscillations upon subsequent addition of delta drugs could 
account for the cytotoxicity caused due to auto-oxidation of high levels DA upon AMPH 
application (as seen in Carvalho et al., 2012). 
Recently, Krishnan et al., (2016) has developed an in silico model that was sufficient to 
cater the needs to study sleep-wake cycle characteristics which included populations of 
interneurons (IN) and pyramidal cells (PY) in cortex, thalamic reticular nucleus (RE) and 
thalamic relay neurons from thalamus based on the previous evidence from literature 
(Bazhenov et al., 1998, 1999; Timofeev et al., 2000; Bonjean et al., 2011; Chen et al., 2012; 
Wei et al., 2016). In their study, Krishnan et al show transition from NREM2 to deep sleep 
(NREM3 & 4) stages required neuromodulatory actions within cortex itself and thalamus 
was not required. In our own study, we saw delta in slices containing cortex only, confirming 
the in silico results of Krishnan et al., however, it is not possible for transition to awake 
states from sleep stages within cortex in our experiments. We speculate that the role of 
thalamo-cortical connections is critical to reversal of the sleep-like state in our in vitro 
preparation. This may explain why it was possible to induce delta oscillations in M1 and S1 
slices but not possible to reverse it to equivalent awake state. Slice preparations containing 
various regions involved in sleep, including thalamus, would be helpful to address this issue 
however, this was currently not possible due to time limitations.  
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4.3.8 Possible mechanism of delta oscillations in M1 
In the current study, we have shown KA and CCh induced theta and gamma oscillations 
simultaneously which is comparable to previous work in the lab. Delta oscillations are 
pharmacologically induced in layer V of Primary motor cortex (M1) by maintaining low 
cholinergic and low dopaminergic tone which is the characteristic feature in deep sleep 
stages and we have illustrated the transition from fast (gamma and theta) oscillations to 
slow (mu and beta) oscillations before a high amplitude delta rhythm emerged. Delta rhythm 
was characterised using various receptor modulators to determine the role of various 
receptors in the rhythm generation. Current study suggests that these delta oscillations are 
dependent on GABAR, AMPAR, KAR, mAChR and gap junctions but are independent of 
NMDAR. mGluRs do not seem to show much contribution to the generation of delta rhythm 
however mGluR agonists showed a general reduction in the activity whilst the antagonists 
showed an increase in the activity which is significant only in case of group l mGluR 
antagonists (MPEP & MTEP). These suggestions were based on the pharmacology 
performed using various receptor modulators and comparing them with control. 
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4.3.9 Final conclusions 
To our knowledge, this is the first demonstration of motor cortical delta oscillation in vitro 
and was identified to have a distinct mechanism to that of delta in secondary 
somatosensory/parietal area (S2/Par2) (also in vitro) (Carracedo et al., 2013). These 
extracellular studies could prove significant in investigating neuronal network oscillations in 
pathological states such as PD, AD by using animal models that can enable the comparison 
of mechanisms. Delta oscillations were induced by KA, CCh, D1 and D2 antagonists and 
are reliant on both inhibitory and excitatory network activity. AMPAR contribute to overall 
excitation of the cells, CCh to activate the cells and GABAR to the set the frequency similar 
to that of gamma oscillations except delta are found independent of NMDAR both in M1 and 
S1. Based on suggestion that cortical delta oscillations are generated in a use-dependent 
manner, in that the cortical circuits that are active during awake states generate these 
oscillations in the succeeding sleep (Kattler et al., 1994; Huber et al., 2004) and in a region 
specific way, implying a self-organising property of local neuronal networks (Krueger and 
Oba´l, 1993; Vassalli and Dijk, 2009; Vyazovskiy et al., 2011) reflecting previously prevalent 
gamma oscillations then become delta oscillations. Pharmacologically induced delta 
oscillations were found to be irreversible since the frequency of the oscillations had not 
changed when pharmacologically equivalent awake state was maintained possibly due to 
experimental limitations. A slice preparation with both cortex and thalamus preserved and 
also using various wake promoting compounds such as caffeine, adenosine, and orexin 
would probably enable delta reversal. 
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5. Characterisation of delta oscillations in 
S1 and interaction between M1 and S1 at 
delta frequency. 
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5.1 Introduction 
In some studies (Werth et al., 1997; Finelli et al., 2001), the appearance of slow wave 
activity was found to follow an ascending pattern from anterior to posterior regions in 
cerebral cortex, with highest power in frontal areas. This was identified to be promising in 
the first NREM sleep suggesting a role of frontal regions such as M1 and S1 in sleep 
management. This was found to be evident in the vibratory stimulation study performed in 
awake state enhanced the power of delta oscillations in somatosensory cortex during the 
first cycle of sleep (Kattler et al., 1994) and gradually decreased in subsequent cycles. S1 
was chosen based on the fact that it is the primary source of sensory information in rats 
(Burwell et al., 1995). The term ‘primary’ is used to describe sensory cortex that receives 
unimodal input directly from the thalamus.   
Anatomical studies have shown that M1 receives input from S1 and thalamus (Zin-Ka-Leu, 
1998; Miyachi et al., 2005) and the highly reciprocal nature of functional connections 
between M1 and S1 have been demonstrated in an optimum plane sensorimotor slice 
preparation developed by Rocco et al., (2007). Similarly, studies using voltage-sensitive 
dye imaging (VSD) and anterograde and retrograde tracers or viral vectors provide strong 
evidence that sensory input and whisker movement are related in rats (Ferezou et al., 2007) 
and inactivation of S1 results in altered chewing (Lin et al., 1993; Hiraba et al., 2000), 
muscle contractions and motor co-ordination (Rothwell et al., 1982; Hikosaka et al., 1985, 
Johansson and Westling, 1984). These reports suggest the role of sensory input from S1 in 
modulating motor output from M1. Topographical organisation of S1 was found to be similar 
to that of M1 (Huffman and Krubitzer, 2001) and have close association with M1 via 
reciprocal connections. Axonal projections of LIII of S1 (otherwise known as area 3a) have 
been identified to terminate throughout the cortical column of M1 (Porter 1991, 1992, 1996; 
Porter and Sakamoto, 1988) by performing retrograde labelling studies. These studies have 
also revealed Lll and LVI of M1 send projections to S1 (Porter, 1991, 1993).  
Sensorimotor integration has been studied in vivo (Smith et al., 1983; Wannier et al., 1991) 
but this does not enable the full understanding of the pathways. However, sensorimotor 
slice preparation by Rocco et al., enables to investigate further on sensorimotor connections 
in vitro (Rocco et al., 2007). Detailed information and significance of M1 and S1 interactions 
were discussed in chapter 3 (section 3.3). 
This chapter deals with pharmacology of delta oscillations in LV of S1 and compared to 
delta oscillations in M1. To determine the origin of delta oscillations, various sagittal slice 
preparations were made (see Methods section 2.2 for details). Experiments in the first part 
(5.2) of this chapter was performed in LV of a sensorimotor slice (slice type A) with both 
regions and surroundings intact. The following section (5.3) utilised the various types of 
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slice preparation (as seen in Methods 2.2 section) with a view towards identifying whether 
M1 and S1 have their own delta rhythm generator or if one region was leading the other or 
if there was any thalamic dependence for rhythm generation.  
Previous studies on local circuits have suggested the existence of strong excitatory inputs 
to LV from other layers (Weiler et al., 2008; Yu et al., 2008; Anderson et al., 2010; Hooks 
et al., 2011). Based on the fact that high amplitude oscillations were recorded from layer V 
of M1 as shown in laminar studies (section 4.2.2) in 4th chapter as well as structural 
similarities (Huffman and Krubitzer, 2001), all experiments in this chapter were performed 
in deep layer (LV) of either M1 and/or S1.  
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5.2    Pharmacology of delta oscillations in S1 
5.2.1 Pharmacological induction of delta oscillations in LV of S1 
Primary somatosensory cortex (S1) is adjacent to primary motor cortex (M1) and shares 
structural similarities with it. Investigations were made to examine the ability of S1 to 
generate delta oscillations. All recordings in this chapter are made from LV of S1 unless 
otherwise stated. In the presence of KA (150 nM) and (10 µM), theta and gamma oscillations 
were induced (see chapter 3 for details). In the intact sensorimotor slice containing M1, S1 
and surrounding regions, a transition similar to that of in M1 was identified. When perfused 
with aCSF containing KA (150 nM), CCh (2 µM), SCH23390 (10 µM) and Haloperidol (10 
µM), fast oscillations, theta (6-11 Hz) and gamma (30-37 Hz) gradually shifted to slow 
oscillations: slow theta (5-7 Hz) and beta oscillations (25-30 Hz) before high amplitude delta 
oscillations (2-4 Hz, ~300 μV2, n=50) with a mean frequency of 3.2 ± 0.7 Hz emerged 
(figures 5.1, 5.2). 
Figure 5.1 Pharmacological induction and transition of theta-gamma to delta 
oscillations (2-4 Hz) in LV of S1 
(A) Representative extracellular voltage recordings of activity during development of delta
rhythm in SCH23390 & haloperidol. Gamma (30-40 Hz), beta (25-29 Hz), theta-1 (7-14 Hz),
theta-2 (5-7 Hz) and delta (1-4 Hz) oscillations (scale: 20 μV x 250 ms). (B) Power spectra
of oscillatory activity during application of SCH23390 & haloperidol at 30 min (dotted line)
and at 90 min (red line). Note how gamma-theta activity gradually shifted into beta and slow
theta (5-7 Hz) oscillations (dotted), before a high amplitude (20-400 µV2) delta rhythm (red)
emerged.
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Pharmacological studies were performed using various receptor modulators. Control for 
each recording was normalised to 100% and in experiments of this chapter, stable delta 
oscillations were characterised as showing no change noticed in frequency and amplitude 
over 20 min period. The effect of a drug was measured just after 40 min of bath application 
of the drug (unless otherwise stated) which was compared to control. 
 
Figure 5.2 Representative typical delta oscillation in LV of S1 (2-4 Hz) 
(A) Raw data of an example typical delta oscillation recorded from LV of S1 (scale: 50 μV x 
500 ms) (B) representative power spectrum of pharmacologically induced delta activity in 
‘sleep’ neuromodulatory state (low dopaminergic and low cholinergic tone). 
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5.2.2 Cholinergic modulation of delta oscillations in LV of S1 
To examine the effect of CCh was through muscarinic acetylcholine receptors, pirenzepine 
(PIR), an mAch antagonist was bath applied when oscillations were stable for 20 min. 10 
μM of PIR significantly decreased the peak delta power to 23 ± 1% of control (normalised 
to 100%) suggesting a role of mAch receptors in generation of delta oscillations in LV of S1 
as in M1 (n=8, p<0.001) (figure 5.3)  
 
 
Figure 5.3 Muscarinic receptor block decreases delta oscillatory power 
(A) Effect of pirenzepine (10 µM) on delta oscillations. (i) Raw data showing the changes in 
oscillatory activity before (black) and after (red) drug application (scale: 100 μV vs 500 ms). 
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak 
responses before (black) and after (red) PIR (iii) Bar graphs showing peak oscillatory power 
of oscillations before (grey) and after (red) drug application normalised to control. ** p<0.01, 
n=8. 
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5.2.3 GABAR modulation of delta oscillations in LV of S1 
To determine the involvement of inhibitory GABAR, a competitive GABAAR antagonist 
gabazine (GBZ) and a non-competitive channel blocker picrotoxin (PTX) were bath applied. 
Application of GBZ at 250nM and 2.5 μM significantly reduced the synaptic synchronous 
delta activity to 36.50 ± 3% and 22 ± 5% of control respectively (n=8, p<0.001) (figure 5.4A). 
5 μM of PTX significantly reduced the delta synchronous activity to 38 ± 5% of control (n=8, 
P<0.01) (figure 5.4B). 
Figure 5.4 GABAA receptor block decreases delta oscillatory power 
(A) Effect of gabazine (250 nM and 2.5 µM) on delta oscillations. (i) Raw data showing the
changes in oscillatory activity before (black) and after (red) 250 nM, 2.5 µM drug application
(scale: 60 μV vs 500 ms). (ii) Representative power spectra of 60s of extracellular recording
demonstrating peak responses before (black), after GBZ 250 nM (red) and GBZ 2.5 µM
(dashed line) (iii) Bar graphs showing peak oscillatory power of oscillations before (grey)
and after (red) drug application normalised to control. **p<0.01, n=8.
(B) Effect of picrotoxin (5 µM) on delta oscillations. (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 100 μV vs 500 ms).
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after picrotoxin (red) (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey) and after (red) drug application normalised to control.
**p<0.01, n=8.
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5.2.4 iGluR modulation of delta oscillations in LV of S1 
5.2.4.1 AMPAR modulation of delta oscillations 
The dependence of delta oscillations on AMPAR was investigated by using SYM2206, a 
specific AMPAR antagonist. Application of 20 μM of SYM2206 significantly desynchronised 
the delta activity. It reduced the power to 49 ± 4% of control (n=8, p<0.01) (figure 5.5A). 
Bath application of 25 μM CNQX, KAR/AMPAR antagonist significantly reduced the 
synchronous delta activity (figure 5.5B) to 40 ± 7% of control (n=8, P<0.01) revealing the 
role of both KA and AMPA receptors in generation of delta oscillations. 
Figure 5.5 AMPA receptor block decreases delta oscillatory power 
(A) Effect of SYM2206 (20 µM) on delta oscillations. (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 20 μV vs 500 ms).
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) SYM2206 (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey) and after (red) drug application normalised to control.
**p<0.01, n=8.
AMPA/kainate receptors block decreases delta oscillatory power 
(B) Effect of CNQX (25 µM) on delta oscillations. (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 50 μV vs 500 ms).
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) CNQX (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey) and after (red) drug application normalised to control. ***
p<0.001, n=8.
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5.2.4.2 NMDAR modulation of delta oscillations 
The role of NMDA receptors was tested using 2-AP5, a competitive NMDAR antagonist. 50 
μM 2-AP5 did not alter the delta peak (n=8, P>0.05) (figure 5.6) suggesting generation of 
delta oscillations does not require NMDA receptors, as obseverved in M1 (see chapter 4 for 
details). 
Figure 5.6 NMDA receptor block has no effect on delta oscillatory power 
(A) Effect of 2-AP5 (50 µM) on delta oscillations. (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 50 μV vs 500 ms).
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) DL-AP5 (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey) and after (red) drug application normalised to control. ns
p>0.05, n=8.
(B) Effect of MK801 (10 µM) on delta oscillations. (i) Raw data showing the changes in
oscillatory activity before (black) and after (red) drug application (scale: 50 μV vs 500 ms).
(ii) Representative power spectra of 60s of extracellular recording demonstrating peak
responses before (black) and after (red) MK801 (iii) Bar graphs showing peak oscillatory
power of oscillations before (grey) and after (red) drug application normalised to control. ns
p>0.05, n=8.
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5.2.5 Summary of results 
Pharmacology of delta oscillations in LV of S1 was summarised in table below 
Table 5.1 Pharmacology of delta oscillations in LV of S1 
Peak power changes after application of various receptor modulators is represented as 
mean ± SEM when compared to control (normalised to 100%). N= number of recordings 
(obtained from 3 different animals), significance: ns p>0.05, * p<0.05, **p<0.01, ***p<0.001. 
Drug  (concentration) % Change of 
Control 
N Significance 
pirenzepine (10 µM) [mAch 
antagonist] 
23 ± 0.5 8 *** 
gabazine (250 nM,2.5 µM) 
[GABAAR antagonist] 
36 ± 3, 22 ± 5 8 **,*** 
picrotoxin (5 µM) [GABAAR 
antagonist] 
38 ± 5 8 ** 
SYM2206 (20 µM) [AMPAR 
antagonist] 
49 ± 4 8 ** 
CNQX (25 µM) [KA/AMPAR 
antagonist] 
40 ± 7 8 ** 
AP-5 (50 µM) [NMDAR 
antagonist] 
N/A 8 ns 
MK 801 (10 µM) [NMDAR 
antagonist] 
N/A 8 ns 
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5.3  M1-S1 interactions at delta frequency 
In order to study interactions between M1 and S1, I used a series of sagittal brain slice 
preparations designated as slice type A-F, detailed in Methods (section 2.2). 
5.3.1 Correlation studies of delta oscillations in slice type A 
It was observed in the experiments of pharmacological induction of delta oscillations in the 
presence of KA (150 nM), CCh (2 µM), SCH23390 (10 µM) and haloperidol (10 µM) in LV 
of M1 and S1 that delta oscillations in S1 were time delayed to that of M1. Mean peak power 
of delta oscillations were plotted against time both in M1 and S1. This revealed a significant 
time delay of 19 ± 3 min in incidence of delta oscillations in S1 (n=8, p<0.01). A linear 
regression graph suggested that intercepts were different when compared M1 with S1 delta 
mean peak suggesting a significant delay in elevation (n=8, p<0.001) (figure 5.7). 
Figure 5.7 Development of delta oscillations in S1 is significantly time delayed with 
respect to delta in M1 in slice type A 
(A) A representative power spectrum representing the transition of fast oscillations (black)
to slow oscillations (dotted line) and to delta (red) oscillations in LV of M1 (B) in S1 (C)
graph comparing the mean delay in incidence of delta oscillations in M1 (black) to that of
S1 (red) (D) a linear regression graph showing significant difference in y-intercept
(elevation) between M1 (black) and S1 (red) with slopes being almost equal (n=8, p<0.01,
p<0.001).
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To further investigate this, correlation analysis was conducted in various slice types (refer 
methods section). In slice type A, Auto-correlation enabled to identify the signal as delta (2-
4 Hz) frequency in a given time (figures 5.8 A-B). Good correlation (correlation coefficient 
=0.5) of delta oscillations also existed between M1 and S1. However, delta oscillations in 
S1 were found to be phase lagged by 2.5 ± 0.6 ms with reference to M1 whilst delta in M1 
was preceded by 2.4 + 0.4 ms with reference to S1 (figures 5.8 C-D) suggesting the origin 
of delta oscillations to be M1. 
Figure 5.8 LV of M1 is the place of origin of the delta frequency activity in slice type 
A 
(A) auto-correlation analysis of delta oscillations in M1 (B) in S1 (C) cross-correlation
between M1/M1 (black) and S1/M1 (red) (D) cross-correlation between M1/M1(black) and
M1/S1 (red). Red dashed line represents the deviation from zero (black dashed line).
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5.3.2 Correlation studies of delta oscillations in slice type B 
To further investigate if the time delay in incidence and phase delay in correlation studies 
of delta in S1 suggested that M1 to be the origin, a cut was made between two regions. In 
slice type B, it was noticed that delta oscillations emerged in M1 but not in S1 in the 
presence of KA (150 nM), CCh (2 µM), SCH23390 (10 µM) and Haloperidol (10 µM). Auto 
correlation revealed the oscillations to be in delta range (2-4 Hz) in M1 but theta range (6-
11 Hz) in S1 suggesting there is no local delta rhythm generator in S1 (figure 5.9 A-D).  
Figure 5.9 M1 drives the oscillatory activity at delta frequency in S1 
(A) A representative power spectrum representing the transition of fast oscillations (black)
to slow oscillations (dotted line) and to delta (red) oscillations in LV of M1 (B) An example
power spectrum showing theta and gamma oscillations in the presence of KA and CCh
(black) and in the presence of SCH+HAL (red) (C) correlation analysis of delta oscillations
within M1 (D) correlation analysis revealed theta oscillations in S1. Note: there is no delta
in S1 in this slice type.
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5.3.3 Correlation studies of delta oscillations in slice type C 
To examine if M1 solely can generate delta oscillations, slice type C was used. In this type 
of slice delta was induced with a high power in the presence of KA (150 nM), CCh (2 µM), 
SCH23390 (10 µM) and Haloperidol (10 µM) which were stable for 2-3hrs. Auto and cross 
correlation suggested that the frequency was in delta range and a good correlation exists 
within two electrodes placed slightly apart in the same slice (correlation coefficient=0.7). 
Figure 5.10 LV of M1 is the place origin of delta oscillations in slice type C 
(A) A representative power spectrum of typical delta oscillation (4 Hz) in LV of M1 (B) auto
and cross correlation analysis of delta oscillations in M1 within LV of single slice.
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5.3.4 Correlation studies of delta oscillations in slice type D 
Experiments were performed on slice type D, however, there was no delta transition in the 
S1 only slice type in the presence KA (150 nM), CCh (2 µM), SCH23390 (10 µM) and 
Haloperidol (10 µM). Correlation analysis revealed theta frequency range (6-11) suggesting 
delta oscillations were driven by M1 in intact slice as shown above (figure 5.11). 
Figure 5.11 No transition to delta oscillations was found in S1 slice without M1 in 
slice type D. 
(A) An example power spectrum showing theta and gamma oscillations in the presence of
KA and CCh (black) and in the presence of SCH+HAL (red). (B) Correlation analysis of
revealed theta oscillations within S1. Note: there is no delta oscillations.
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5.3.5 Correlation studies of delta oscillations in slice type E 
To investigate if adjacent regions (other than M1 and S1) contribution is necessary for 
pharmacological induction of delta oscillations in M1 and S1, experiments were performed 
in slice type E (micro slice) in which both M1 and S1 are collectively isolated from 
neighbouring regions (see Methods section for details). In the presence KA (150 nM), CCh 
(2 µM), SCH23390 (10 µM) and Haloperidol (10 µM) delta oscillations were reliably induced 
both in M1 and S1 with again a slight delay in S1. However, the power and stability (1 hr) 
was much less than that was noticed in intact slices.  This is probably because of the many 
cuts that were made to obtain micro slice. Mean peak power was 40 ± 8 µV2 and 25 ± 10 
µV2 in M1 and S1 respectively. A good correlation existed (correlation coefficient=0.3) 
between two regions with a phase lag of 2.3 ± 0.8 ms in S1 with reference to M1 (figure 
5.12). 
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Figure 5.12 LV of M1 is the origin of delta oscillations and drives the activity in S1 in 
slice type E 
(A) An example power spectrum of delta oscillations in LV of M1 (B) in S1 (C) auto-
correlation analysis of delta oscillations in M1 and in (D) S1. (E) cross-correlation analysis
between M1/M1 (black) and S1/M1 (red) (F) cross correlation analysis between M1/M1
(black) and M1/S1 (red). Red dashed line represents the deviation from zero (black dashed
line).
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5.4 Discussion 
5.4.1 Mechanism of delta oscillations in S1 
No spontaneous activity was observed when recorded in S1 similar to that of in M1 and 
gamma oscillations were induced upon the application of KA and CCh. Interactions between 
M1 and S1 at theta and gamma frequency were detailed in chapter 3. Persistent delta 
oscillations were induced in LV of S1 by maintaining a low cholinergic and low dopaminergic 
tone as this was the precondition to induce delta in M1 (section 4.1). Pharmacology 
performed revealed the dependence of delta oscillations in S1 are dependent on GABAR, 
AMPAR, mAChR and KAR. Similar pharmacological profile to that of M1 was identified in 
S1 probably because M1 drives S1 at this frequency. AMPAR contribute to overall excitation 
of the cells, CCh to activate the cells and GABAR to the set the frequency similar to that of 
gamma oscillations except that delta are found independent of NMDAR both in M1 and S1. 
Based on the suggestion that cortical delta oscillations are generated in a use-dependent 
manner, in that the cortical circuits that are active during awake states generate these 
oscillations in the succeeding sleep (Kattler et al., 1994; Huber et al., 2004) and in a region 
specific way, implying a self-organising property of local neuronal networks (Krueger and 
Oba´l, 1993; Vassalli and Dijk, 2009; Vyazovskiy et al., 2011) reflecting previously prevalent 
gamma oscillations then become delta oscillations. However, delta oscillations in S1 
showed a significant delay in occurrence which lead to further cut/isolated region studies 
(discussed below).  
5.4.2 M1 and S1 interactions 
Functional connectivity between M1 and S1 has been reported.  Intra-cortical micro 
stimulation (ICMS) of S1 resulted in short latency and mono-synaptic EPSPs in cells that 
were present in M1 (Kosar et al., 1985). Experiments described above showed that M1 and 
S1 interactions facilitated the expression of delta in both regions, with M1 providing the drive 
and activity in S1 following, as evidenced by the clear delay between delta induction in S1 
when compared to M1 and the similarity of the S1 pharmacology to that in M1. Auto-
correlation studies in slice type A, reflected a high correlation within the region in a time 
series and revealed the signal obtained to be in delta frequency range. However, cross-
correlation studies revealed a phase lag in S1 when compared to M1 suggesting M1 to be 
a leading signal. This is in contrast to that of theta and gamma oscillations and beta 
oscillations in same regions. In an intact slice (slice type A), S1 seems to be the leading 
signal for both theta and gamma oscillations as there was a lag in M1 with reference to 
S1(section 3.3 for details). Although two signals were in near synchrony at beta frequency 
it was observed that desynchronisation first occurred in S1 and then followed by M1 upon 
the application of zolpidem (Prokic, 2011). It was reported that there were direct connections 
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between the two regions in rodents and cats (Asunama et al., 1982, Donoghue and Parham, 
1983; Porter and Sakamoto, 1988, Izraeli and Porter, 1995). To further explore this, a cut 
was made carefully between two regions and it was evident from the results obtained that 
M1 is be the source of origin of delta rhythm, since there is no occurrence of delta 
oscillations in S1 when separated from M1 by a cut. However, it was suspected that the 
origin of delta oscillations in M1 did involve neighbouring regions. It has been established 
that there are two pathways between S1 and M1 (intra-cortical) with one being direct and 
the other indirect via thalamus (Kaneko, 1994a, 1994b).To address this issue, a slice 
preparation (slice type C) with only M1, isolated from surrounding regions including S1 was 
recorded based on the fact that LTP in M1 of cats is induced by stimulation of M1 alone 
(Keller et al., 1990) independent on S1.  This type of slice has enabled delta induction 
proving M1 as the source of origin. Then recordings were made from slice type D in which 
only S1 was isolated, no activity was identified in contrast to that theta and gamma 
oscillations, as theta and gamma oscillations were induced in slice type C and D reflecting 
individual and independent rhythm generators at these frequencies (section 3.3 for details). 
Furthermore, a micro slice (slice type E) was prepared in which both M1 and S1 are 
collectively isolated from surrounding regions. Recordings from this type of slice has 
induced delta oscillations in both oscillations but the power was observed to be much lower 
compared to slice type A and also they were identified to be not persistent suggesting loss 
or damage of network connectivity due to several cuts made around the regions. It was 
possible to speculate that loss of M2 in this slice type could form the ground for this 
instability as there was evidence that optogenetic inhibition of inputs from M2 to M1/S1 had 
reduced the activity in behaving mice (Manita et al., 2015). The role of M2 in delta oscillation 
generation was not explored in our study due to practical limitations. 
The origin of delta oscillations from deep layers of M1 could mean that the retrograde and 
anterograde connections between two regions do not contribute to initiation of deep sleep 
states because M1 on its own had enabled the generation of delta oscillations. However, 
these connections may have a role in maintenance of delta oscillations since S1 followed 
M1 with a significant delay in intact slices (types A and E). The neuronal populations that 
were recruited for delta rhythm generation might be just resident in M1 and not in S1. For 
instance, betz cells were observed in layer V of M1 (Betz, 1894). These cells are unique in 
their morphology and may appear as both pyramidal and interneurons (Braak, 1976). Also, 
this fits with the idea of increasing power towards frontal parts of the brain (Werth et al., 
1997; Finelli et al., 2001). Based on this it is reasonable to say that M1 is the source of 
origin for delta oscillations. However, S1 seems to be a potential source of theta and gamma 
frequency, although both M1 and S1 have individual rhythm generators. Given that delta 
oscillations are assumed to be sub served by previously active gamma oscillations (Kattler 
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et al., 1994; Huber et al., 2004) in M1 however, this is not the case for S1 as it does not 
enable delta generation on an isolated slice preparation. 
Nevertheless, further histological and immuno-labelling studies to determine the types of 
cells and receptors that were involved in the generation of delta oscillations and functional 
connectivity between two regions would be beneficial to further address this issue. 
Preparing slices in different plane other than sagittal would preserve thalamus and /or M2, 
S2 besides M1 and S1 and would provide an opportunity to investigate the influence of 
thalamus (if any) in delta rhythm generation since cells present across all layers in M1 have 
been implicated in long-range projections (Peter and Jones, 1984). 
 
5.5 Final conclusions 
Delta oscillations in S1 are dependent on both inhibitory and excitatory networks similar to 
that of in M1 and in line with pharmacology of gamma oscillations suggesting previously 
prevalent gamma oscillations then become delta oscillation due to changes in 
concentrations of neuromodulators. A significant time delay in occurrence and phase lag 
that was observed in correlation studies performed in various slice preparations revealed 
M1 as the rhythm generator. Inability of S1 to generate delta oscillations on its own suggests 
that S1 follows M1 at delta frequency in intact slice.  
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6. Dopamine augments an inward current
in fast spiking interneurons in layer V of 
primary motor cortex  
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6.1 Introduction 
6.1.1 Dopamine (DA) 
In the current study, network activity in primary motor cortex (M1) has been shown to be 
powerfully modulated by DAR (see chapter 3) (Alexander et al., 1986; Ozkan et al., 2017; 
Johnson et al., 2017). These actions of dopamine almost certainly depend on DAR present 
within M1 itself. M1 and PFC (pre-frontal cortex) show similar laminar organisation of 
receptors (although M1 has fewer DAR than PFC (Lidow et al., 1989)) and D1-like DR are 
more abundant than D2-like DR in rat cortex (Boyson et al., 1986). The laminar distribution 
of both D1-like and D2-like receptors is found to correspond to the dopaminergic terminals 
in M1 which are predominantly in deep layers (LV and LVl) (Martes et al., 1985; Dawson et 
al., 1986; Descarries et al 1987; Raghanti et al., 2008; Vitrac et al., 2014). Many studies 
have studied the differential effects of DA on firing rate in various regions such as 
ventrobasal thalamus (Munsch et al., 2005; Yague et al., 2013) and was shown that DA did 
not affect action potential firing evoked by somatic current injection (Zhou and Hablitz, 1999; 
Gonzalez-Islas and Hablitz, 2001).  Some studies previously have indicated that in STN, 
firing rate of neurons was augmented upon DA administration (Mintz et al., 1986; Kreiss et 
al., 1996; Tofighy et al., 2003; Cragg et al., 2004; Loucif et al., 2008). While some studies 
suggest that DA mediated depolarisation in STN was via D2-like DR (Zhu et al., 2002; 
Tofighy et al., 2003), others suggest via D1-like DAR (Baufreton et al., 2003). DA regulation 
of various voltage-gated channels may reflect these diverse effects but firing rate has not 
been measured in our study.  
6.1.2 Interneurons (IN) 
Different types of interneurons with distinctive features have been identified in neocortex 
(Deuchars and Thomson, 1996; Thomson et al., 1996; Tamas et al., 1997; Kawaguchi and 
Kubota, 1997; Cauli et al., 1997) and hippocampus (Halasy et al., 1996; Miles et al., 1996; 
Klausberger et al., 2003, 2005). Although IN make up only a subset (10-20%) of the whole 
cell population (Benardo and Wong, 1995), they play a critical role in oscillatory neuronal 
activity in cortex (McBain and Fisahn. 2001). Post-synaptic pyramidal neurons that are 
present in peri-somatic region are the target sites for most FS cells in sensory and primary 
motor cortices (Kawaguchi and Kubota, 1997; Cauli et al., 1997; Yamawaki et al., 2008; 
Prokic et al., 2015). The peri-somatic region is defined as “that part of the plasma membrane 
including the proximal dendrites, the cell body and the axon initial segment” (Szabo et al., 
2010). These FS cells are thought to regulate overall pyramidal activity (Freund and Katona, 
2007) due to their ability to induce IPSCs with faster kinetics in conditions where excitatory 
synaptic inputs are abolished (Miles, 1990; Freund and Katona, 2007). FS cells that are 
characterised by rapid IPSC kinetics are suggested to be crucial for maintaining network 
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activity by regulating coherence and frequency in M1 (Bartos et al., 2001, 2002; Yamawaki 
et al., 2008; Prokic et al., 2015). 
6.1.3 DA and interneurons 
DA effects on FS interneurons have been shown to be mediated by PKA-dependent 
suppression of leak, inward rectifying, and depolarisation-activated K+ channels (Gorelova 
et al., 2002) and amplification of depolarising currents mediated by HCN channels 
(Gorelova et al., 2002; Trantham-Davidson et al., 2008; Wu and Hablitz, 2005). Additionally, 
many reports have indicated that DA modulates GABAAR. Pyramidal neurons localised in 
PFC have shown reduction in IPSCs via downregulation of D4 surface receptors (Seamans 
et al., 2001; Wang et al., 2002; Graziane et al., 2009). Additionally, recent studies have 
indicated that DA modulates tonic currents in various regions of brain (Aman et al., 2007; 
Yague et al., 2013; Liang et al., 2014) and may directly inhibit GABAAR (Hoerbelt et al., 
2015). These novel activities of DA may impel new definitions of dopaminergic signalling in 
the brain. Distinct types of cells express DAR with different combinations across the cortical 
layers (Wang et al., 2006). DA was reported to modulate the intrinsic excitability of both 
pyramidal cells and interneurons (reviews Seamans and Yang, 2004; Tritsch and Sabatini, 
2012). However, the modulatory effects on isolated cells and individual currents mediated 
by DA are often unclear due to complexity of network in which these cells are embedded, 
as well as the various types of receptors and signalling mechanisms.  
Here, we have determined to investigate the effect of DA on pyramidal cells and FS 
interneurons in LV of M1 slices using whole-cell voltage clamp recordings. FS cells were 
identified based on the morphological features as described by Prokic et al., (2015), based 
upon deep layer Betz cell-FS cell pairing.  
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6.2 Results 
All the experiments in this chapter are whole cell, voltage clamp recordings with a holding 
current of -70 mV performed in layer V of M1 unless otherwise indicated. FS interneurons 
and pyramidal neurons were patched and were identified by their shape and size. Slice type 
F (refer methods section) was used in these experiments. With the internal solution used in 
the experiments (see methods section for full composition), the reversal potential of Cl (ECl) 
was 0 mV; therefore, GABAA receptor-mediated currents (IPSCs) appeared inward as 
shown in results below. Tonic/inward current is measured by the change in the baseline 
after the drug application in relation to control. Whereas, phasic current was measured by 
changes in the amplitude and time difference of IPSCs (IEI) before and after drug 
application.  
6.2.1 GABAergic modulation of tonic and phasic currents in FS cells 
To investigate the role of GABAR in tonic and phasic inhibition in FS cells of LV of M1,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
bicuculline (Bic, 20 µM) a competitive GABAAR antagonist was bath applied. After drug 
application, both tonic and phasic components of inhibitory activity in FS cells were 
abolished suggesting constitutively active GABAergic inhibition in interneurons of LV of M1.  
Bic significantly decreased the holding current by 36.3 ± 6 pA (n=5, p<0.01).  Mean 
amplitude change was found to be 61.5 ± 2 pA and 1.71 ± 0.1 pA in control and after 
application of Bic respectively, (n=5, p<0.01) whilst the mean inter event interval (IEI) 
increased from 187.3 ± 19 ms to 2511.2 ± 403 ms (n=5, p<0.05) (figures 6.1, 6.2) suggesting 
the reduction in both Itonic and Iphasic. 
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Figure 6.1 Bicuculline (Bic 20 µM) decreases tonic inhibitory current in FS 
interneurons in LV of M1 
(A) Representative voltage clamp recording demonstrating the effect of Bic (scale: 50 pA,
1 min). Black horizontal line indicates the presence of drug in bath and dotted line indicates
the relative current shift from baseline (control). (B) Itonic before and after Bic application of
individual FS cells. (C) Pooled data of Itonic before (grey) and after (red) drug application
(n=5, p<0.01).
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Figure 6.2 Bicuculline (Bic 20 µM) decreases phasic inhibitory current in FS 
interneurons in LV of M1 
(A) (B) Representative voltage clamp recording from a FS cell demonstrating IPSCs before
(left) and after (right) drug application (scale: 100 pA, 200 ms) (C) bar graph (D) cumulative 
probability plot showing the effect of drug on amplitude (n=5, P<0.001) (E) bar graph (F) 
cumulative probability plot showing the effect of drug on inter event interval (IEI) (n=5, 
p>0.001).
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In order to confirm the actions of Bic were mediated solely by the GABAAR, we next 
examined the effects of picrotoxin (PTX), a non-competitive channel blocker GABAAR which 
acts by preventing the entry of Cl- ions into the neuron. PTX abolished both Itonic and Iphasic 
confirming GABA receptors significant role in this constitutively active tonic and phasic 
currents in FS cells in LV of M1. Mean decrease in holding current by PTX was 20 ± 6 pA 
(n=5, p<0.01). Decrease in the mean amplitude was found to be 46.5 ± 5 pA and 1.81 ± 0.2 
pA (n=5, p<0.01) and mean increase in IEI 137 ± 4 to 1790 ±214 (n=5, p>0.05, p<0.001 in 
control and in the presence of PTX respectively (figures 6.3, 6.4). 
 
 
Figure 6.3 Picrotoxin (PTX 50 µM) decreases tonic inhibitory current in FS 
interneurons in LV of M1 
(A) Representative voltage clamp recording demonstrating the effect of PTX (scale: 100 
pA, 1 min). Black horizontal line indicates the presence of drug in bath and dotted line 
indicates the relative current shift from baseline (control). (B) Itonic before and after PTX 
application of individual FS cells. (C) Pooled data of Itonic before (grey) and after (red) drug 
application (n=5, p<0.01). 
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Figure 6.4 Picrotoxin (PTX 50 µM) decreases phasic inhibitory current in FS 
interneurons in LV of M1 
(A) (B) Representative voltage clamp recording from a FS cell demonstrating IPSCs before
(left) and after (right) drug application (scale: 100 pA, 200 ms) (C) bar graph (D) cumulative
probability plot showing the effect of drug on amplitude (n=5, P<0.001) (E) bar graph (F)
cumulative probability plot showing the effect of drug on inter event interval (IEI) (n=5,
p>0.001).
181 
6.2.2 Dopaminergic modulation of currents in FS cells 
To determine the role of dopamine receptors on holding current (-70 mV), dopamine (DA) 
30 µM was bath applied. DA induced a slow inward current (IDA) which was reversed less 
than half upon wash. Mean increase in the holding current was -32 ± 11 pA from the 
baseline (n=5, p<0.05, p<0.01) in the presence of DA and was reduced to -11.5 ± 5 pA in 
wash (n=5, p<0.05). DA has shown no effect on both amplitude (41.7 ± 2 vs 39.4 ± 2) and 
IEI (174.4 ±4 vs 200 ± 5) of IPSCS (figure 6.5, 6.6).  
Figure 6.5 Dopamine (DA 30 µM) induces an inward current (IDA) in FS interneurons 
(A) Representative voltage clamp recording demonstrating the effect of DA (scale: 100 pA,
10 min) black horizontal lines indicates the presence of drug in bath and dotted line indicates
the relative current shift from baseline (control). (B) IDA before and after wash of individual
FS cells. (C) Pooled data of IDA before (grey) and after (red) wash (n=5, p<0.01, p<0.05).
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Figure 6.6 Dopamine (DA 30 µM) has no effect on phasic inhibition in FS interneurons 
in LV of M1 
(A) (B) Representative voltage clamp recording from a FS interneuron demonstrating IPSCs
before (left) and after (right) drug application (scale: 100 pA, 200 ms) (C) bar graph (D)
cumulative probability plot showing the effect of drug on amplitude (n=5, P>0.05). (E) Bar
graph (F) cumulative probability plot showing the effect of drug on inter event interval (IEI)
(n=5, p>0.05).
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To investigate whether IDA was mediated by GABAAR, Bic (20 µM) and PTX (50 µM) were 
bath applied. The holding current was reduced upon application of either Bic or PTX. Mean 
IDA of -34 ± 7 pA was reduced to -21 ± 3 pA and -18 ± 2 pA (when Bic (n=5, p<0.01) and 
PTX (n=5, p<0.05) were bath applied respectively) from baseline (control) (figures 6.7, 6.8). 
Figure 6.7 Bic decreased the holding current of IDA in FS cells 
(A) Representative voltage clamp recording demonstrating the effect of Bic (scale: 100 pA,
10 min) on IDA. Black horizontal lines indicate the presence of drug in bath and dotted line
indicates the relative current shift from baseline (control). (B) IDA before and after Bic of
individual FS cells. (C) Pooled data of IDA before (grey) and after (red) application of Bic
(n=5, p<0.01, p<0.01).
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Figure 6.8 PTX reduced the holding current of IDA in FS cells 
(A) Representative voltage clamp recording demonstrating the effect of PTX (scale: 100 
pA, 10 min) on IDA. Black horizontal lines indicate the presence of drug in bath and dotted 
line indicates the relative current shift from baseline (control). (B) IDA before and after PTX 
of individual FS cells. (C) Pooled data of IDA before (grey) and after (red) application of PTX 
(n=5, p<0.05, p<0.05). 
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The experiments with Bic and PTX suggested a significant component ( 20 pA)  of IDA was 
not mediated by GABAAR. To confirm this, Bic, was applied prior to DA to examine if DA 
still induced inward current or increased the holding current in the presence of the GABAAR 
blockade. It was observed that DA still induced an inward current. Under these conditions, 
Bic reduced the holding current by 26.2 ± 1 pA. From this new baseline, DA induce a current 
(IDA) of 13 ± 1 pA (n=5, p<0.01, p<0.05) confirming there is a non-GABAergic component in 
IDA (figures 6.9). 
 
 
 
Figure 6.9 IDA was induced in FS interneurons in the presence of Bic 
(A) Representative voltage clamp recording demonstrating the effect of IDA in the presence 
of Bic (scale: 100 pA, 10 min) on IDA. Black horizontal lines indicate the presence of drug in 
bath and dotted line indicates the relative current shift from baseline (control). (B) IDA before 
and after DA in the presence of Bic in individual FS cells. (C) Pooled data of IDA before 
(grey) and after (red) application DA in the presence of Bic (n=5, p<0.05, p<0.01). 
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Further investigations were made to uncover the role of D1 receptors IDA. D1 agonist, 
SKF38393 (10 µM) and antagonist, SCH23390, (2 µM) were bath applied. Both SKF38393 
and SCH23390 have no effect on Iphasic, as the amplitude (34 ± 1 vs 36 ± 1; 33.2 ± 0.9 vs 
30.3 ± 1.3) and IEI (227.6 ± 14 vs 231 ± 20; 237± 6.8 vs 250 ± 24) respectively, did not 
show any significant difference (figure 6.10, 6.11, 6.12). Please note that the raw data trace 
below implies a small change in holding current as well as IPSC amplitude but this was not 
found significant when data were pooled (n=5, p>0.05). 
 
 
Figure 6.10 D1 agonist and antagonist does not affect holding current in FS 
interneurons 
(A) Representative voltage clamp recording demonstrating the effect of D1R modulators 
(scale: 100 pA, 10 min) black horizontal lines indicates the presence of drug in bath and 
dotted line indicates the relative current shift from baseline (control). (B) Effect of D1R 
modulators on holding current of individual FS cells. (C) Pooled data of inward current in 
the presence of SKF38393 (grey) and SCH23390 (red) (n=5, p<0.01, p<0.05).  
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Figure 6.11 D1R agonist, SKF38390 has no effect on phasic inhibition in FS 
interneurons in LV of M1 
(A) (B) Representative voltage clamp recording from a FS interneuron demonstrating IPSCs 
before (left) and after (right) drug application (scale: 100 pA, 200 ms) (C) bar graph (D) 
cumulative probability plot showing the effect of drug on amplitude (n=5, P>0.05). E) Bar 
graph (F) cumulative probability plot showing the effect of drug on inter event interval (IEI) 
(n=5, p>0.05). 
 
188 
 
 
 
Figure 6.12 D1R antagonist, SCH23390 has no effect on phasic inhibition in FS 
interneurons in LV of M1 
(A) (B) Representative voltage clamp recording from a FS interneuron demonstrating IPSCs 
before (left) and after (right) drug application (scale: 100 pA, 200 ms) (C) bar graph (D) 
cumulative probability plot showing the effect of drug on amplitude (n=5, P>0.05). (E) Bar 
graph (F) cumulative probability plot showing the effect of drug on inter event interval (IEI) 
(n=5, p>0.05). 
 
 
 
 
 
189 
Since the role of D1 agonist and antagonist was found to be insignificant, the role of D2 
receptors were investigated. D2 agonist, quinpirole (10 µM) when bath applied induced an 
inward current by increasing holding current by -38 ± 6 pA (n=5, p<0.0.1) whilst D2 
antagonist significantly decreased the holding current by -13 ± 8 of control (n=5, p<0.01). 
Both quinpirole and sulpiride have shown no contributions to Iphasic as the amplitude (38 ± 
0.9 vs 30 ± 1.3; 38 ± 1.8 vs 34.5 ± 5) and IEI (142 ± 4.7 vs 161 ± 5.7; 150 ± 5.4 vs 160 ± 
5.9) respectively, did not show any significant differences (figures 6.13, 6.14, and 6.15). 
Figure 6.13 Quinpirole increased the holding current whilst sulpiride decreased it in 
FS interneurons 
(A) Representative voltage clamp recording demonstrating the effect of D2R modulators
(scale: 100 pA, 10 min) black horizontal lines indicates the presence of drug in bath and
dotted line indicates the relative current shift from baseline (control). (B) Effect of D2R
modulators on holding current of individual FS cells. (C) Pooled data of inward current in
the presence of quinpirole (grey) and sulpiride (red) (n=5, p<0.01, p<0.05).
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Figure 6.14 D2R agonist, quinpirole has shown no effect on phasic inhibition in FS 
interneurons in LV of M1 
(A) (B) Representative voltage clamp recording from a FS interneuron demonstrating IPSCs 
before (left) and after (right) drug application (scale: 100 pA, 200 ms) (C) bar graph (D) 
cumulative probability plot showing the effect of drug on amplitude (n=5, P>0.05). (E) Bar 
graph (F) cumulative probability plot showing the effect of drug on inter event interval (IEI) 
(n=5, p>0.05). 
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Figure 6.15 D2R antagonist, sulpiride has no effect on phasic inhibition in FS 
interneurons in LV of M1 
(A) (B) Representative voltage clamp recording from a FS interneuron demonstrating IPSCs 
before (left) and after (right) drug application (scale: 100 pA, 200 ms) (C) bar graph (D) 
cumulative probability plot showing the effect of drug on amplitude (n=5, P>0.05). (E) Bar 
graph (F) cumulative probability plot showing the effect of drug on inter event interval (IEI) 
(n=5, p>0.05). 
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6.2.3 Ih current modulation of IDA in FS cells in LV of M1 
IDA might be due to the activation of several types of ion channel, including TRP channels, 
Ih or tonic NMDAR currents besides D2-like DR. In order to investigate this, we first focused 
on Ih. To investigate if IDA was mediated via hyperpolarising current (Ih) of HCN channels, 
ZD7288 (30 µM), an Ih blocker was bath applied as soon as the slice was placed on the 
recording chamber. In the presence of ZD7288, DA induced inward current by increasing 
the holding current by -48 ± 20 pA. Subsequent addition of Bic decreased the holding 
current (n=5, p<0.05, p<0.01) suggesting IDA was Ih independent (figure 6.16). 
 
Figure 6.16 IDA in FS interneurons was independent of Ih channels 
(A) Representative voltage clamp recording demonstrating the effect of ZD7288 on IDA 
(scale: 100 pA, 10 min). Black horizontal lines indicate the presence of drug in bath and 
dotted line indicates the relative current shift from baseline (control). (B) IDA before and after 
Bic of individual FS cells. (C) Pooled data of IDA before (grey) and after (red) application of 
Bic (n=5, p<0.01, p<0.01) in the presence of Ih channel blocker. 
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6.2.4 TRPC modulation of tonic and phasic currents in FS cells 
Next, to uncover if TRP channels were involved in IDA, TRP channel antagonists 2-APB and 
SKF96365 were bath applied. Both drugs significantly decreased the holding current that 
was increased by DA. Mean amplitude of -26.4 ± 2 pA and -27.2 ± 7 pA were reduced to -
0.65 ± 1.8 pA and 1 ± 0.3 pA in the presence of 2-ABP and SKF96365 respectively, n= 5, 
p<0.01(figures 6.17, 6.19). However, none of them showed significant effect on Iphasic (n=5, 
p>0.05) (figures 6.18, 6.20). Please note that in the presence of TRPC antagonist holding
current was reduced slightly beyond baseline (control). 
Figure 6.17 Blockade of TRP channels by 2-ABP (100 µM) decrease holding current 
slightly beyond control. 
(A) Raw data of representative voltage clamp demonstrating the effect of SKF96365 on IDA 
(scale: 100 pA, 10 min) black horizontal lines indicate the presence of drug in bath and
dotted line indicates the relative shift from baseline (control). (B) Line graph showing the
effect of DA and SKF96365 on holding current of individual FS cells. (C) Bar graph
representing pooled data of IDA in control (black), DA (red), SKF96365 (grey) (n=5, p<0.01).
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Figure 6.18 2-ABP has no effect on phasic inhibition in FS interneurons in LV of M1 
(A) (B) Representative voltage clamp recording from a FS interneuron demonstrating IPSCs 
before (left) and after (right) drug application (scale: 100 pA, 200 ms) (C) bar graph (D) 
cumulative probability plot showing the effect of drug on amplitude (n=5, P>0.05). (E) Bar 
graph (F) cumulative probability plot showing the effect of drug on inter event interval (IEI) 
(n=5, p>0.05). 
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Figure 6.19 Blockade of TRP channels by SKF96365 (100 µM) decreases holding 
current slightly beyond baseline. 
(A) Raw data of representative voltage clamp demonstrating the effect of SKF96365 on IDA 
(scale: 100 pA, 10 min) black horizontal lines indicate the presence of drug in bath and 
dotted line indicates the relative shift from baseline (control). (B) Line graph showing the 
effect of DA and SKF96365 on holding current of individual FS cells. (C) Bar graph 
representing pooled data of IDA in control (black), DA (red), SKF96365 (grey) (n=5, p<0.01). 
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Figure 6.20 TRPC channel antagonist, SKF96365 has no effect on phasic inhibition in 
FS interneurons in LV of M1 
(A) (B) Representative voltage clamp recording from a FS interneuron demonstrating IPSCs
before (left) and after (right) drug application (scale: 100 pA, 200 ms) (C) bar graph (D)
cumulative probability plot showing the effect of drug on amplitude (n=5, P>0.05). (E) Bar
graph (F) cumulative probability plot showing the effect of drug on inter event interval (IEI)
(n=5, p>0.05).
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As of now, the results above showed that DA induced an inward current in FS cells. IDA was 
induced even in the presence of Bic but much smaller than with DA on its own. On the other 
hand, TRPC channel antagonist have shown a decrease in IDA almost to the level of baseline 
suggesting a significant role in IDA. Further investigation was made to determine if by 
blocking both GABAR and TRPC channels would decrease the holding current beyond 
baseline.  When slices were treated with both SKF96365 (100 µM) and Bic (20 µM), IDA was 
reversed more than 100% (control: -32 ± 9 pA to 33 ± 6 pA) which was significantly beyond 
control (n = 5, p<0.01 figure 6.21). This may suggest that all the tonic currents in FS cells 
are attributed to GABAR and DAR. 
 
 
 
Figure 6.21 SKF96365 and Bic decreases holding current much beyond the baseline 
in FS cells. 
(A) Representative voltage clamp recording demonstrating the effect SKF96365+Bic on IDA. 
Black horizontal lines indicate the presence of drug in bath and dotted line indicates the 
relative current shift from baseline (control). (B) Line graph indicating IDA in presence of 
SKF96365+Bic of individual FS cells. (C) Bar graph representing pooled data of IDA in 
control (black), DA (red), SKF96365+Bic (grey) (n=5, p<0.01) 
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6.2.5 Effect of DA on holding current of pyramidal cells in LV of M1. 
When treated slices with Bic (20 µM), pyramidal cells showed reduction in Itonic and Iphasic.  
Mean Itonic was 15 ± 0.8 pA (n=5, p<0.01). DA, however, did not show any influence on 
holding current in pyramidal cells (n=5, p>0.05) (figure 6.22). 
 
 
Figure 6.22 DA has no effect on holding current in pyramidal neurons in LV of M1 
(A) Representative voltage clamp recording from a pyramidal cell demonstrating the effect 
of DA and Bic (scale: 20 pA, 2 min) black horizontal line indicates the presence of drug in 
bath and dotted line indicates the relative current shift from baseline (control). (B) Effect of 
DA and Bic on holding current of individual pyramidal cells (C) pooled data of change sin 
holding current before (grey) and after (red, black) drugs application (n=5, p>0.05 p<0.01). 
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6.3 Discussion 
6.3.1 Itonic and Iphasic in FS cells and pyramidal cells in LV of M1 
The tonic activation of GABAAR was first reported in the voltage clamp recordings performed 
in cerebellar granule cells of rat (Kaneda et al., 1995). In their study, GABAAR antagonists, 
Bic and GBZ, abolished spontaneous IPSCs as well as decreased the holding current, 
which was used to clamp the cell at a given membrane potential. This holding current 
reduction could reflect the reduction of number of open receptors (Kaneda et al., 1995; 
Brickley et al., 1996; Tia et al., 1996; Wall and Usowicz, 1997). Several studies have shown 
Itonic in several regions of brain such as: granule cells of dentate gyrus (Nusser and Mody, 
2002), pyramidal neurons in LV of somatosensory cortex (Yamada et al., 2004), 
thalamocortical relay neurons of the ventral basal complex (Porcello et al., 2003), pyramidal 
neurons in CA1 (Bai et al., 2001) and certain interneurons in CA1 (Semyanov et al., 2003). 
Phasic receptor activation is the transient mode of GABA exposure to postsynaptic 
receptors which could indicate fast diffusion away from release site (Overstreet et al., 2003). 
Effective functioning of GABAAR requires binding of two GABA molecules (Baumann et al., 
2003) and the short dwell time may imply that not all the postsynaptic receptors are being 
occupied however, postsynaptic GABAR saturation may be observed in certain synapses. 
The occupancy extent varies with different synapses on different neurons and may even 
vary at synapses on a single neuron (Frerking et al., 1996; Nusser et al., 1997; Perrais et 
al., 1999; Hajos et al., 2000; Mozrzyymas et al. 2003). Phasic activation depends on various 
factors such as vesicle size and the amount of GABA in them, vesicle fusion type, synaptic 
cleft geometry, number and arrangement of GABA transporters. Governing time course and 
peak GABA concentration has enabled to study the occupancy as well as the channel 
opening, based on which kinetic properties of phasic receptor activation were established 
(Weiss et al., 1989; Twyman et al., 1990; Jones et al., 1995; Jayaraman et al., 1999; Haas 
et al., 1995; Burkat et al., 2001). 
FS cells in LV of M1 at holding current -70 mV exhibited a constitutively active Itonic and Iphasic 
when GABAAR antagonist, Bic, was bath applied. Since Bic is a competitive antagonist 
(Andrews and Johnston, 1979), PTX, a non-competitive antagonist (Krishek et al., 1996) 
which was known to block the pore of these ligand gated channels (Krishek et al., 1996; 
Thompson et al., 2010) was bath applied and revealed active Itonic and Iphasic similar to that 
of Bic. We found that Itonic in FS cells was found much higher than that was observed in 
pyramidal cells without any externally applied GABA (Scimemi et al., 2005) due to the 
differential regulation of GABA uptake as demonstrated in other studies (Semyanov et al., 
2003; Prokic et al., 2015).  
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6.3.2 DA induces an inward current (IDA) possibly mediated by D2-like receptors 
Bath application of DA has induced an inward current in FS cells. The holding current of IDA 
was reduced to a little extent on wash. 30 µM of DA was used throughout the experiments 
as this concentration has shown a maximum response in previous studies (Tofighy et al., 
2003; Loucif et al., 2008). Initially DA was co-applied with ascorbic acid (AA) to prevent DA 
oxidation.100 µM of AA was used given that this concentration does not affect IPSC kinetics 
(Yague et al., 2013). However, AA often damaged the cell in our study and hence, was not 
applied in subsequent experiments.  Oxidation of DA was identified by discolouration of the 
perfusing aCSF after 50 min of DA application. Since the time periods used in our study 
were less than the time required for DA oxidation, it was assumed that the inward current 
was mediated by DA prior to conversion into quinones and free radicals that causes neuro-
toxicity (Sulzer and Zecca, 2000).  This effect of DA on holding current contrasted with the 
work in ventrobasal thalamus (VB) of Wistar rats in which the D2R agonist quinpirole and 
the selective D4 agonist PD-168,077 strongly decreased GABAAR mediated inward current 
while D1R activation remained ineffective (Yague et al., 2013) which could mean the DA 
action is mediated by distinct mechanisms in various regions of brain. 
Application of Bic showed partial reduction in IDA. It is noteworthy that Itonic revealed by Bic in 
the experiments where DA was pre-applied was significantly smaller than in control 
suggesting the possible involvement of GABAergic as well as non-GABAergic component 
in IDA. Indeed, IDA was induced in the presence of GABAAR antagonist, Bic but IDA was much 
smaller in this case suggesting the involvement of GABAergic component in IDA. Blocking 
GABAergic transmission by GABAAR antagonist and blocking glutamatergic transmission 
by blocking KAR, AMPAR and NMDAR using CNQX and 2-AP5 (data not shown) had no 
effect on IDA reflecting the independency of synaptic transmission but a direct postsynaptic 
effect. IEM 1460 is known to block voltage dependent AMPAR, selective of GluA2 subunit 
lacking which are calcium permeable (Buldakova et al., 1999). This compound has shown 
a selective block on synaptic excitation of FS interneurons but not medium spiny pyramidal 
neuron in mouse striatum (Gittis et al., 2011) suggesting improvement in inhibitory 
functions. Therefore, all experiments were carried out with IEM 1460 in the internal solution 
(see methods for full composition). 
To determine the involvement of receptor subtype mechanisms in IDA, D1- and D2- like DR 
specific agonists and antagonists were bath applied. Interestingly, SKF38393 and 
subsequent application of SCH23390 did not show any significant effect on holding current. 
In contrast, quinpirole, a non-selective D2 like DAR agonist that binds to both D2 and D3 
receptors (Seeman and Van Tol, 1994) mimicked the effect of DA suggesting the actions of 
DA via D2 like receptors. To further confirm this, a non-selective D2 like receptor antagonist, 
sulpiride, which binds equally to both D2 and D3 receptors was administered (Seeman and 
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Van Tol, 1994). Sulpiride showed a significant reversal of Iquinpirole suggesting a major role of 
D2-like DAR in IDA in accordance with previous studies that reported that DA induced a slow 
membrane depolarisation or an inward current mediated via D2-like DAR in several other 
brain regions (Uchimura et al., 1986; Yang et al., 1991; Munsch et al., 2005).  
Several in vitro studies reported that DA enhances the intrinsic excitability of pyramidal 
neurons in PFC by decreasing the resting membrane potential or by elevating a long lasting 
increase in number of action potentials via depolarisation in conditions where synaptic 
contributions were eliminated by pharmacological manipulations (Penit-Soria et al., 1987; 
Yang and Seamans, 1996; Shi et al., 1997; Ceci et al., 1999; Lavin and Grace, 2001;  
Gulledge and Jaffe, 2001; Gao and Goldman-Rakic, 2003; Gulledge and Stuart, 2003; 
Wang and Goldman-Rakic, 2004; Kroener et al., 2009; Moore et al., 2011). One of the 
prominent effects of DA on pyramidal neurons is to increase in the frequency of 
spontaneous IPSCs and IPSPs indicating a net increase in GABAergic interneuron spiking 
activity mainly from PV-expressing FS basket and chandelier cells (Gulledge and Jaffe, 
2001; Kröner et al., 2007; Penit-Soria et al., 1987; Seamans et al., 2001b; Zhou and Hablitz, 
1999). In vitro studies have suggested that D1-like DR induce depolarisation and increased 
excitability of FS interneurons in PFC slices (Gao and Goldman-Rakic, 2003; Gao et al., 
2003; Gorelova et al., 2002; Kröner et al., 2007; Towers and Hestrin, 2008; Trantham-
Davidson et al., 2008; Zhou and Hablitz, 1999). On the other hand, D2-like DR have also 
been shown to promote excitability in FS interneurons (Tseng and O’Donnell, 2004; Wu and 
Hablitz, 2005). DA did not show any effect on IPSC amplitude and IEI in FS cells of LV in 
M1. None of the DR modulators or TRPC antagonists have influenced phasic currents. 
Please note that the traces presented in the results above belong to a single recording and 
the effect of a drug shown in an individual trace might not reflect in pooled data using 
statistical analysis. For example, TRPC antagonist, SKF96365, has shown no effect on 
amplitude and IEI of IPSCs in figure 6.19 but the IEI has seen to be decreased implying 
increases in IPSC events in figure 6.20. This could probably reflect various cell types 
surrounding FS cell that was recorded from and also various receptor subtypes expressed 
on the cell. Further cell type characterisation and interactions with neighbouring cells would 
be beneficial as well as increasing `n` numbers. Exploring IPSC shape and decay time of 
individual recordings would uncover interesting mechanisms. 
Additionally, DA has shown influence neither on holding current nor on IPSC amplitude and 
IEI in pyramidal cells holding at -70 mV in our study. In vivo studies in rats and cats revealed 
that pyramidal neuron activity was decreased upon administration of DA mediated via both 
D1 and D2-like DR (Awenowicz and Porter, 2002; Huda et al., 2001). Pyramidal neurons in 
PFC have displayed a low event frequency (Hajos et al., 2003). Vitrac et al., (2014) have 
reported that DA enhances event rate of pyramidal neurons via D2 –like DRs which is in 
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line with excitation effect pyramidal neuron in LV of adult mice PFC mediated by D2-like DR 
(Gee et al., 2012). However, DA has been reported to exhibit bi-directional modulation on 
PFC pyramidal neurons (Seamans et al., 2001). In their study, DA decreased the IPSC 
amplitude via D2-like DR in 2- 20 min time period with a subsequent increase in IPSC 
amplitude which was mediated via D1-like DR with 20-40 min after DA application. In our 
current study the drug effect was analysed after 20 min of DA application which means 
insufficient time was given to investigate bi-directional effect of DA on FS cells in LV of M1. 
Also, it is presently not known whether DA mediated effects on pyramidal cells are mediated 
by direct actions onto pyramidal cells or via modulations of interneurons. Hence, further 
exploration is required to study the DA effect on pyramidal-interneuron possibly via dual 
patching technique. 
6.3.3 DA mediated inward current (IDA) is independent on Ih in FS cells 
The inwardly rectifying hyperpolariaation-activated current (Ih) is mediated by the flow of 
Na+ and K+ ions via hyperpolarisation activated and cyclic nucleotide-gated channels (HCN), 
which open at potentials more negative than -50 mV and are classified as a non-specific 
cation conducting channels (Pape, 1996; Robinson & Siegelbaum, 2003; Biel et al. 2009; 
Shah et al., 2010). These channels (HCN1-4 subunits) are expressed in thalamic relay 
neurons (McCormick and Pape, 1990a; McCormick and Pape, 1990b), hippocampus, 
neocortex, brain stem (Moosmang et al., 1999; Notomi & Shigemoto, 2004). DA was 
implicated in modulating Ih in rat ventral tegmental neurons (Jiang et al., 1993), in 
interneurons in Ll of neocortex (Wu and Hablitz, 2005), in relay neurons in the dorsal 
geniculate nucleus (dLGN) Govindaiah and Cox, 2005). This is based on the fact that HCN 
channels are regulated by intracellular cyclic nucleotide levels (Chen et al., 2001) and 
dopamine receptor activation is known to alter intracellular cAMP levels (Missale et al., 
1998). To test the possibility of Ih in mediating effect on DA induced inward current, we have 
used a selective hyperpolarisation-activated cyclic nucleotide-gated channel antagonist, 
ZD7288. In the presence of ZD7288, application of DA still induced IDA suggesting IDA
independent of Ih. This finding is in line with study in neurons of subthalamic nucleus (STN) 
(Loucif et al., 2008). 
6.3.4 IDA was fully reversed by TRPC antagonists in FS cells 
The transient receptor potential canonical (TRPC) channels are widely distributed in the 
brain (Strubing et al., 2001; Riccio et al., 2002). TRPC is a family of 7 proteins (TRPC1-
TRPC7) that mediates a diverse group of non-selective cation currents (Harteneck et al., 
2000; Clapham et al., 2001). A study performed in dorsal raphe serotonin neurons has 
revealed the involvement of DA mediated depolarisation or inward current (Aman et al., 
2007). To test the possibility of activation of cation channels via DAR in FS interneurons in 
203 
LV of M1, we have investigated the effect of TRPC antagonists, 2APB and SKF96365 (Li 
et al., 1999; Clapham et al., 2001) on IDA. Both these drugs strongly reduced the amplitude 
of IDA even beyond the baseline when bath applied. Subsequent bath application of Bic has 
revealed further Itonic leading to further questions for future work. 
Evidence exists that activation of D2-like DAR in accumbens has induced an inward current 
by supressing a potassium conductance (Uchimura et al., 1986; Higashi et al., 1989). This 
may not be true in our case as the IPSC solution contained CsCl which blocks potassium 
channels but could be ruled out by investigating the ability of DA to induce inward current 
by using cesium gluconate based internal solution and in the presence of extracellular 
cesium which block most potassium channels. The current-voltage plots using current 
clamp technique would provide more clues about the relationship before and after DA 
application. The other possible way to confirm that IDA is mediated by cations is by replacing 
sodium chloride extracellular solution with choline chloride as shown in a study by Aman et 
al., 2006. In their study, reducing sodium levels have shown a reduction in amplitude of IDA 
as well as a negative shift of the reversal potential of IDA.  Moreover, the mechanism of IDA 
induction can be investigated by using several second messenger modulators (Gi 
inhibitors).  
There is growing evidence that DA modulates Itonic in various regions of brain like striatal 
medium spiny neurons (Janssen et al., 2009), ventrobasal thalamus (Yague et al., 2013) 
and medium spiny neurons (MSNs) of the nucleus accumbens (Maguire et al., 2014). In 
striatum, D1-like DR expressing MSNs display tonic current mediated by δ subunit 
containing GABAAR (Ade et al., 2008; Kirmse et al., 2008). Recent study has reported that 
DA directly modulates GABAAR that are present both synaptic and extra-synaptic sites 
(Hoerbelt et al., 2015). This could possibly be the case with FS interneurons in M1 in our 
study but further experiments are necessary to prove DA modulation of Itonic.  This could be 
examined by observing if DA induces any inward currents in the presence of both GABAR 
antagonist and TRPC antagonist. Also, there exists a definite need for specific drugs 
targeting subunit specific GABA-DA interactions. Besides examining an constitutively active 
DA currents, another interesting aspect to investigate in order to uncover the mechanisms 
of IDA is to investigate the effect of AMPH on holding current of whole cell recording as well 
as on IDA based on the evidence that DA release is augmented by AMPH (Daberkow et al., 
2013, see review Calipiri and Ferris, 2013). 
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6.3.5 Final conclusions 
Dopamine augmented an inward current in fast spiking interneurons in layer V of primary 
motor cortex via non-selective cation currents mediated by TRPC channels independent of 
Ih current via D2-like DAR. This suggests an absent role of D1-like DAR in IDA and this could 
be further investigated by bath application of DR antagonists to test if there are any 
constitutively active currents.  
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7 General discussions, conclusions 
and future work 
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Initial investigations in the lab (Yamawaki, 2008) using coronal sensorimotor slices that are 
obtained from decapitated animals using standard storage glucose-based aCSF and the 
cutting aCSF was sucrose-based which contained neuro-protectants such as indomethacin, 
a cyclooxygenase inhibitor. There was no spontaneous activity in these slices, however, 
bath application of KA (400 nM) and CCh (50 µM) (as used by Buhl et al., 1998) induced 
beta oscillations consistent with previous in-vivo studies (Murthy and Fetz, 1992; Baker et 
al., 1997; Jensen et al., 2005). Therefore, we have recently developed a novel slice 
preparation method (details in section 3.3) (Prokic et al., 2011) by adding ascorbate, taurine 
and NAC. Also, indomethacin, uric acid and ascorbic acid and aminoguanidine were added 
to modified aCSF as neuro-protectants which aided preservation of inhibitory neurons 
critical for maintenance of rhythmic network activity. We determined to use the same slice 
preparation to induce oscillatory activity and to explore rhythms generated in both M1 and 
S1 at varied frequency ranges, with a view to exploring potential interactions between M1 
and S1 in the functionally connected sagittal cortical slice. However, the mechanisms 
involved the usage of neuro-protectants have not been explored yet. 
Co-application of KA and CCh reliably induced theta and gamma oscillations in both M1 
and S1 which were stable for 3-4 hrs in line with other in vitro studies (Dickinson et al., 
2003). Basic pharmacology performed using various receptor modulators has revealed the 
contributions of GABAAR, NMDAR, AMPAR and DAR. Gamma oscillations were decreased 
by GABAAR antagonists (gabazine and picrotoxin) and also by AMAPAR antagonist 
(SYM2206), whilst increasing theta power in these cases. GABABR antagonist 
(CGP55845), GABA positive modulators such as diazepam, zolpidem, NMDAR antagonist 
(MK 801) and mGluR antagonists have shown an increase in both theta and gamma 
oscillations (Johnson et al., 2017). Theta and gamma oscillations were found reliant on gap 
junctions as the activity was abolished when carbenoxolone, a gap junction blocker was 
bath applied (Johnson et al., 2017) consistent with beta oscillations in M1 (Yamawaki et al., 
2008) and delta oscillations (chapter 4). Dependence of oscillatory activity on mAchR in M1 
is reflected by the fact that the induction of oscillatory activity requires CCh. (Johnson et al., 
2017) along with KA and was further demonstarted by bath application of mAchR 
antagonist. Atropine abolished both theta and gamma oscillations (Johnson et al., 2017) in 
consistent with various studies (Konopacki et al., 1987; Lukatch and MacIver, 1997; Buhl et 
al., 1998; Fisahn et al., 1998). 
Interactions between two different types of oscillations is defined as cross-frequency 
coupling (CFC). In the current study, PAC was performed between theta and gamma 
oscillations, with theta frequency (3 –10 Hz) as phase and gamma frequency (25-50 Hz) as 
amplitude that was driven by low frequency using a MATLAB script developed by Tort et 
al., 2010. PAC was performed on 60 s epochs of data in various slice types (refer methods 
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section) and was represented as Modulation Index (MI) which indicates the degree of 
coupling between the two oscillations. It is interesting to note that isolated M1 slice type 
shows high MI.  The presence of PV+ interneurons in deep layers of M1 could form the 
basis for high coupling in M1 based on the evidence that PV+ interneurons contribute to the 
generation and coupling of theta and gamma oscillations since selective removal of fast 
synaptic inhibition from PV+ cells using transgenic mouse protocols did not induce theta 
and gamma oscillations (Wulff et al., 2009). However, the extent of coupling varied with 
each slice. This is probably caused by biological differences such as viability of each slice, 
receptor expression, interneurons and pyramidal cell expression in each slice obtained 
daily. As each subtype fire at distinct patters (phase) each subtype of interneurons probably 
has a unique role in entraining nested rhythms in various regions. Hence, the need for 
further investigations is high in order to uncover possible mechanisms behind the coupling. 
The interlaminar (deep and superficial layers) synchrony within human cortex is linked to 
the degree of coupling between the theta and gamma oscillations (PAC) (MacGinn and 
Valiante, 2014) which needs further investigation in our slices. Also, pharmacological 
agents such as ketamine have been shown to influence PAC (Caixeta et al., 2013). 
Therefore, it is essential to perform PAC before and after various receptor modulators to 
identify how they are contributing PAC giving plenty of room for future work. Interestingly, 
human hippocampus and cortex exhibited different properties in that PAC in hippocampus 
was the strongest at the phase of slow theta band (2.5-5 Hz) and both low (35-70 Hz) and 
high gamma (70-130 Hz) whilst, the phase of high theta band (4-9 Hz) was preferred with 
low gamma exhibiting greater coupling in cortex (Lega et al., 2016). This observation may 
prove the difference of hippocampal theta oscillations between humans (< 5Hz) and rats (6-
12Hz) (Lega et al., 2012; Watrous et al., 2013; Jacobs et al., 2014) and may reflect the big 
brain size in humans. It would be beneficial to apply these frequency specific studies in the 
PAC data that was obtained in M1 and S1 of rat slices. 
Although much literature is documented the origin of delta oscillations (1-4 Hz) in thalamus 
(Amzica et al., 1992), relatively less is known about cortical based delta oscillations. A delta 
rhythm of purely cortical origin has been implicated in in vivo studies (Amzica and steriade, 
1998; Fell et al., 2002) but the mechanisms underlying were not as clear as those of 
thalamic origin (Pirchio et al., 1997; Hughes et al., 1999; 2002). A study has revealed that 
transition of NREM2 to NREM3&4 stages has required the neuromodulatory action of cortex 
itself but not thalamus (Krishnan et al., 2016).  We have assumed that the origin of delta 
oscillations could possibly be primary motor and sensory cortices with these regions being 
primary projection sites for thalamus, hence the term ‘primary’. A recent in vitro study has 
indicated delta oscillations in secondary somatosensory cortex/parietal area, S2/Par2 slices 
prepared from male Wistar rats (Carracedo et al., 2013). None of these studies have 
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indicated the mechanisms and origin of cortical delta rhythm probably because it is 
challenging to induce delta oscillations unlike gamma oscillations, which can be identified 
spontaneously or with minimal pharmacological manipulations. Anatomical studies have 
shown that M1 receives input from S1 and thalamus (Zin-Ka-Leu, 1998; Miyachi et al., 2005) 
and the highly reciprocal nature of functional connections between M1 and S1 have been 
demonstrated in an optimum plane sensorimotor slice preparation developed by Rocco et 
al., (2007). Sensorimotor integration has been studied in vivo (Smith et al., 1983; Wannier 
et al., 1991) but this does not enable a full understanding of the pathways.  
Delta oscillations are pharmacologically induced in layer V of M1 and S1 by maintaining low 
cholinergic and low dopaminergic tone which is the characteristic in deep sleep stages and 
we have illustrated the transition from fast (gamma and theta) oscillations to slow (mu and 
beta) oscillations before a high amplitude delta rhythm emerged. Delta rhythm was 
characterised using various receptor modulators to determine the role of various receptors 
in rhythm generation. The current study suggests that these delta oscillations in both 
regions are dependent on GABAR, AMPAR, KAR, mAChR and gap junctions but are 
independent of NMDAR. mGluR do not seem to show much contribution in generation of 
delta rhythm however mGluR agonists showed a general reduction in the activity whilst the 
antagonists showed an increase in the activity which is significant only in case of group l 
mGluR antagonists (MPEP & MTEP). These suggestions were based on pharmacology 
performed using various receptor modulators.  
Our current study (chapter 4 and 5) performed in LV of M1 and S1 demonstrates the 
generation of delta oscillations by pharmacological manipulations and investigates the 
contribution of various receptors involved in the rhythm generation and the pharmacological 
equivalent awake state. Characterisation of delta rhythm in control slice preparations may 
facilitate understanding of the mechanisms underlying various pathological conditions like 
Alzheimer’s disease. Further research may be extended to comparing to a disease model 
and also examine delta in other regions such as V1. However, further work on 
characterisation of cell types recruited in generation of delta oscillations using calcium 
imaging and optogenetic techniques, would enable a better understanding of the 
mechanistic origin of the rhythm. Expression of receptors, receptor subtypes and receptor 
subunit could be of a great benefit using immunochemical studies and two-photon 
microscopy studies so that live cells can be imaged for extended time periods in deep 
tissue.   The advantages of using two photon microscopy imaging technique are ther eis 
little damage to the surrounding tissue. Also, the contribution of various receptors could be 
confirmed using KO animal models. Additionally, it was believed LV to be the origin but this 
was not completely ruled out and it was evident that LVl has several cell types that could 
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contribute to rhythm generation. To address this tissue we should find a way to delineate 
LV and LVI and Grainger causality analysis might help address this issue. 
Topographic maps of both M1 and S1 are well established (Brooks et al., 1961, Woolsey 
1952, Li and Waters 1991) and interactions between these two regions are known to play 
critical roles in motor learning and control skills (Asanuma and Arissian, 1984; Asanuma 
and Pavlides, 1997).  The origin of delta oscillations from deep layers of M1 could mean 
that the retrograde and anterograde connections between the two regions do not contribute 
to initiation of deep sleep states. However, these connections may have a role in 
maintenance of delta oscillations since S1 followed M1 with a significant delay in intact slice 
(type A and E). The neuronal populations that were recruited for delta rhythm generation 
might be just resident in M1 and not in S1. For instance, betz cells were implicated in layer 
V of M1 (Betz, 1894). These cells are unique in their morphology and may appear as both 
pyramidal and interneurons (Braak, 1976). Based on this it is logical to say that M1 is the 
source of origin for delta oscillations. However, S1 has been identified to lead M1 at higher 
frequencies but both regions have individual rhythm generators. Nevertheless, further 
histological and immuno-labelling studies to determine the types of cells and receptor types 
that were involved in generation of delta oscillations and functional connectivity studies 
between two regions would be beneficial to further address this issue. Preparing slices in 
different plane other than sagittal would preserve thalamus and /or M2, S2 besides M1 and 
S1 and would provide an opportunity to investigate the influence of thalamus (if any) in 
delta, theta and gamma rhythm generation. Also, characterising cell types involved in each 
oscillation using optogenetic studies would give a better insight. Also, region specific 
stimulation studies may reveal the individual region contribution. Another way to look at is 
multi electrode recording which enables to examine the navigation pattern of oscillations 
between layers as well as between regions (for instance M1 and S1). Our current study is 
limited in terms of making cuts between regions during the experiments but if there is a 
secure way to perform cut, that would demonstrate the interaction between regions. 
In the current study, DA modulated network activity at delta, theta and gamma frequencies. 
D1-like DR are more abundant than D2-like DR in rat cortex. DA effects on FS interneurons 
have been identified to be mediated by PKA-dependent suppression of leak, inward 
rectifying, and depolarisation-activated two pore domain K+ channels (Gorelova et al., 2002) 
and amplification of depolarising currents mediated by HCN channels (via Gs)Gorelova et 
al., 2002; Trantham-Davidson et al., 2008; Wu and Hablitz, 2005). Additionally, many 
reports have indicated that DA modulates GABAAR. Here (chapter 6), we determined the 
effect of DA on pyramidal cells and FS interneurons in LV of M1 slices using voltage clamp, 
whole cell recordings. FS cells were identified as based on the morphological features as 
described by Prokic et al., (2015) and are known to be highly encountered in deep layers 
210 
forming Betz cell-FS cell pairing. Our investigations revealed that DA induced a slow inward 
current via non-specific cation TRPC channels. Morphological, functional and electrical 
properties of cell types in M1 needs further examination using whole cell voltage clamp as 
well as current clamp techniques. Since, Betz-FS cell pairing was observed in LV of M1, 
dual patch recordings would uncover the mechanistic insights on how one cell interacts with 
the other. Also, stimulation techniques may be incorporated to observe how one cell type 
impacts on another cell type. Additionally, there is growing evidence that DA modulates Itonic 
in various regions of brain. Given the link between Itonic and   delta subunit within extra 
synaptic GABA receptor complexes (Nusser et al., 1998), this can be addressed by using 
the delta subunit-selective agonist, THIP in the experiments. On an interesting note, D2 
mediated IDA could account for vhanges in thet and gamma oscillations when DA and 
amphetamine were bath applied. It will be interesting to see if the oscillations were 
modulated by TRPC antagonists. 
In conclusion, trans-cardial perfusion, sagittal slice preparation, modified aCSF solution as 
well as addition of neuro-protectants has greatly enhanced the slice viability. Co-application 
of KA and CCh induced persistent theta and gamma oscillations. These dual oscillations 
seem to have distinct mechanisms and were identified to be coupled from PAC analysis. 
However, the percentage of coupling varied in various types of slice preparations with high 
modulation index (MI) in M1 only slice followed by S1 only slice when compared to intact 
slice preparations. To our knowledge, this is the first demonstration of motor cortical delta 
oscillation in vitro which was identified to have a distinct mechanism in comparison with that 
of delta in secondary somatosensory/parietal area (S2/Par2) (also in vitro) (Carracedo et 
al., 2013) These extracellular studies could prove significant in investigating neuronal 
network oscillations in pathological states such as PD, AD by using animal models that can 
enable the comparison of mechanisms. Delta oscillations were induced by KA, CCh, D1 
and D2 antagonists and are reliant on both inhibitory and excitatory network activity. 
Pharmacologically induced delta oscillations were identified to be irreversible since the 
frequency of the oscillations had not changed when pharmacologically equivalent awake 
state was maintained possibly due to experimental limitations. This may imply the need 
other inhibitory input to reverse delta such as from thalamus. Therefore, a slice preparation 
with both cortex and thalamus preserved would probably enable delta reversal. Delta 
oscillations in S1 are dependent on both inhibitory and excitatory networks similar to that of 
in M1. A significant time delay in occurrence and phase lag that was observed in correlation 
studies performed in various slice preparations revealed M1 as the rhythm generator. 
Inability of S1 to generate delta oscillations on its own suggests that S1 follows M1 at delta 
frequency However, both M1 and S1 have local generators at nested theta and gamma 
band. Dopamine augmented an inward current in fast spiking interneurons in layer V of 
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primary motor cortex via non-selective cation currents mediated by TRPC channels 
independent on Ih current via D2-like DAR without affecting IPSC amplitude and IEI. 
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